Alternative isoform regulation in myotonic dystrophy by Wang, Eric T. (Eric Tzy-shi)
Alternative Isoform Regulation in Myotonic
Dystrophy
by
Eric T. Wang
B.A., Harvard University (2004)
Submitted to the Harvard-MIT Division of Health Sciences and
Technology
in partial fulfillment of the requirements for the degree of
Doctor of Philosophy in Medical Engineering and Medical Physics
at the
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
February 2012
© Massachusetts Institute of Technology 2012. All rights reserved.
A u th o r ..............................................................
Harvard-MIT Division of Health Sciences and Technology
January 13, 2012
C ertified b y ............ .............................................
Christopher B. Burge
Professor
Thesis Supervisor
Certified by.........................................
David E. Housman
Professor
Thesis Supervisor
A ccepted by . ... ......... ..................... .... ...............
Ram Sasikekharan
Director, Harvard-MIT Division of Health Sciences and Technology
2
Alternative Isoform Regulation in Myotonic Dystrophy
by
Eric T. Wang
Abstract
Myotonic dystrophy (DM) is the most common form of adult onset muscular dys-
trophy, affecting more than 1 in 8000 individuals globally. The symptoms of DM
are multi-systemic and include myotonia, severe muscle wasting, cardiac arrhyth-
mias, cataracts, gastrointestinal dysfunction, and cognitive deficits. DM is caused by
the expansion of CTG or CCTG repeat sequences expressed in noncoding portions of
RNA, which sequester or activate RNA splicing factor proteins, leading to widespread
deleterious changes in transcriptome isoform usage.
We developed a method for studying transcriptomes, RNAseq, which provides
a high resolution, digital inventory of gene and isoform expression. By applying
RNAseq to human tissues and cell lines, we discovered that essentially 92-94% of all
human genes are alternatively spliced, 86% of them with a minor isoform frequency
15% or more. We found that the majority of alternative splicing and alternative
polyadenylation and cleavage events are tissue-regulated, and that patterns of these
RNA processing events are strongly correlated across tissues, implicating protein
factors that may regulate both types of events.
We applied this method towards the goal of identifying transcriptome changes
occurring in DM, focusing on the Muscleblind-like (MBNL) family of RNA bind-
ing proteins, which are functionally inactivated by CUG or CCUG repeats. Using
RNAseq to profile tissues and cells depleted of MBNLs, we found that MBNL1 and
MBNL2 co-regulate hundreds of redundant targets. MBNL1 UV cross-linking and
immunoprecipitation, followed by sequencing (CLIPseq), was used to identify the in
vivo transcriptome-wide binding locations of MBNL1, and facilitated the construc-
tion of a context-dependent RNA map for MBNL1 splicing regulation. Extensive 3'
UTR binding of MBNL1 was found to localize mRNAs to membrane compartments
of mouse myoblasts, suggesting a new global function for MBNLs, and additional
mechanisms by which MBNL depletion can lead to DM symptoms.
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Chapter 1
Introduction
1.1 Overview
Myotonic Dystrophy (DM) is the most common form of adult onset muscular dystro-
phy and affects over 1 in 8000 people globally. The symptoms of DM include myotonia,
severe muscle wasting, cardiac arrhythmias, cataracts, gastrointestinal dysfunction,
and cognitive deficits (Harper 1979). The autosomal dominant disease is caused by
either CTG repeat expansions in the 3' UTR of the DMPK gene (DM1) (Brook et al.
1992; Mahadevan et al. 1992), or CCTG repeat expansions in the first intron of the
CNBP gene (DM2) (Liquori et al. 2001). A notable feature of DM is that it is an RNA
gain-of-function disease; while forming intranuclear foci, RNA repeats sequester and
activate splicing factors in trans, and cause global defects in RNA processing (Cooper
et al. 2009). Within this thesis, I describe my efforts towards establishing a system
by which these changes in RNA processing can be accurately measured, and its use
in understanding the functions of the Muscleblind-like (MBNL) family of splicing
factors, a set of proteins that are functionally depleted in DM and responsible for the
regulation of a number of molecular events perturbed in DM.
1.2. Background
1.2 Background
1.2.1 Myotonic dystrophy is an RNA gain-of-function dis-
ease
First formally described in 1909 by Hans Steinert, myotonic dystrophy, also known as
Steinert's Disease, has captured the attention of neurologists and geneticists through-
out history because the disease possesses several interesting yet puzzling features
(Harper 1979). It is a progressive, multi-systemic disease, and is dominantly inher-
ited. The hallmark symptom of DM is myotonia, or the inability to relax muscles after
contraction, and is often one of the first symptoms experienced by patients during
the first phenotypic onset of symptoms. Other symptoms include muscle wasting and
weakening, cardiac arrhythmias, smooth muscle dysfunction, cataracts, insulin resis-
tance, cognitive abnormalities, and hypersomnia. However, these symptoms occur
with such variable frequency among different patients that DM has been described
as "the most variable disease known to mankind". Perhaps the most consistently
observed feature of DM is the characteristic manner in which it affects younger gen-
erations of a DM-affected family more severely than older generations (Ashizawa et
al. 1992). This phenomena of genetic anticipation often produces a picture in which
parents and grandparents, having experienced minor DM symptoms, are formally di-
agnosed only after their children, in whom the repeat has expanded further, are born
with severe developmental defects. The repeat length-dependent age of onset (Harper
1979), also observed in other diseases such as Huntington's disease (Snell et al. 1993),
presented a mystery for disease pathogenesis, and was not explained until several
years after discovery of the causative disease locus.
The causative locus for type 1 DM was successfully mapped in 1992 by several
different research groups (Brook et al. 1992; Fu et al. 1992; Mahadevan et al. 1992);
the trinucleotide repeats were found to reside in the 3' untranslated region of a gene
on chromosome 19q13. This gene was named DMPK and studied for possible clues
that might reveal the molecular events leading to the myriad phenotypes observed
in DM patients. It was observed that protein levels of DMPK were reduced to ap-
proximately 50% of normal levels in DM patients, and therefore for several years it
was hypothesized that the cause of the DM phenotype was partly due to haploinsuf-
ficiency of the DMPK protein. DMPK null mice were created to test this hypothesis,
but while they exhibited a minor cardiac phenotype late in life, in general they did not
exhibit phenotypes characteristic of DM such as myotonia or muscle wasting (Reddy
et al. 1996). Studies investigating the molecular basis for DMPK haploinsufficiency
revealed important clues about DM pathogenesis. In particular, it was found that
measured levels of DMPK RNA depended critically on the procedure used to isolate
RNA; typical guanidium-based methods resulted in DMPK measurements ~2-fold
less than those obtained if treating RNA with proteinase K or ultracentrifugated
through a cesium chloride cushion (Davis et al. 1997). This finding was consistent
with the observation that the expanded repeats in DMPK formed insoluble nuclear
foci, visible upon in situ hybridization against CUG RNA (Taneja et al. 1995).
The discovery of a second type of DM, DM type 2, provided important evidence
that the pathological effects of the expanded repeats occur in trans rather than in cis.
DM2 patients were found to exhibit many symptoms of DM1, including myotonia,
cataracts, frontal balding, and insulin resistance. However, in contrast to DM1, the
pattern of skeletal muscle wasting in DM2 was found to proceed in a proximal to dis-
tal fashion. The causative locus in DM2 was found to be an expanded CCTG repeat
tract in the first intron of a completely different gene, CNBP, found on chromosome
3q21, suggesting that RNA expression of CTG-containing repeat sequence, the com-
monality between DM1 and DM2, could be causative of disease pathology (Liquori et
al. 2001). To formally test the hypothesis that expanded CUG repeats were causative
of DM, a mouse model was generated in which 250 CTG repeats were placed in the
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3' UTR of an unrelated gene, and driven by the human skeletal actin promoter, such
that it was expressed primarily in skeletal muscle (Mankodi et al. 2000). This mouse
(Human Skeletal Actin-Long Repeat, HSALR), indeed exhibited several DM pheno-
types, including myotonia, centralized muscle nuclei, and heterogeneous muscle fiber
cross sectional area. In parallel, proteins which bound the expanded repeat RNA
in a repeat length-dependent manner were biochemically purified and identified, us-
ing ultraviolet cross-linking and mass spectrometry approaches (Miller et al. 2000).
These proteins were found to be homologous to the highly conserved Muscleblind-like
(MBNL) family of RNA binding proteins, first identified in Drosophila (Begemann et
al. 1997). With the information that expanded CUG repeat expression is sufficient to
cause DM pathology, and that MBNL proteins bind CUG repeats, experiments were
performed to test the hypothesis that nuclear sequestration of MBNLs contributes
to DM phenotypes. An MBNL1 loss of function mouse was created, in which the
exon containing the translation initiation codon was deleted (Kanadia et al. 2003).
This mouse was found to exhibit myotonia, cataracts, and various muscle defects,
confirming that functional depletion of MBNL1 could lead to at least a subset of DM
phenotypes. Furthermore, at the molecular level, the alternative splicing patterns of
several mRNAs were found to be aberrantly regulated in mice lacking MBNL1, sug-
gesting that the cellular pool of MBNL1 protein available to regulate these targets was
perturbed by expression of expanded CUG repeats. To confirm that sequestration of
MBNLs in DM was responsible for its functional depletion, exogenous over-expression
of MBNL1 was attempted in the HSALR mouse model. Adenoviral-mediated over-
expression of MBNL1 protein -2-fold above endogenous protein levels was sufficient
to partially rescue myotonia (Kanadia et al. 2006). Over-expression of MBNL1 was
also sufficient to rescue aberrant alternative splicing patterns that were observed in
the CUG repeat-expressing mice, confirming that the regulation of these targets is
sensitive to the intracellular concentration of free MBNL1. These three major ex-
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periments, the creation and characterization of the HSALR mouse, the creation and
characterization of the MBNL1 knockout mouse, and over-expression of MBNL1 in
HSALR complete a loop of biochemical and genetic logic stating that a major portion
of DM pathology is caused by expanded CUG repeats which sequester MBNL proteins
in trans, leading to their functional depletion in cells and tissues, resulting in down-
stream molecular changes causative of DM symptoms. The repeat length-dependent
age of onset for DM could also be explained by MBNL depletion; greater numbers
of repeats, further expanded somatically during the lifetime of an individual (Wong
et al. 1995), lead to increased sequestration of MBNL, and a more severe phenotype
occurring at an earlier age.
In a separate line of investigation, it was observed that over-expression of CUG
repeats leads to the stabilization of another RNA-binding protein, CUGBP and ETR-
like 1 (CELFI) (Timchenko et al. 1996; Wang et al. 2007). CELF1 was previously
discovered to regulate a number of pre-mRNAs also observed to be aberrantly spliced
in DM, including cardiac troponin T exon 5 and insulin receptor exon 11 (Philips et al.
1998; Savkur et al. 2001). DM patient tissues and myoblasts contain -2-fold elevated
levels of CELF1 protein as compared to normal tissues, suggesting that CELF1 activa-
tion may lead to a cascade of MBNL1-independent cellular events responsible for other
DM symptoms. Using a combination of pharmacological and genetic approaches, it
was demonstrated that the stabilization of CELF1 protein in DM1 occurs through
hyperphosphorylation by members of the protein kinase C (PKC) family of signaling
molecules; these modifications to CELF1 lead to increased half-life, particularly in
the nucleus as compared to the cytoplasm (Kuyumcu-Martinez et al. 2007; Orengo
et al. 2008). Through unknown mechanisms, one or several isozymes of PKC are phos-
phorylated and activated by expression of the expanded CTG-containing DMPK 3'
UTR. Pharmacological inhibition of PKC successfully blocked the over-expression of
CELF1 in a separate mouse model of DM in which the 3' end of DMPK, with ex-
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panded CTG repeats, was over-expressed in heart (Wang et al. 2009). Furthermore,
while the MBNL knockout mouse does not exhibit muscle wasting, over-expression
of CELFI in skeletal muscle of mice does (Ward et al. 2010), and suggests that this
characteristic DM symptom is downstream of CELFI activation and independent of
MBNL1 depletion. This series of experiments suggested that hyperphosphorylation
of CELFI could be a critical event responsible for an MBNL-independent arm of
DM cellular pathology, and that CELF1-dependent RNA processing events may lie
proximal to the skeletal muscle wasting phenotype.
While sequestration of MBNLs and over-expression of CELFs have received the
greatest amount of attention from investigators in the DM field as pathways most
likely to be relevant to DM pathogenesis, a number of additional hypotheses for how
expanded repeats lead to DM symptoms have been proposed and investigated over
the past 19 years. These hypotheses include the epigenetic silencing of genes adjacent
to DMPK, including DMAHP and SIX5, via altered DNA structure (Thornton et al.
1997; Klesert et al. 1997), the sequestration of other RNA binding proteins (Kim
et al. 2005; Paul et al. 2006), transcription factor leaching (Ebralidze et al. 2004),
dysregulation of RNA stability and localization (Du et al. 2010; Adereth et al. 2005),
and aberrant translation of trinucleotide repeats (Zu et al. 2011). Some or all of these
pathways could be activated in DM patients; unclear is the extent to which each
pathway leads to the phenotypic consequences, and how it does so at the molecular
level. The complexity of DM pathogenesis motivates global, unbiased evaluations of
all the molecular changes that occur in response to expression of expanded repeats.
Several studies using this type of approach have already revealed valuable insights.
For example, the majority of splicing changes in the mouse expressing expanded CUG
repeats in skeletal muscle is reproduced in MBNL1 knockout mouse muscle, suggest-
ing that MBNL1 depletion accounts for most of the transcriptome changes observed
in the HSALR model (Du et al. 2010). While previous studies have primarily focused
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on splicing, additional types of RNA regulation, such as alternative cleavage and
polyadenylation, and regulation of RNA localization, may be perturbed in DM. Fur-
ther global studies which address these other areas and utilize other mouse models
and DM patient tissue samples should yield additional valuable insights which will
help identify the relevant pathways and molecular changes that cause DM pathogen-
esis, facilitating a greater understanding of DM and the development of therapeutic
interventions to treat its symptoms.
1.2.2 Regulation of mRNA in the transcriptome by a cis-
trans code
Normal function of numerous biological processes requires the proper regulation of
mRNA. This regulation is often achieved through interactions of cis elements found
in primary, secondary, or tertiary RNA sequence, with other trans-acting complexes
composed of protein and/or RNA components. These interactions can change the
abundance, sequence, and locations of mRNA in the cell, which in turn dictate
whether and where the mRNA is degraded, translated, or stored. The types of reg-
ulation most relevant to studies discussed in this thesis include pre-mRNA splicing,
cleavage and polyadenylation, message stability, and regulation of RNA localization.
Each of these processes involves a number of core and auxiliary factors, some of
which are only active in specific pre-mRNA or mRNA contexts and can exert varying
functions depending on how they interact with the RNA substrate.
Pre-mRNA splicing Pre-mRNA splicing is the process by which introns are re-
moved and exons are joined, via trans-esterification and ligation reactions, respec-
tively (Berget et al. 1977; Chow et al. 1977). For each intron being spliced, the core
spliceosomal factors U1 and U2 snRNPs, together with mBBP, bind to the 5' and 3'
splice sites of the intron (Lerner et al. 1980; Rogers and Wall 1980). The 2'-hydroxyl
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of the branch point attacks the phosphodiester bond of the 5' splice site, separating
the previous exon from a newly formed lariat structure. The free hydroxyl at the 3'
end of 5' splice site then attacks the phosphodiester bond of the 3' splice site, joining
the 5' splice site to the 3' splice site, and releasing the lariat (Wahl et al. 2009).
While this process occurs with high fidelity for constitutively spliced exons and
introns, the information found at true splice sites is insufficient for directing splicing
machinery to function at the appropriate locations (Lim and Burge 2001). Addi-
tional cis elements, exonic splicing silencers (ESS), exonic splicing enhancers (ESE),
intronic splicing silencers (ISS), and intronic splicing enhancers (ISE) perform the
important role of either enhancing weaker splice sites and suppressing decoy splice
sites (Black 1995; Fairbrother et al. 2004) These elements have been identified using
both computational and biochemical methods, and often form the binding sites for
the serine/arginine-rich (SR) proteins and heterogeneous nuclear ribonucleoproteins
(hnRNPs), which bind preferentially in exons and introns, respectively. These trans
factors bind to specific ESS, ESE, ISE, and ISS motifs to recruit or block core spliceo-
somal components, and their binding in different spatial orientation relative to splice
sites can produce different types of activity (Matlin et al. 2005).
Alternative splicing differs from constitutive splicing in that different pairs of
splice sites can be joined together in different tissues, cell types, or contexts, resulting
in the production of mRNAs with different exonic sequences. The different mRNA
isoforms produced by alternative splicing provide a means by which multiple mRNAs
and proteins with different properties can be produced from the same gene locus,
and are thought to significantly contribute to the diversity of the transcriptome and
proteome (Blencowe 2006). Alternative splicing can lead to exon skipping, alternative
3' or 5' splice site usage, the use of adjacent exons in a mutually exclusive manner, or
the use of distinct first or last exons. Like constitutive splicing, alternative splicing
is regulated by a complex cis-trans code, in which regulatory sequences or structures
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are bound by protein factors that can differ in their expression or activity in different
contexts (Matlin et al. 2005). Understanding the rules by which these protein factors
exert their functions is a fundamental goal in the study of RNA splicing, and RNA
biology.
Regulation of alternative splicing is particularly relevant in myotonic dystrophy
because the MBNL family of alternative splicing regulators is sequestered by expanded
RNA repeats, and functionally inactivated (Cooper et al. 2009). For example, MBNL1
normally represses the inclusion of exon 7a of the chloride channel 1 (CLCN1) pre-
mRNA, preventing the inclusion of a premature stop codon-containing exon (Mankodi
et al. 2002). This allows full length CLCN1 mRNA to be translated, leading to CLCN1
protein production and expression at the sarcolemma. Loss of MBNL1 activity leads
to exon 7a inclusion, degradation of CLCN1 mRNA by nonsense-mediated decay,
and loss of CLCN1 protein expression, leading to defective chloride ion transport and
myotonia symptoms. In contrast, MBNL1 normally activates the inclusion of insulin
receptor (IR) exon 11, but in myotonic dystrophy cells, exon 11 is aberrantly skipped,
leading to the increased production of a protein isoform of IR that is less responsive to
changes in glucose concentration (Savkur et al. 2001). From these two examples, it is
clear that both splicing repression and activation can be mediated by the interactions
between pre-mRNA and RNA binding proteins.
Regulation of mRNAs via 3' end processing A subset of alternative splicing
regulators have also been demonstrated to regulate processes occurring at the 3' ends
of messages (Maniatis and Reed 2002). Cis-elements encoding both stabilizing and
de-stabilizing elements recruit various RNA binding proteins, which can exert various
activities through binding to 3' UTRs. For example, CELF1 has been demonstrated
to destabilize messages via binding to GU-rich sequences in 3' UTRs, in the tumor
necrosis factor 3' UTR (Zhang et al. 2008; Lee et al. 2010) and perhaps many other 3'
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UTRs containing these sequences (Vlasova et al. 2008). While the precise mechanism
by which CELF1 binding leads to decreased mRNA half-life, one possibility is that
it recruits deadenylases that degrade the polyA tail, which normally protects the
mRNA from degradation by exonucleases. Other de-stabilizing elements include AU-
rich elements (Barreau et al. 2005), first discovered in 3' UTRs of cytokine mRNAs
(Caput et al. 1986), and microRNA sites, which serve as cis-elements that can recruit
~23 nucleotide-long mature microRNAs, products of cleavage by proteins Drosha (Lee
et al. 2003) and Dicer, in a manner dependent on base complementarity (Bartel 2004).
The microRNA-mRNA interaction leads to Argonaute protein-dependent recruitment
of the RNA-induced silencing complex, and subsequent degradation of the mRNA
via enhanced deadenylation (Lim et al. 2005), and/or reduced translation (Guo et al.
2010; Hendrickson et al. 2009; Selbach et al. 2008; Baek et al. 2008).
Regulation of other processes occurring at 3' ends of mRNAs, for example cleavage
and polyadenylation, can also influence the rate at which mature mRNA is produced
and the levels at which it is expressed. During cleavage and polyadenylation, cleavage
and polyadenylation specificity factor (CPSF) recognizes the consensus AAUAAA (or
similar) poly(A) signal sequence, and cleavage stimulating factor (CstF) recognizes a
U- or GU-rich downstream element. CPSF catalyzes the cleavage of pre-mRNA, and
collaborates with poly(A) polymerase and poly(A) binding protein to subsequently
adds a tail of adenosines to the cleaved substrate (Mandel et al. 2008). Enhanced
or decreased rates of assembly of these complexes can affect the efficiency of mRNA
maturation, and therefore gene expression levels for those mRNAs. For example, the
RNA binding protein hnRNP H has been demonstrated to enhance the efficiency of of
cleavage and polyadenylation through recruitment of poly(A) polymerase to 3' UTRs
to which it binds (Alkan et al. 2006).
Over half of all human genes contain multiple cleavage and polyadenylation sites
(Zhang et al. 2005), allowing the production of diverse 3' UTRs, which may con-
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fer distinct properties to their mRNAs. The selection of particular cleavage and
polyadenylation sites can be mediated by trans factors in a tissue-specific manner,
as has been shown for the RNA binding factor Nova2 (Licatalosi et al. 2008). When
binding within 30 nucleotides of the poly(A) signal sequence, Nova2 inhibits usage
of the site, likely through preventing formation of a functional 3' processing com-
plex. In contrast, when binding to distal elements, Nova2 enhances the usage of the
associated poly(A) site, potentially through antagonizing the action of other repres-
sive factors. Several dynamic biological processes, for example T-cell activation or
cancer progression and metastases, exhibit global changes in alternative cleavage and
polyadenylation (Sandberg et al. 2008; Mayr and Bartel 2009). During each of these
transformations, the majority of 3' UTRs are shortened, and it has been proposed
that this provides a means for these transcripts to avoid targeting by intracellular
degradative machinery, for example microRNAs, to enhance protein production ca-
pacity in conditions of high metabolic demand.
Subcellular localization of mRNA Yet another mode of regulation that can
occurs through the interaction of RNA binding proteins, often with 3' ends, is that
of RNA localization (Lecuyer et al. 2009). While the composition of mRNA is not
directly altered via differential localization, the decay or storage of the mRNA, and
subcellular locations of subsequently translated proteins can be drastically affected
by where the mRNA is transported. Localized RNA was first described for actin
mRNA in ascidian embryos (Jeffery et al. 1983), and since that time, proper mRNA
localization has been associated with cellular function in E. coli (Nevo-Dinur et al.
2011), S. cerevisiae (Bertrand et al. 1998), Drosophila (Gavis and Lehmann 1994;
Kugler and Lasko 2009), and mammalian systems (Lawrence and Singer 1986). ASHI
mRNA is localized to the budding tip in dividing yeast, and its mis-localization leads
to a loss of mate type switching. Localization of bicoid, oskar, and nanos mRNAs in
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Drosophila are critical for the establishment of polarity during embryo development
(Gavis and Lehmann 1994; Kugler and Lasko 2009). The proper localization of /-
-actin to the leading edge of motile fibroblasts is required for efficient synthesis of
F-actin at the cell periphery, responsible for generating the forces necessary to propel
a cell forward along a surface (Shestakova et al. 2001). A recent global study of over
six thousand Drosophila mRNAs in embryos suggest that the majority of mRNAs are
distributed in a non-uniform pattern, and that these patterns are linked to function
(Lecuyer et al. 2007).
RNA localization has been demonstrated to be mediated through 3' UTR se-
quences or structures that allow their recognition by trans factors, which act as
adaptors to facilitate their transport along cytoskeletal filaments by molecular motors
(Kislauskis et al. 1994). For example, #-actin mRNA contains a CACCC "zipcode"
sequence, which is recognized by Zipcode-Binding Protein (ZBP), and subsequently
interacts with an actin-myosin motor complex which carries cargo to the periphery
of the cell (Ross et al. 1997). The role of RNA binding proteins in the regulation of
RNA localization still largely remains to be explored, and the elucidation of a cis-trans
code for RNA localization will require the integrated use of molecular, biochemical,
cellular, and image-based techniques.
1.2.3 Methods to assay the transcriptome
Similar to the DM field, approaches to assess the transcriptome have undergone rapid
evolution over the past 19 years. Around the same time that the gene for DM1 was
successfully identified, dbEST, a database for expressed sequence tags (ESTs), was
established as a division of GenBank at the National Center for Biotechnology Infor-
mation (NCBI) (Adams et al. 1991). These tags, short subclones of cDNA sequence
isolated from biological material, have been used to identify gene transcripts and
gene structures. When mapped to particular loci in in sufficient quantities, ESTs
1.2. BackgroundChap~ter 1. Introduction
have been used to make quantitative inferences about transcript isoform abundances.
Similarly, the first use of Serial Analysis of Gene Expression (SAGE) was published
in 1995 (Velculescu et al. 1995); SAGE also employs census methods to quantitate
the number of transcript fragments sampled, sequenced, and therefore present in a
biological sample. The primary difference between SAGE and EST approaches is the
length of RNA insert sequenced; SAGE tags are typically created by concatemerizing
fragmented RNA and therefore are much shorter, allowing for increased sequencing
depth of overall shorter tags. Commonly used for cancer samples, SAGE provided a
quantitative metric for transcript abundance, and foreshadowed the advent of deep
sequencing approaches for assaying transcriptomes.
Both SAGE and EST sequencing approaches were limited in depth by cost consid-
erations, and a technology that was pioneered much earlier but not popularized until
SAGE was established was complementary cDNA microarrays (Schena et al. 1995).
Comprised of spotted DNA clusters on a glass slide, microarrays facilitated the bind-
ing of RNA or cDNA to individual spots whose identities could be recorded and
mapped back to specific transcripts or transcript isoforms. The extent of binding of
dye-labeled RNA or cDNA to particular spots was demonstrated to be proportional
to the starting amount present in a biological sample, and therefore quantitative,
transcriptome-scale measurements were made routinely using this technology. Sig-
nificant efforts were put forth to standardize the production, use, and interpretation
of transcriptome measurements using microarrays, and as a result this technology
has partly fueled a revolution in biology and its relationship to computation. While
microarrays catalyzed a cultural transition in the psyche of many biologists, they suf-
fered from a number of technical drawbacks, including cross-hybridization of probes
with similar sequence and poor dynamic range. A decade or so of widespread "ana-
log" microarray usage by many laboratories around the world paved the way for
a digital revolution, in which sequencing census methods reminiscent of EST and
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SAGE approaches provided high resolution information at greater throughput and
lower cost.
The digital revolution in transcriptomics has been made possible by a Moore's
Law-like phenomenon in which the cost of sequencing has decreased exponentially at
least over the past decade (Mardis 2008), accelerating in the past 5 years or so with
the advent of so-called "next-generation" sequencing technologies. Miniaturization
of sequencing reactions has allowed millions of assays in parallel, using quantities
of enzymes and substrates similar to before, but harnessing advances primarily in
imaging and optics. High throughput sequencing of DNA fragments, from DNA
samples or RNA samples converted to DNA libraries, has made possible the true
application of digital census methods in the characterization and quantitation of
transcript and isoform abundancies. Its application to specific biological problems is
discussed extensively in this thesis, particularly in Chapter 2.
High throughput sequencing has thus been applied not only to studying the tran-
scriptome, but to studying trans factors which interact with the transcriptome. Bio-
chemical techniques can be used to purify subsets of nucleic acid which interact with
DNA- or RNA- binding proteins, with which deep sequencing libraries can be pre-
pared. One technique that will be described in Chapter 3, Appendix A, and Appendix
B is ultraviolet (UV) cross-linking and immunoprecipitation (CLIP), a procedure
which relies on the ability of UV irradiation to cause covalent cross-linking between
protein and nucleic acid interacting within Angstrom distances (Ule et al. 2005). UV
cross-linking of these interactions in live cells, followed by cell lysis and immuno-
capture of proteins of interest, enables the preparation of deep sequencing libraries
which reveal the transcriptome-wide binding locations of an RNA binding protein,
and valuable clues about its function (Licatalosi et al. 2008).
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1.3 Goals and Organization
My goals for this thesis were to develop a method for assaying the transcriptome with
high resolution and accuracy, and apply it towards questions about myotonic dystro-
phy. Chapter 2 describes work in which I characterized the use of high-throughput
sequencing for assaying transcriptomes (RNAseq), and demonstrates its utility in
studying the regulation of alternative isoforms between various human tissues and cell
lines. Chapter 3 describes work in which RNAseq and other sequencing approaches
were used to characterize the cellular activities of the Muscleblind-like family of RNA
binding proteins, the major protein family whose activity is perturbed in myotonic
dystrophy. The approaches I describe in this thesis embody a model I have chosen
in the larger endeavor to comprehensively survey the DM transcriptome and under-
stand the rules by which proteins dysregulated in DM perform their normal cellular
functions. The completion of this goal is beyond the scope of this thesis, but in the
conclusion chapter, I describe next steps that must be taken to fulfill that goal in its
entirety.
Appendix A contains a publication building on the findings described in Chapter
2, and further characterizes differences between different tissue transcriptomes and
their implications for the organization of biological systems. Appendix B contains a
publication describing the context-dependent functions of the RNA-binding protein
hnRNP H, in which my first efforts with CLIP produced data informative about the
binding locations and function of hnRNP H. Appendix C contains a publication in
which a method for computing posterior distributions of alternative isoform usage
under a Bayesian mixture model was developed, and describes additional context-
dependent functions of hnRNP H in regulating alternative cleavage and polyadenyla-
tion, and also describes our experiments characterizing the strengths and weaknesses
of paired-end RNAseq libraries for analysis of the transcriptome. Appendix D con-
tains a publication in which a subset of RNA processing events regulated during the
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differentiation of myoblasts into myotubes is studied, to characterize their temporal
behavior and identify trans factors that may mediate their regulation. Appendix E
contains supplementary information for Chapter 2, and Appendix F contains supple-
mentary information for Chapter 3.
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Chapter 2
Alternative Isoform Regulation in
Tissue Transcriptomes
Abstract
Through alternative processing of pre-messenger RNAs, individual mammalian genes
often produce multiple mRNA and protein isoforms that may have related, distinct
or even opposing functions. Here we report an in-depth analysis of 15 diverse human
tissue and cell line transcriptomes on the basis of deep sequencing of complementary
DNA fragments, yielding a digital inventory of gene and mRNA isoform expression.
Analyses in which sequence reads are mapped to exon-exon junctions indicated that
92-94% of human genes undergo alternative splicing, 86% with a minor isoform fre-
quency of 15% or more. Differences in isoform-specific read densities indicated that
most alternative splicing and alternative cleavage and polyadenylation events vary
between tissues, whereas variation between individuals was approximately twofold
to threefold less common. Extreme or "switch-like" regulation of splicing between
tissues was associated with increased sequence conservation in regulatory regions and
with generation of full-length open reading frames. Patterns of alternative splicing
and alternative cleavage and polyadenylation were strongly correlated across tissues,
suggesting coordinated regulation of these processes, and sequence conservation of
a subset of known regulatory motifs in both alternative introns and 3' untranslated
regions suggested common involvement of specific factors in tissue-level regulation of
both splicing and polyadenylation.
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2.1 Introduction
The mRNA and protein isoforms produced by alternative processing of primary RNA
transcripts may differ in structure, function, localization or other properties (Black
1995; Matlin et al. 2005). Alternative splicing in particular is known to affect more
than half of all human genes, and has been proposed as a primary driver of the evolu-
tion of phenotypic complexity in mammals (Lander et al. 2001; Johnson et al. 2003).
However, assessment of the extent of differences in mRNA isoform expression between
tissues has presented substantial technical challenges (Blencowe 2006). Studies using
expressed sequence tags have yielded relatively low estimates of tissue specificity, but
have limited statistical power to detect differences in isoform levels (Xu et al. 2002;
Gupta et al. 2004; Yeo et al. 2004). Microarray analyses have achieved more consis-
tent coverage of tissues (Sugnet et al. 2006), but are constrained in their ability to
distinguish closely related mRNA isoforms. High-throughput sequencing technologies
have the potential to circumvent these limitations by generating high average coverage
of mRNAs across tissues while using direct sequencing rather than hybridization to
distinguish and quantify mRNA isoforms (Mortazavi et al. 2008; Sultan et al. 2008).
Tissue-specific alternative splicing is usually regulated by a combination of tissue-
specific and ubiquitously expressed RNA-binding factors that interact with cis-acting
RNA elements to influence spliceosome assembly at nearby splice sites (Black 1995;
Matlin et al. 2005). Many factors can both activate and repress splicing in different
contexts, with activity often summarizable by an "RNA map" describing dependence
on the location of binding relative to that of core spliceosomal components (Ule et al.
2006; Wang et al. 2006).
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2.2 Results
A digital inventory of mRNA isoforms To assess gene and alternative mRNA
isoform expression, the mRNASeq protocol (Supplementary Methods) was used to
amplify and sequence between 12 million and 29 million 32-base-pair (bp) cDNA
fragments from ten diverse human tissues and five mammary epithelial or breast
cancer cell lines, generating over 400 million reads in total (Supplementary Fig. la).
Tissue samples were derived from single anonymous unrelated individuals of both
sexes; for one tissue, cerebellar cortex, samples from six unrelated men were analysed
to assess variation between individuals (Supplementary Table 1). In total, -60% of
reads mapped uniquely to the genome, allowing up to 2 mismatches, and an additional
4% mapped uniquely to splice junctions. Thus, about two-thirds of reads could be
assigned unambiguously to individual genes; the frequency of mapping to incorrect
genomic locations was estimated to be -0.1% (Supplementary Table 2).
Read density (coverage) was over 100-fold higher in exons than in introns or inter-
genic regions (Supplementary Fig. 1c), and only -3% of reads mapped to ribosomal
RNA genes, indicating that most reads derived from mature mRNA. Comparison of
relative mRNA-Seq read densities to published quantitative polymerase chain reac-
tion with reverse transcription (RT-PCR) measurements for 787 genes in two reference
RNA samples (MAQC Consortium et al. 2006) yielded a nearly linear relationship
across -5 orders of magnitude (Supplementary Fig. 1d), indicating that mRNA-Seq
read counts give accurate relative gene expression measurements across a very broad
dynamic range (Mortazavi et al. 2008).
Alternative splicing is nearly universal The mRNA-Seq data were used to
assess the expression of alternative transcript isoforms in human genes, as illustrated
for the mitochondrial phosphate transporter gene SLC25A3 in Fig. 2-la. Exons 3A
and 3B of this gene are "mutually exclusive exons" (MXEs), meaning that transcripts
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from this gene contain one or the other of these exons, but not both. Much greater
read coverage of exon 3A was seen in heart and skeletal muscle, with almost exclusive
coverage of exon 3B in testes and liver (as well as in other tissues studied), consistent
with the predominant heart and muscle symptoms of exon 3A mutation (Mayr et al.
2007).
The genome-wide extent of alternative splicing was assessed by searching against
known and putative splicing junctions using stringent criteria that required each
alternative isoform to be supported by multiple independent splice junction reads
with different alignment start positions. Binning the multi-exon genes in the RefSeq
database (94% of all RefSeq genes) by read coverage and fitting to a sigmoid curve
enabled estimation of the asymptotic fraction of alternatively spliced genes in this set
as ~98% when excluding cell line data (Supplementary Fig. 2) and -100% when using
all samples (Fig. 2-1b). This analysis indicated that alternative splicing is essentially
universal in human multi-exon genes, which comprise 94% of genes overall, with the
important qualification that a portion of detected alternative splicing events may
represent allele-specific splicing (Graveley 2008; Nembaware et al. 2004).
Some of these events may involve exclusively low frequency alternatively spliced
isoforms. However, 92% of multi-exon genes were estimated to undergo alternative
splicing when considering only events for which the relative frequency of the minor
(less abundant) isoform exceeded 15% in one or more samples (Fig. 2-1). Thus, 0.92 x
0.94 or -86% of human genes were estimated to produce appreciable levels of two or
more distinct populations of mRNA isoforms. Conversely, no evidence of alternative
splicing was detected in the 6% of RefSeq genes annotated as consisting of a single
exon, even when searching against junctions between predicted exons in these genes.
New exons and splice junctions not previously seen in transcript databases were
identified by mapping the reads against predicted exons and junctions. This approach
yielded a set of 1,413 high-confidence new exons (Supplementary Table 3), with an
estimated false discovery rate (FDR) of <1.5% (Supplementary Information), and
thousands of putative new splice junctions (not shown). Thus, mRNA-Seq has strong
potential for discovery of new exons, although very substantial read depth is required
to efficiently detect low abundance isoforms (Supplementary Fig. 3).
Tissue-specific isoform expression To explore the extent of tissue regulation of
alternative transcripts, we examined eight common types of "alternative transcript
events" (Black 1995; Matlin et al. 2005), each capable of producing multiple mRNA
isoforms from human genes through alternative splicing, alternative cleavage and
polyadenylation (APA) and/or alternative promoter usage (Fig. 2-2). Event types
considered included skipped exons and retained introns, in which a single exon or
intron is alternatively included or spliced out of the mature message, and MXEs, de-
scribed previously. Also included were alternative 5' splice site (A5SS) and alternative
3' splice site (A3SS) events, which are particularly difficult to interrogate by microar-
ray analysis because the variably included region is often quite small. Tandem 3'
untranslated regions (UTRs) and alternative last exons (ALEs), in which alternative
use of a pair of polyadenylation sites results in shorter or longer 3' UTR. isoforms or
in distinct terminal exons, respectively, were also considered. Finally, we considered
alternative first exons (AFEs), in which alternative promoter use results in mRNA
isoforms with distinct 5' UTRs.
For each of these event types, reads deriving from specific regions can support
the expression of one alternative isoform or the other (Fig. 2-2). The "inclusion
ratio", defined as the ratio of the number of "inclusion" (blue) reads to inclusion
plus "exclusion" (red) reads, can be used to detect changes in the proportions of the
corresponding mRNA isoforms. The fraction of mRNAs that contain an exon - the
"per cent spliced in" (PSI or ') value - can be estimated as the ratio of the density of
inclusion reads (that is, reads per position in regions supporting the inclusion isoform)
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to the sum of the densities of inclusion and exclusion reads.
To assess tissue-regulated alternative splicing, a comprehensive set of -105,000
events of these eight types was derived on the basis of available human cDNA and ex-
pressed sequence tag data. Reads supporting both alternative isoforms were observed
for more than one-third of these events (Fig. 2-2), and the extent of tissue-specific
regulation of these events was assessed by comparison of the inclusion ratio in each
tissue relative to the other tissues, requiring a minimum of a 10% absolute change in
inclusion ratio (Supplementary Fig. 4). Naturally, transcripts or isoforms identified
as being differentially expressed between tissues will reflect the combined effects of
cell-type-specific differences in transcript levels, variation in the relative abundances
of cell types between tissues, and variations between the individuals from whom the
tissues derived.
Notably, a high frequency of tissue-specific regulation was observed for each of
the eight event types, including over 60% of the analysed skipped exon, A5SS, A3SS
and tandem 3' UTR events (Fig. 2-2 and Supplementary Table 4). In all, a set of
over 22,000 tissue-specific alternative transcript events was identified, far exceeding
previous sets of tissue-specific alternative splicing events that have typically num-
bered in the hundreds to low thousands (Xu et al. 2002; Gupta et al. 2004; Yeo et
al. 2004; Sugnet et al. 2006; Pan et al. 2004; Xing and Lee 2005). Tissue-regulated
skipped exon and MXE events are listed in Supplementary Tables 5 and 6, respec-
tively. Binning events by expression level commonly yielded sigmoid curves for the
fraction of tissue-regulated events of each type, enabling estimation of the true fre-
quency of tissue regulation for each event type (Supplementary Figs 5 and 6). These
estimates, ranging from 52% to 80% (Fig. 2-2), indicated that most alternative splic-
ing events are regulated between tissues, providing an important element of support
for the hypothesis that alternative splicing is a principal contributor to the evolution
of phenotypic complexity in mammals.
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Individual-specific isoform expression To assess the extent of alternative splic-
ing isoform variation between individuals in comparison to tissue-regulated alterna-
tive splicing, the correlations among the vectors of inclusion ratios for all expressed
skipped exons between pairs of samples were determined (Fig. 2-3); this was per-
formed similarly for other event types (not shown). In this analysis, strong clustering
of the six cerebellar cortex samples was observed, with generally higher correlations
among these samples than between pairs representing distinct tissues. Strong cluster-
ing of the five cell lines was also observed. This probably results from a combination
of factors, including the common mammary epithelial origin of the cell lines studied,
similar adaptations to culture conditions, and the high diversity of the tissues chosen.
The extent of variation in alternative isoform expression between individuals was
also addressed by determining the number of differentially expressed exons among
the six cerebellar cortex samples. Using the same approach as in Fig. 2-2, between
10% and 30% of alternative transcript events showed individual-specific variation,
depending on the event type (Supplementary Fig. 7), providing updated estimates
of the scope of mRNA isoform variation between individuals (Graveley 2008). These
numbers are higher than estimates based on microarray analyses (Kwan et al. 2008),
but are in general agreement with an integrated analysis of multiple data types that
estimated that ~21% of alternatively spliced genes are affected by polymorphisms
that alter the relative abundances of alternative isoforms (Nembaware et al. 2004).
However, these frequencies are still below the 47-74% of events that showed variation
among the ten tissues (Fig. 2-2), and approximately twofold to threefold less than
the frequencies observed in comparisons among subsets of six tissues (Supplementary
Fig. 7), indicating that, although inter-individual variation is fairly common, it is
still substantially less frequent than variation between tissues. Thus, most of the dif-
ferences observed between tissue samples are likely to represent tissue-specific rather
than individual-specific variation.
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Switch-like alternatively spliced exons The quantitative nature of the mRNA-
Seq approach allowed assessment of both subtle and switch-like alternative splicing
events. By comparing inclusion levels of skipped exons between tissues, a class of
"switch-like" exons was observed that had markedly different inclusion levels between
different tissues (shown for heart versus nine other tissues in Fig. 2-4a). The examples
shown in colour in Fig. 2-4a (for example, TPM1 exon 2, with T of 2% in heart and
95% in skeletal muscle, and the SLC25A3 MXE pair shown in Fig. 2-la) underscore
the flexibility of the splicing regulatory machinery, with a sizeable number of exons
being recognized predominantly as exons in one tissue and predominantly as introns
in another tissue, even for developmentally related pairs of tissues such as heart and
skeletal muscle.
To characterize functional features of such switch-like exons, skipped exons and
MXEs were divided into groups depending on their "switch score", defined as the
maximum pairwise T difference between tissues. Switch scores for pairs of MXEs
were shifted towards higher values relative to skipped exons (P = 3.7 x 10--5, Kol-
mogorovSmirnov test; Fig. 2-4b), suggesting that MXEs are more often involved in
regulating highly tissue-specific functions. Preservation of the reading frame in both
isoforms was observed more commonly for exons with higher switch scores both for
skipped exons, consistent with ref. (Xing and Lee 2005), and to an even greater
extent for MXEs (Fig. 2-4c). Thus, switch-like regulation seems to be used prefer-
entially to express distinct "full-length" protein isoforms in different tissues rather
than as a means to switch off genes through production of truncated proteins or of
messages subject to nonsense-mediated mRNA decay (Lewis et al. 2003) . Indeed,
genes containing skipped exons with high switch scores were enriched for Gene Ontol-
ogy functional categories including "developmental processes", "cell communication",
"signal transduction" and "regulation of metabolism" that are likely to contribute to
fundamental differences in the biology of different human tissues (Supplementary
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Table 7).
Notably, skipped exons with switch scores exceeding 0.5 showed higher sequence
conservation in the regulated exon itself (Xing and Lee 2005) and in portions of the
flanking introns than exons with lower switch scores (Fig. 2-4d). This observation
suggested that such exons are of unusual biological importance and that switch-
like regulation between tissues requires the presence of additional splicing regulatory
sequence information, particularly in adjacent intronic regions.
FOX-1 and FOX-2 activity map Among the best-characterized tissue-specific
splicing factors are the FOX-i (also known as A2BP1) and FOX-2 (RBM9) proteins,
which bind RNA cis-elements that contain UGCAUG hexanucleotides or closely re-
lated sequences (Underwood et al. 2005; Auweter et al. 2006; Nakahata and Kawamoto
2005). Analysis of UGCAUG frequencies revealed substantial enrichment in the intron
immediately downstream of exons with increased inclusion in heart, skeletal muscle,
brain and cerebellar cortex (Fig. 2-4e) - tissues where FOX proteins are highly ex-
pressed, suggesting common splicing activation activity in this location (Underwood
et al. 2005; Auweter et al. 2006; Nakahata and Kawamoto 2005). Enrichment of UG-
CAUG hexanucleotides was also noted upstream of exons that had reduced inclusion
in skeletal muscle, suggesting possible repressive activity in this context. This ex-
ample illustrates the power of these expanded tissue-specific exon sets for inference
of "tissue RNA maps", summarizing both the location-dependent activity and tissue
specificity of splicing regulatory elements.
Applying a similar approach to analyse enrichment of all hexanucleotides in re-
gions adjacent to tissue-specific exons identified 362 motif/tissue enrichment patterns
(at an estimated 17% FDR), representing hexanucleotides that showed significant
enrichment adjacent to exons with increased or decreased inclusion in specific cell
lines or tissues (Supplementary Table 8). Enrichment of UGCAUG downstream of
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exons with high inclusion in skeletal muscle appears as the third most significant mo-
tif/tissue pair, after enrichment of UCUCUC and CUCUCU (resembling the binding
motifs of PTBP1 (also known as PTB) and PTBP2 (nPTB) (Oberstrass et al. 2005))
upstream of exons with increased inclusion in cerebellar cortex. The remaining mo-
tif/tissue pairs contained a variety of known regulatory elements, including ACUAAC
(see later), as well as putative new regulatory motifs.
Coordination of splicing and polyadenylation Tandem 3' UTR events showed
an even higher frequency of tissue-regulated expression than skipped exons or other
alternative splicing events studied (Fig. 2-2), yet little is known about how tissue
regulation of tandem UTRs is accomplished (for example, whether through APA or
through the differential stability of alternative UTR isoforms). By grouping tandem
3' UTRs by switch score, the most switch-like events showed increased sequence con-
servation relative to events with lower switch scores in the vicinity of and upstream of
the proximal (5') polyadenylation signal (PAS), and also upstream of the distal (3')
PAS (Fig. 2-5a). Whereas cis-regulatory elements contributing to differential stability
should be located predominantly in the region unique to the long UTR isoform, APA
could be regulated by elements located near to either or both PASs. The observation
of increased conservation around and upstream of the proximal PAS in switch-like
tandem UTRs therefore supports a primary role for regulation at the level of APA.
In assessing the spectrum of cis-elements that may drive tissue regulation of tan-
dem 3' UTRs, a set of heptanucleotides was identified that showed high conservation
in the extension region of tandem 3' UTRs (Fig. 2-5a, inset), with signal:background
ratios in four mammals (Lewis et al. 2005) exceeding 2:1. As expected, this set
included the extended (seven-base) seed matches to a number of conserved mam-
malian microRNAs (miRNAs) (Lewis et al. 2005; Xie et al. 2005; Majoros and Ohler
2007). Surprisingly, it also included all eight of the heptanucleotides that contain the
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FOX-1/FOX-2 consensus binding motif, UGCAUG: all such heptanucleotides had sig-
nal/background ratios above 2.5:1, exceeding the signal/background ratio observed
for seed matches to important miRNAs such as miR-7 and miR-181 (inset, Sup-
plementary Table 9). Strong conservation of UGCAUG motifs in this location (>1
kilobase on average from the nearest splice site) would not be expected on the basis
of the canonical splicing regulatory activity of FOX-1/FOX-2 proteins. Instead, the
high conservation observed in extended 3' UTR regions suggests that these factors (or
others with identical RNA-binding specificity) have additional 3' UTR-related roles,
for example, in APA or in mRNA localization and/or translation.
To investigate possible connections between tissue-specific regulation of alterna-
tive splicing and APA further, global patterns of tissue-specific alternative isoform
expression were compared. By applying singular value decomposition (SVD) (Sup-
plementary Methods) to the vectors of inclusion ratios across samples for each alter-
native splicing and APA event type separately, a strong and consistent separation
of the breast cell lines (four cancer-derived and one immortalized cell line) from all
tissue samples was observed (Fig. 2-5c, d). This separation implied the existence of
a systematic difference in RNA processing regulation between cell lines and tissues
that held for all types of alternative events studied. For most alternative splicing
and APA events, SVD analysis yielded similar groupings of tissues, for example, with
heart, skeletal muscle, brain and liver consistently clustered (Supplementary Fig. 8).
Consistent with this observation, pairwise distances between SVD projections for dif-
ferent types of alternative splicing events, for example, skipped exons, A5SS and A3SS
events, were all highly correlated (Fig. 2-5e), suggesting similarities in the regulatory
control of these types of events (Black 1995; Matlin et al. 2005; Wang et al. 2006).
More surprisingly, distances between SVD projections for tandem 3' UTR events also
correlated highly with distances for events controlled purely at the level of splicing
such as skipped exons (Fig. 2-5e). This observation raised the possibility that splicing
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and polyadenylation may be coordinately regulated across human tissues.
To explore possible regulatory connections between splicing and polyadenylation
regulation (for example, (Maniatis and Reed 2002; McCracken et al. 2002; Castelo-
Branco et al. 2004; Zhang et al. 2008)), the conservation of hexanucleotides adjacent
to conserved alternative splicing and APA events was compared. Whereas canonical
3' UTR regulatory motifs such as the consensus PAS hexanucleotide AAUAAA and
various miRNA seed matches showed high signal:background ratios, often 1.5:1 or
higher, in extended 3' UTR regions, these motifs generally had signal/background
ratios close to 1:1 in alternatively spliced introns. However, a distinct subset of mo-
tifs with high signal:background ratios in both UTRs and introns was also observed,
several of which corresponded to well-known splicing-related motifs (Fig. 2-5h and
Supplementary Table 9). This set included not only the FOX-1/FOX-2 motif UG-
CAUG and variations, consistent with the heptanucleotide analysis of Fig. 2-5a, but
also permutations of (CUG)n, which represent putative substrates of the bruno-like
(BRUNOL, also known as CELF) and muscleblind-like (MBNL) families of muscle-
and brain-specific splicing factors (Ladd and Cooper 2002) . The highly significant
signal:background ratio in both 3' UTRs and introns suggested that these well-known
splicing-related motifs also commonly have 3' UTR-related rolesfor example, control
of APA or of mRNA stability, localization or translationas recently demonstrated for
the NOVA family of splicing factors (Licatalosi et al. 2008) .
The hexanucleotide ACUAAC, an excellent match to the consensus binding mo-
tifs of STAR family RNA-binding factors, in particular quaking homologue (QKI)
(Galarneau and Richard 2005), was also notable. Not only did ACUAAC have signif-
icant signal:background ratio in 3' UTRs, as expected from the known role of QKI in
control of mRNA stability (Kim and Gorospe 2008), but it also showed an extremely
high signal:background ratio in introns, exceeding 7:1. This extreme conservation
suggested a common and important function in splicing regulationa role that has
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been suggested but not yet directly demonstrated (Sugnet et al. 2006; Wu et al.
2002). Motif enrichment analyses also suggested a possible role in brain-specific APA
regulation (Supplementary Fig. 9).
2.3 Discusssion
We conclude that the coordination between tissue-specific alternative splicing and
APA events implied by the correlated patterns of tissue bias observed in Fig. 2-5
may be mediated at least in part by tissue-specific RNA-binding factors that have
roles in regulation of both of these RNA processing steps. Such factors may include
both canonical tissue-specific splicing factors (for example, of the FOX-1/ FOX-2
and CELF families), moonlighting in 3' UTR-related roles, and also canonical UTR-
binding factors such as QK. Such functional duality has the potential to enable tightly
coordinated regulation of polyadenylation and splicing, ensuring that the appropriate
UTR regulatory sequences are expressed in conjunction with the coding regions for
the relevant tissue-specific protein isoforms.
2.4 Methods summary
Tissues and cell lines. Tissue samples from individual unrelated anonymous donors
(Supplementary Table 1) were obtained from Ambion for the following tissue types:
adipose, whole brain, breast, colon, heart, liver, lymph node, skeletal muscle and
testes. Cerebellar cortex samples were obtained from six anonymous unrelated donors,
according to NIH guidelines for confidentiality and privacy using protocols described
previously (Paz et al. 2006). HME is a human mammary epithelial cell line immor-
talized with human TERT (Elenbaas et al. 2001). The other cell lines are all breast
cancer cell lines derived from invasive ductal carcinomas (ATCC). MCF-7, BT474
and T47D are oestrogen-receptor- and progesterone-receptor-positive; MDA-MD435
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is negative for both.
Library preparation for Illumina sequencing. Poly-T capture beads were used
to isolate mRNA from 10 mg of total RNA. First-strand cDNA was generated using
random hexamer-primed reverse transcription, and subsequently used to generate
second-strand cDNA using RNase H and DNA polymerase. Sequencing adaptors
were ligated using the Illumina Genomic DNA sample prep kit. Fragments -200
bp long were isolated by gel electrophoresis, amplified by 16 cycles of PCR, and
sequenced on the Illumina Genome Analyser.
Computational analyses of mRNA-Seq read data. Computational and sta-
tistical methods used in analysis of the read data are described in the Supplementary
Methods. High-confidence new exons were required to be supported by at least one
splice juction read involving each splice site, and at least one exon body read; putative
new splice junctions required splice junction read support only (Pan et al. 2008).
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2.6 Figure Legends
Figure 2-1. Frequency and relative abundance of alternative splicing iso-
forms in human genes. a, mRNA-Seq reads mapping to a portion of the SLC25A3
gene locus. The number of mapped reads starting at each nucleotide position is dis-
played (log1O) for the tissues listed at the right. Arcs represent junctions detected by
splice junction reads. Bottom: exon/intron structures of representative transcripts
containing mutually exclusive exons 3A and 3B (GenBank accession numbers shown
at the right). b, Mean fraction of multi-exon genes with detected alternative splicing
in bins of 500 genes, grouped by total read count per gene. A gene was considered
as alternatively spliced if splice junction reads joining the same 5' splice site (5'SS)
to different 3' splice sites (3'SS) (with at least two independently mapping reads sup-
porting each junction), or joining the same 3'SS to different 5'SS, were observed. The
true extent of alternative splicing was estimated from the upper asymptote of the
best-fit sigmoid curve (red curve). Circles show the fraction of alternatively spliced
genes. c, Frequency of alternative splicing in the top bin (black bars) and after es-
timation (as in b, red bars), considering only events with relative expression of less
abundant (minor) splice variant exceeding a given threshold. Error bars, s.e.m.
Figure 2-2. Pervasive tissue-specific regulation of alternative mRNA iso-
forms. Rows represent the eight different alternative transcript event types dia-
grammed. Mapped reads supporting expression of upper isoform, lower isoform or
both isoforms are shown in blue, red and grey, respectively. Columns 14 show the
numbers of events of each type: (1) supported by cDNA and/or EST data; (2) with
>1 isoform supported by mRNA-Seq reads; (3) with both isoforms supported by
reads; and (4) events detected as tissue-regulated (Fisher's exact test) at an FDR
of 5% (assuming negligible technical variation1O). Columns 5 and 6 show: (5) the
observed percentage of events with both isoforms detected that were observed to be
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tissue-regulated; and (6) the estimated true percentage of tissue-regulated isoforms
after correction for power to detect tissue bias (Supplementary Fig. 6) and for the
FDR. For some event types, "common reads" (grey bars) were used in lieu of (for
tandem 3'UTR events) or in addition to "exclusion" reads for detection of changes in
isoform levels between tissues.
Figure 2-3. The extent of individual-specific differences in alternative iso-
form expression. Spearman correlations of inclusion ratios for skipped exons in
human tissues and cell lines (see Methods Summary). Correlations were computed
separately for each pair of tissues and cell lines, and clustered according to similarity
using average linkage hierarchical clustering.
Figure 2-4. Conservation and function of switch-like alternative splicing
exons. a, Scatter plot showing T values of skipped exons and MXEs for which
switch score was determined on the basis of comparison of heart (x-axis) with a
second tissue (y-axis). Exons with a switch score >0.5 are shown as filled symbols;
others are shown as small grey dots. b, Cumulative distribution functions of switch
scores for skipped exons and MXE pairs (P-value based on Kolmogorov-Smirnov test).
c, Reading frame preservation of skipped exons and MXEs grouped by switch score.
Skipped exons with lengths divisible by 3 and MXE pairs with lengths differing by 0
or a multiple of 3 were considered to preserve the reading frame. P-values are based
on Fisher's exact test. d, Conservation in skipped exon and flanking intron regions
grouped by skipped exon switch score. The mean per-position phastCons score (from
alignment of four mammalian genomes) and s.e.m. are shown. e, Enrichment of
UGCAUG motifs near tissue-regulated skipped exons. Coloured squares represent
-log1O(P-value) for the enrichment of UGCAUG counts relative to cohorts of control
hexanucleotides in regions surrounding skipped exons with significantly increased
(red) or decreased (blue) inclusion in each tissue with respect to other tissues.
Figure 2-5. Evidence for coordination between splicing and polyadeny-
lation. a, Mean and s.e.m. of per-position phastCons score in the region 300bp
upstream of proximal and distal cleavage sites for tandem 3'UTRs grouped by switch
score. Inset, increased conservation of FOX-1/FOX-2 motifs in tandem 3'UTR ex-
tension regions. All non-CpG-containing heptanucleotides (grey line), miRNA seed
matches (black), and 7-mers containing UGCAUG (red) are shown. b, SVD anal-
ysis of skipped exon inclusion ratio values across tissues and cell lines for skipped
exons meeting minimum read coverage criteria in each of the 14 samples. Projections
are shown in the dimensions corresponding to the two leading eigenvalues, which ac-
counted for 25% of the variance. c, SVD analysis of tandem UTR inclusion ratio values
(as in b). d, SVD analysis was conducted for the 14 samples on the basis of inclusion
ratio values for the five indicated alternative transcript event types or on the basis of
gene expression values. Spearman correlations between corresponding pairwise dis-
tances in projections of the sort shown in b and c are shown. e, Signal:background
(S:B) ratios of non-CpG-containing hexanucleotides in introns flanking skipped exons
(x-axis) and in extended 3'UTR regions (y-axis). The canonical PAS hexanucleotide
AAUAAA (black triangle), hexanucleotides corresponding to seed matches to con-
served mammalian miRNAs (black dots), hexanucleotides corresponding to binding
motifs for the indicated splicing or 3'UTR-binding factors (coloured), and other hex-
anucleotides (small gray dots) are shown.
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Chapter 3
Transcriptome Regulation by
MBNLs via Splicing and
Non-splicing Mechanisms
Abstract
The Muscleblind-like (MBNL) family of RNA binding proteins is a set of highly con-
served, developmentally regulated splicing factors that has been implicated in the
genetic disease Myotonic Dystrophy (DM). In DM, MBNL proteins are sequestered
by expanded CUG or CCUG repeats and functionally depleted, leading to decreased
MBNL activity in the cell and loss of regulation of their pre-mRNA targets. To
identify the genome-wide functional targets of these proteins, we assayed the tran-
scriptomes of brain, heart, and muscle from MBNL1 knockout mice, and the tran-
scriptomes of mouse myoblasts depleted of MBNL1, MBNL2, or both. To identify
the biophysical targets of MBNL1, we performed UV cross-linking, immunoprecipita-
tion, and sequencing (CLIPseq) of MBNL1-bound complexes in mouse brain, heart,
muscle, and mouse myoblasts. We identified hundreds of splicing events whose reg-
ulation is dependent on MBNL function, and observed that MBNL1 and MBNL2
likely co-regulate a large subset of targets. We constructed an RNA map for MBNL1
splicing regulation, demonstrating that in general, MBNLs activate splicing when
binding downstream of cassette exons, and repress splicing when binding upstream of
or within cassette exons. We observed extensive binding of MBNL1 in 3' untranslated
regions, and that the target mRNAs are enriched for integral membrane, extracellular
matrix, and synaptic proteins. Using subcellular fractionation approaches, we found
that in both mouse and fly cells, messages with evidence of MBNL 3' UTR bind-
ing are biased towards the membrane and insoluble cellular compartments, and that
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following MBNL depletion, their distribution is depleted from the membrane com-
partment. Similarly, 3' UTR isoform-specific regulation of mRNA localization was
observed in particular for messages with MBNL binding in 3' UTRs. Secretion assays
demonstrated that MBNL sequestration by over-expression of CUG repeats leads to
decreased secretion of proteins whose mRNA templates are bound by MBNL1. To-
gether, our analyses identify thousands of MBNL1 binding locations, large cohorts of
positively and negatively regulated targets, and reveal a general, conserved function
for MBNL1 binding of mRNA 3' UTRs.
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3.1 Introduction
Muscleblind-like (MBNL) proteins are a deeply conserved, developmentally regulated
family of RNA binding factors which have been implicated in the genetic disease
myotonic dystrophy (DM) (Begemann et al. 1997; Artero et al. 1998; Miller et al.
2000). There are 3 MBNL proteins in mammalian organisms, and 1 in fly, where it
was first discovered. In mouse and human, MBNL1 and MBNL2 are expressed across
many tissues, including brain, heart, and muscle, while MBNL3 is expressed primarily
in the placenta (Kanadia et al. 2003b; Fardaei et al. 2002; Squillace et al. 2002).
Mammalian MBNL proteins contain two pairs of highly conserved zinc fingers, which
can bind to pre-mRNA to regulate alternative splicing. In DM, MBNL proteins are
sequestered by expanded CUG or CCUG repeats, each of which forms a high affinity
substrate for binding, and titrated away from their normal RNA targets (Miller et al.
2000). Loss of MBNL activity in DM leads to changes in alternative splicing, which
mimics a reversal in developmentally regulated isoform usage (Lin et al. 2006).
The hypothesis that MBNL proteins are responsible for a large fraction of the
aberrant splicing patterns observed in DM has been strongly supported by a recent
study in which hundreds of splicing changes observed in a CUG-expressing mouse
model of DM were reproduced in a mouse model lacking functional MBNL1 protein
(Du et al. 2010). These results suggest that many of the downstream consequences of
expanded CUG repeat expression are MBNL-dependent. A key question remains as
to which events result from a direct loss of regulation by MBNLs.
To identify direct targets of MBNL1 splicing regulation, we performed RNA-seq on
brain, heart, and muscle tissue isolated from mice lacking functional MBNL1 protein
(Kanadia et al. 2003a), in conjunction with MBNL1 UV cross-linking and immuno-
precipitation (Ule et al. 2005), followed by deep sequencing (Licatalosi et al. 2008),
in the same tissues. To assess the extent to which MBNL1 and MBNL2 family mem-
bers may co-regulate shared targets, we also performed RNA-seq on C2C12 mouse
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myoblasts depleted of MBNL1, MBNL2, or both proteins, and MBNL1 CLIPseq in
myoblasts.
We generated a transcriptome-wide RNA map for MBNL-dependent splicing reg-
ulation, and identified high confidence sites for MBNL binding at nucleotide resolu-
tion. The observation that MBNL1 binds extensively to 3' UTRs of mRNAs encoding
membrane and synaptic proteins was consistent with previous observations that the
stability of ECM mRNAs is altered in response to MBNL sequestration, and led us
to uncover a widespread, conserved role for MBNLs in regulating RNA localization,
generalizing the role of MBNL2 in localizing the integrin a3 mRNA to the plasma
membrane. Our findings suggest that mechanisms independent of MBNL-dependent
splicing regulation can lead to molecular changes responsible for DM pathology.
3.2 Results
MBNL-dependent splicing regulation is dependent on aggregate levels of
MBNL proteins To identify the transcriptome-wide functional targets of MBNL1,
we performed RNA-Seq using RNA extracted from brain, heart, and we performed
RNA-seq using RNA extracted from brain, heart, and muscle of 4 month-old MBNL1AE 3/AE3
mice and age-matched control mice from the same background (129/SvJ). These mice
lack expression of exon 3 between the XbaI and BamHI sites used for cloning, but
maintain expression of subsequent exons, as previously described (Kanadia et al.
2003a) (Figure F-1). We performed single-end sequencing of poly(A)+ RNA from
the tissues of five knockout and five wild type mice, obtaining a total of 247M uniquely
mapped reads (Langmead et al. 2009), each 48 bases in length. We used MISO (Katz
et al. 2010) to compute exon inclusion levels (T) for all cassette exons and observed
hundreds of changes between wild type and knockout animals, with muscle exhibiting
the most dramatic changes and brain the least (Figure F-2). Many exons exhibited
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some individual-specific variation but clear separation in ' between wild type and
knockout. For example, exon 8 of Trim55 was included 59-72% of the time in wild
type heart, but 15-30% of the time in knockout heart (Figure 3-lA). Considering all
of the samples together, skipped exon 4 values clustered first by tissue, and then by
genotype, as expected (Figure 3-iB). Two knockout brains were omitted from sub-
sequent analyses, because they were determined to be outliers, likely due to slight
differences in brain harvest and tissue composition (data not shown). Our estimates
of cassette exon splicing changes (AT) correlated extremely well with previously pub-
lished estimates by splicing microarray (Du et al. 2010) (Figure F-3), and augment
the set of MBNL-dependent exons in muscle tissue and other cell types.
An open question is whether MBNL family members regulate shared or distinct
splicing targets. To supplement our analysis of MBNL-depleted tissues, and to address
a potential role for MBNL2 in splicing regulation, we stably infected C2C12 mouse
myoblasts with lentiviral hairpins against MBNL1, MBNL2, or both MBNLs, and
profiled the their transcriptomes by RNA-Seq. Upon confirming reduction in protein
levels by Western blot (Figure F-4), we noticed the increased production of a higher
molecular weight isoform of MBNL2 in MBNL1-depleted cells, and a higher molecular
weight isoform of MBNL1 in MBNL2-depleted cells, suggesting cross-regulation of
splicing.
We quantified mRNA expression levels for all genes and isoforms in each sam-
ple, and calculated the amount of MBNL1, MBNL2, and total MBNL (MBNL1
+ MBNL2) expression in each sample relative to control (Figure 3-iC), yielding a
dynamic range of 0-90%, 35-150%, and 30-75% of control expression, for MBNL1,
MBNL2, and total MBNL, respectively. MBNL3 was minimally expressed in all sam-
ples analyzed (RPKM < 1 in all tissues, and RPKM < 7 in myoblasts) and did not
vary significantly between MBNL-depleted and control samples.
To assess the overall extent of splicing changes resulting from depletion of MBNL
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protein(s), we calculated the "mean splicing change", defined as the mean lA4' for
the set of cassette exons which exhibited significant regulation in at least one sample
relative to control lA4| > 0.3, Bayes Factor > 5, n = 229 cassette exons). The mean
splicing change was only modestly correlated to the level of MBNL1 (Figure 3-iD)
or MBNL2 (Figure F-5) individually, but showed very strong correlation with total
MBNL levels (MBNL1 + MBNL2) (Figure 3-1E). This trend not only held for exon
skipping, but also for alternative 3' splice site usage (251 events), gene expression
changes, and to a lesser extent, alternative 5' splice site usage (172 events) (Figure F-
5). Additionally, the trend held when computing T separately for each animal, rather
than when computing I using pooled reads from all animals. Together, these data
suggested that regulation of a large set of splicing targets is achieved interchangeably
by either MBNL1 or MBNL2, and therefore that net depletion of both of these factors
by triplet repeats is more important in DM than depletion of either factor by itself.
Transcriptome-wide binding locations for MBNL1 in brain, heart, muscle,
and myoblast cells To distinguish between direct and indirect MBNL targets,
and to further explore context-dependent rules for MBNL splicing regulation, we per-
formed UV-crosslinking and immunoprecipitation followed by deep sequencing (CLIP-
seq) to identify the biophysical RNA targets of MBNL1. Dissociated cells derived from
brain, heart, skeletal muscle, and C2C12 mouse myoblasts were UV irradiated (254
nm) and IP'd using a rabbit polyclonal antibody against a constitutive C-terminal
segment of endogenous MBNL1 and Illumina libraries were prepared as described
previously (Wang et al. 2009). We generated high coverage, RNase I-treated libraries
from 129/SvJ brain and C2C12, and lower coverage RNase A-treated libraries from
C57BL/6 brain, heart, and muscle. Using adapter sequences with "random barcodes"
to distinguish PCR duplicates in the high coverage libraries (Konig et al. 2011), we
trimmed adapter sequences from our CLIP tags, collapsed identical sequences, and
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mapped the tags to the genome and transcriptome using Bowtie (Langmead et al.
2009), allowing up to 2 substitutions. This procedure yielded 1.6M, 2.06M, 250K,
120K and 71K reads uniquely mapping in the 129/SvJ brain, C2C12, and C57BL/6
brain, heart, and muscle samples, respectively.
We first assessed whether binding locations for MBNL1 are conserved across tis-
sues and cell types. This analysis accounted for variation in gene expression, since, as
expected, CLIP tag abundance was correlated with mRNA levels across samples (Yeo
et al. 2009). For genes highly expressed in multiple cell types, for example Reticulon
4 (350 RPKM in myoblasts, 230 RPKM in brain), we observed MBNL1 CLIP sites in
similar locations across various tissues and cell lines (Figure 3-2A). These locations
were essentially uncorrelated with CLIP sites for a different RNA binding protein,
Nova (Zhang et al. 2010). Binding locations of both proteins exhibited similar de-
gree of consistency, with very high consistency seen in the same tissue, and weaker
but still substantial correlation between binding locations in different cell and tissue
types. Global analysis using 3' UTRs from all genes expressed above 100 RPKM
in myoblasts and brain confirmed that, at 5-nucleotide resolution, CLIP density was
highly correlated across tissue types for each RNA binding protein (Figure 3-2B).
We subsequently identified clusters of CLIP tags relative to a simple Poisson null
model using an approach that accounts for differences in pre-mRNA length and gene
expression, similar to that used previously (Yeo et al. 2009). We found that the CLIP
clusters identified in myoblasts were enriched for UGC- and GCU-containing 4mers,
as assessed by Z-score (Figure 3-2C); similar results were observed in other tissues.
Alternative exons with CLIP clusters in regions within 1 kilobase were found to be
more highly conserved than other alternative exons in genes expressed at similar levels
(Figure 3-2D), suggesting that these exons play functional roles under evolutionary
selection.
Context-dependent splicing regulation by MBNL proteins Previous studies
have inferred context-dependent rules for MBNL splicing regulation using motif and
functional analysis, suggesting that MBNL exerts splicing repression when binding
upstream of exons, and splicing activation when binding downstream (Goers et al.
2010; Du et al. 2010). We used the CLIP-Seq and RNA-seq data to determine rules for
these context-dependent functions. This analysis confirmed binding sites discovered
in previous studies, for example the sites downstream of Sercal exon 22 (Hino et al.
2007), which are associated with a dramatic enhancement in exon inclusion (Figure 3-
2F), and uncovered thousands of new locations for MBNL1 binding associated with
splicing repression, for example sites upstream and within exon EIIIB of Fibronectin
I (Figure 3-2E), whose splicing is regulated during development and wound healing
(Ffrench-Constant and Hynes 1989; Ffrench-Constant et al. 1989). Exon EIIIB inclu-
sion is sensitive to total MBNL levels, increasing monotonically with MBNL depletion,
typifying the trend observed in Figure 3-1E. To globally assess the context-dependent
rules for MBNL splicing regulation, we subdivided alternative exons into those which
contained evidence of exclusive MBNL binding within 300 nucleotides upstream of
the 3' splice site, the exon itself, or 300 nucleotides downstream of the 5' splice site,
and computed the mean change in splicing (AI) following depletion of both MBNLs
in mouse myoblasts. We observed that splicing repression is associated with binding
in the upstream intron and exon, and activation is associated with binding in the
downstream intron, all in a dose-dependent manner, where CLIP tag density was
correlated with magnitude of splicing regulation (Figure 3-2G).
Crosslink-induced substitutions reveal high-confidence binding sites for
MBNL1 CLIP tag sequences have been observed to contain a higher rate of mis-
matches when mapped to the genome or transcriptome than sequences derived using
RNA-seq or genomic sequencing protocols (Licatalosi et al. 2008). The high mismatch
67
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rate has been assumed to be caused primarily by errors introduced by reverse tran-
scriptase when it encounters nucleotide residues crosslinked to incompletely digested
peptide fragments. Distinct crosslink-induced patterns characteristic of different RNA
binding proteins have been previously observed (Kishore et al. 2011; Zhang and Dar-
nell 2011; Hafner et al. 2010). Here, we calculated the frequency of crosslink-induced
substitutions (CIS) at any given position in the transcriptome as the fraction of reads
that cover the position but do not match the reference base (Figure 3-3A). In our
MBNL1 CLIP tag clusters, we observed that the base with highest CIS frequency was
cytosine, and that the cytosine to thymine substitution occurred at least 5 to 10-fold
more frequently than any other substitution (Figure 3-3B).
We also found that the sites at which cytosines exhibited high rates of substitu-
tion were flanked by non-random nucleotide sequences. As the frequency of cytosine
substitutions increased, the information content of the -1 base just preceding the
substituted C increased dramatically to 1.5 bits, reflecting a very strong bias toward
guanine (94%). In a similar but less extreme manner, the -2, +1, and +2 bases
relative to frequently substituted cytosines were preferentially uracil (Figure 3-3C).
Because the motif observed at these highly substituted sites resembled the UGCU
motif observed in the CLIP cluster Z-score analysis (Figure 3-2C) and previously
studied MBNL1 binding sites, we hypothesized that these sites comprise a set of
high-confidence binding sites in which the cytosine base directly crosslinks to partic-
ular residues of the MBNL1 zinc fingers, as predicted by crystal structures (Teplova
and Patel 2008).
We first constructed an RNA map for MBNL-dependent splicing regulation us-
ing all CLIP clusters (Figure 3-2D, inset), where relative cluster density for acti-
vated exons is shown above the exon schematic (cyan) and relative cluster density
for repressed exons is shown below the exon schematic (green), for locations less
than 500 nucleotides away from the splice sites of the upstream and downstream
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introns. Increased activation-associated density occurred in the downstream intron
adjacent to the alternative exon, but the maximum density in this location was at
most 30% above the maximum density elsewhere in the RNA map. Likewise, a peak
of repression-associated density occurred at the 3' splice site, but other locations such
as the 5' splice site of the upstream intron also exhibited this peak. In contrast, when
constructing the RNA map using only CLIP clusters with p(CIS)c_4T > 10% (Fig-
ure 3-2D), the signal for activation and repression-associated binding was 2.5-fold and
2-fold higher relative to background, respectively. A clear peak of repression (blue)
lay directly on top of the alternative exon, and a clear peak of activation (red) began
50 nucleotides after the 5' splice site, shortly after the peak of repression decayed.
Features of 3' UTRs with MBNL binding While we expected to find many
MBNL CLIP clusters in alternative exons and their flanking introns, a large pro-
portion of MBNL CLIP reads were also found in 3' UTRs (Figure F-7). Metagene
profiles of binding indicated that binding predominantly occurs on the 5' side of the
polyadenylation (pA) and cleavage site, with increased density close to the pA site,
suggesting that a significant proportion of binding occurs on mature mRNA and not
pre-mRNA (Figure 3-4A). Those 3' UTRs that contained CLIP clusters had higher
levels of phylogenetic conservation relative to other 3' UTRs of similar length and ex-
pression level, suggesting that 3' UTR binding by MBNL is associated with 3' UTR
function (Figure 3-4B).
To address potential functions, we looked for Gene Ontology categories enriched
in the set of genes with MBNL binding. Overwhelmingly, irrespective of the cell
type analyzed, "cellular component" categories were most enriched, as compared to
"molecular function" and "biological process". The mostly highly enriched cellular
component categories included synapse, membrane fraction, and insoluble fraction,
suggesting a potential functional association of MBNL with mRNAs of proteins lo-
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calized to these cellular compartments (Figure 3-4C). Indeed, as has been observed
previously in human myoblasts (Holt et al. 2009), we found that the distribution of
MBNL1 is not exclusively nuclear, and that the distribution is dynamic, becoming
predominantly cytoplasmic at particular times following trypsinization and re-plating
of mouse myoblasts. The distribution did not appear uniform, but in some cases oc-
curred at the periphery of the cell or adjacent to structures appearing to anchor long
projections.
MBNL targets a set of localized RNAs A number of cellular and molecular
functions are associated with 3' end binding, including regulation of RNA stability,
translation, and localization (Zhao et al. 1999; Moore and Proudfoot 2009). The
strong biases for binding to mRNAs associated with particular cellular compartments
and a previous study demonstrating that MBNL2 localizes the integrin a3 mRNA to
the plasma membrane for translation (Adereth et al. 2005) suggested the possibility
that the localization of other mRNAs might be regulated by MBNLs, in particular
those bound in their 3' UTRs.
To address this possibility, we used a cellular fractionation approach, followed
by RNA-Seq, to assess mRNA localization in C2C12 mouse myoblasts. A parallel
analysis was used to assess mRNA localization in drosophila S2 cells (Figure 3-5A).
In myoblasts, we used a detergent-based procedure, while in S2 cells a homogeniza-
tion/centrifugation procedure was used to obtain cytosolic, membrane, and insoluble
compartments (Jagannathan et al. 2011; Vedeler et al. 1991). Western analysis of
protein markers Hsp90, calnexin, and tropomyosin 1 in control and MBNL-depleted
myoblasts in each of these compartments confirmed successful separation (Figure 3-
5B). Hsp90 was exclusively cytosolic (Csermely et al. 1998); calnexin, an endoplasmic
reticulum resident protein (Bergeron et al. 1994), was almost exclusively membrane-
associated; tropomyosin, which decorates F-actin filaments (Gunning et al. 2005), was
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enriched at least 3-fold in the cytoskeletal compartment. Assessment of several marker
proteins in S2 cells also confirmed successful fractionation (Figure F-6). In addition to
observing compartment-biased protein expression, we observed compartment-biased
mRNA expression, where mRNAs encoding proteins of particular functional cate-
gories were biased in a manner which mirrored expected protein distributions, as
discussed below (Figure 3-5C).
To represent the relative localization of each mRNA in a visually intuitive manner,
we displayed genes as points in a simplex, where the distance to each corner of the
simplex represents the relative expression bias towards the cytosolic, membrane, and
insoluble compartments. In control myoblasts, we observed that nucleosome genes
are expressed preferentially in the cytosolic compartment relative to the membrane
and insoluble compartments, and integral plasma membrane and proteinaceous ex-
tracellular matrix proteins are expressed preferentially in the insoluble "corner" of
the simplex. (Figure 3-5C). These observations were consistent with those of similar
studies in which the distribution of mRNAs encoding proteins translated in the rough
ER is biased towards membrane-enriched cellular compartments (Pyhtila et al. 2008),
and studies in which mRNAs encoding cytoskeletal or extracellular matrix proteins
were found to be actively translated on cytoskeletally-anchored ribosomes (Sundell
and Singer 1991; Pachter 1992; Hesketh 1994). Enrichment for these categories was
observed to a similar exent in MBNL knockdown myoblasts, as the differences be-
tween each type of cellular compartment were far greater than the differences due to
effects of MBNL knockdown. This suggested that potential differences observed in
response to MBNL knockdown would not be due to large differences in the compo-
sition of cellular compartments, but likely to specific effects on particular subsets of
genes.
By intersecting our MBNL binding data, we found that MBNL 3' UTR targets
are enriched in genes whose localization is biased towards the insoluble compartment
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(Figure 3-5D, E). We subdivided genes by the number of MBNL CLIP observed
clusters within their 3' UTRs, and plotted their relative density within the simplex
representation. Stratifying mRNAs by the number of CLIP clusters, we observed
that the proportion of genes in biased toward the insoluble corner increased as the
number of CLIP clusters increased. This enrichment for MBNL targets in the insol-
uble corner of the simplex was highly significant, as assessed by performing pairwise
comparisons of gene expression in each cellular compartment across MBNL target
subsets (Figure 3-5E).
MBNL depletion leads to changes in mRNA localization associated with
MBNL binding Using the simplex representation for mRNA localization, we com-
puted the change in localization following depletion of MBNL (in myoblasts) or MBL
(in S2 cells), and represented these changes with vectors, where colored arrows point
in the direction of change following knockdown (Figure 3-6A, B). Because we observed
that MBNL targets are enriched in the insoluble corner, we focused our analyses on
this subset of genes, and further subdivided these genes into those with evidence of
low, medium, or high binding. In myoblasts, we used CLIP clusters to define these
subsets, and in S2 cells, since we lacked binding data, we used density of UGCU motifs
to define these subsets. We observed that, following MBNL or MBL depletion, the
localization of insoluble genes tended to move away from the membrane compartment
and further towards the insoluble compartment (Figure 3-6C, D). This behavior was
quantified and displayed in bar plots, where significant differences in mRNA localiza-
tion change were observed between the low and high binding subsets. This effect was
essentially mirrored between mouse myoblasts and fly S2 cells. Subdividing mouse
myoblast genes by UGCU motif density rather than CLIP clusters revealed similar
but less significant trends, suggesting that information beyond the UGCU motif is
required for MBNL to exert its functions in mouse, in contrast to fly, in which 3'
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UTRs are shorter and the functional significance of primary sequence motifs may be
greater.
It has been demonstrated that cis-regulatory sequences at the RNA level can
play a role in targeting RNA and enhancing nuclear export, and that the proper
localization of mRNA can influence downstream processes such as cell motility and
extracellular sensing, in particular via translation by ribosomes on the cytoskeleton
or rough ER. Furthermore, it has been demonstrated that signal peptide sequences
encode information not only at the protein level, but also at the RNA level to target
mRNAs to the membranes such as the rough ER and nuclear envelope (Palazzo et al.
2007; Cenik et al. 2011; Pyhtila et al. 2008). We noticed that a large proportion of
the MBNL binding targets which exhibit a change in mRNA localization following
MBNL depletion away from membrane compartments and towards the insoluble,
e.g. cytoskeletal, compartment contain signal peptide or signal anchor sequences.
We therefore hypothesized that the mRNA localization of MBNL targets may affect
downstream processes such as local protein translation or secretion.
To test this hypothesis, we used two naturally occurring, secreted luciferases,
Gaussia (Tannous et al. 2005) and Cypridina (Nakajima et al. 2004), each of which
possesses strong signal peptide sequences, to perform a dual luciferase assay in which
3' UTRs exhibiting MBNL binding were cloned into the 3' UTR of Gaussia luciferase.
The Biglycan 3' UTR and the Fibronectin 1 3' UTR, along with its last intron, were
chosen for this assay due to copious MBNL binding and observed change in mRNA
localization following MBNL depletion in myoblasts (Figure 3-6E).
Upon co-transfection of both luciferases with plasmids encoding 960 CUG repeats,
which functionally inactivates MBNLs, essentially mimicking myotonic dystrophy,
we observed a 10-20% reduction in secretion of the luciferase with the Fnl or Bgn
3' UTR, relative to cells co-transfected with both luciferase and an empty control
vector (Figure 3-6F). To demonstrate the specificity of this effect to MBNL levels,
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we attempted to rescue the observed decrease in secretion by overexpressing MBNL1
coding sequence. Over-expression of MBNL1 led to a complete rescue of Fnl 3' UTR-
mediated secretion, and a partial rescue of Bgn 3' UTR-mediated secretion, suggesting
that the effects of CUG repeats on secretion are attributable to the depletion of
MBNLs.
Isoform-specific mRNA localization is associated with MBNL binding and
function Alternative 3' UTRs are regulated between various tissues, cell types,
and cell states. Tandem 3' UTRs favoring distal pA sites have been found to be
enriched in non-dividing, highly polarized cell types such as neurons; the additional
RNA sequence is thought to confer regulatory information for proper localization of
transcripts. Our myoblast fractionation data revealed hundreds of mRNAs exhibiting
differential pA site usage across cellular compartments. One example occurs in the
gene Insig2, whose distal pA usage is significantly greater in the insoluble compart-
ment relative to the cytosolic compartment (Figure 3-7A), and is exhibits 3' UTR
binding by MBNL (Figure 3-7B). This pattern of distal pA usage across cellular com-
partments was recapitulated globally, where distal pA sites were most favored in the
insoluble compartment, followed by the membrane compartment, relative to cytoso-
lic compartment (Figure 3-7C). Upon MBNL depletion, these trends were reversed;
for example, the Insig2 distal pA site no longer exhibited a significant difference be-
tween the cytosolic and insoluble compartments (Figure 3-7A), this pattern typifying
a global effect (Figure 3-7D). To assess whether these differences in isoform localiza-
tion might be associated with direct MBNL binding to the 3' UTR, we subdivided
genes into those with low, medium, and high binding density in the 3' UTR. The
extent of isoform mis-localization following MBNL depletion was greatest for those
UTRs exhibiting high MBNL binding and least for those UTRs exhibiting low MBNL
binding (Figure 3-7E), suggesting that MBNL binding plays a role in the localization
Chapter 3. Transcriptome Regulation by MBNLs 3.2. Results
of specific 3' UTR isoforms. When restricting these analyses to 3' UTRs which do
not exhibit significant differences in distal pA usage as assessed by total RNA, the
effects persisted, suggesting that the differences in isoform-specific localization fol-
lowing MBNL depletion are not due to regulated APA occurring in the nucleus, but
rather differential post-transcriptional processing steps which target specific 3' UTR
isoforms to distinct subcellular locations.
3.3 Discussion
A catalog of MBNL-dependent splicing events MBNLs are a major protein
family responsible for numerous biological processes during development and disease.
Here, we have comprensively profiled transcriptomes of brain, heart, muscle, and my-
oblasts depleted of MBNLs, and obtained transcriptome-wide locations for MBNL1
binding in these tissue and cell types. MBNLs are responsible for regulating a net-
work of RNA processing events that are conserved between species, in a manner that
depends on binding location (Figure 3-8). We found that in general, MBNL1 and
MBNL2 can co-regulate a set of shared splicing targets, and that overall splicing dys-
regulation depends on the depletion of total levels of MBNL1 and MBNL2, and not
MBNL1 alone. Because the ratio of MBNL1 and MBNL2 differ between tissue and
cell types, we predict that phenotypic consequences of MBNL1 or MBNL2 depletion
specifically in these tissues will result in phenotypes of varying severity. For exam-
ple, MBNL2 depletion neurons would be predicted to produce greater changes than
MBNL1 depletion in neurons, and vice versa in muscle; tissue-specific models for DM
must take these observations into account.
Non-splicing functions of MBNLs A number of RNA binding proteins have
been demonstrated to possess global splicing and non-splicing functions, including
Nova, hnRNP H, and several SR proteins. We provide evidence that MBNLs can
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be added as another, whose non-splicing function includes regulation of mRNA lo-
calization. One previous study demonstrated that MBNL2 localizes integrin-a3 to
the plasma membrane (Adereth et al. 2005), and we extend this observation to hun-
dreds of targets whose normal localization is enriched in insoluble and membrane
compartments of myoblasts, in both mouse and fly cells (Figure 3-8).
The previous finding that mRNAs whose steady state levels are decreased in re-
sponse to total MBNL depletion by CUG repeats but not in response to MBNL1
depletion alone (Du et al. 2010) suggests that MBNL2 localizes a set of mRNAs
which are protected from degradation through subsequent translation or anchoring
to membrane compartments. However, the question arises as to whether this is a func-
tion exclusive to MBNL2 or can also be performed by MBNL1. While our CLIP data
specifically captured MBNL1 targeting preferences, combined with our functional
data it revealed that MBNL1 and MBNL2 can essentially regulate the same splicing
targets. A possibility is that the both proteins can perform redundant functions, and
that the threshold level of total MBNL required to perform RNA localization func-
tions is lower than the threshold level required to perform splicing functions. Total
functional MBNL levels in HSALR muscle are lower than in MBNL1AE3/AE 3 mus-
cle, due to extensive sequestration of both MBNL1 and MBNL2. Changes to RNA
stability exclusively in HSALR muscle could represent biological processes which can
proceed normally with ~33% of normal MBNL levels, but are sufficiently inhibited
to be able to measure upon more extensive depletion by CUG repeat expression. In-
deed, we observed only mild changes to RNA stability for messages whose localization
changes following MBNL depletion (data not shown). Use of more direct measure-
ment techniques for RNA localization, including image-based approaches, may allow
increased sensitivity in the detection of such phenomena across a range of MBNL
activity levels.
We have uncovered an extensive network of MBNL-RNA interactions which oc-
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cur throughout the cell, within the nucleus and other cellular compartments. These
interactions mediate pre-mRNA splicing and are associated with mRNA localization.
Coupling of these processes to other phenomena in the cell, such as local translation
and protein secretion, may hold implications for myotonic dystrophy pathogenesis, in
which MBNLs are sequestered away from their targets by expanded repeats. Down-
stream consequences, such as altered levels of extracellular proteins or circulating
factors, may play important roles in disease pathogenesis and serve as easily accessi-
ble diagnostics for monitoring disease progression and assessing response to therapy.
3.4 Methods
RNA-seq library preparation and sequencing Five 16 week-old 129/SvJ MBNL1AE 3/AE3
mice and littermate WT mice were sacrificed for isolation of whole brain, heart, and
skeletal muscle (vastus lateralis). Total RNA was prepared by lysis in guanidium
isothiocyanate, followed by phenol/chloroform extraction. Poly(A)+ RNA was se-
lected by oligo-dT magnetic beads, and prepared for single end RNA sequencing
using Illumina single end sequencing primers as described previously. 50 cycles of
sequencing were performed on Illumina GAII machines. RNA-seq libraries for C2C12
mouse myoblasts were performed similarly, but paired-end adapters and sequencing
primers were used. Agarose gel size selection was performed subsequent to the final
amplification step, to isolate fragments with a specific insert length. 2 x 36 cycles of
sequencing were performed on Illumina GAIIx machines. For the cellular fractiona-
tion experiments, barcodes were used to multiplex 3 samples per lane.
CLIPseq library preparation and sequencing CLIP was performed using 254
nm UV irradation as previously described (Wang et al. 2009) with the following mod-
ifications. Whole brain, heart, and muscle were isolated from 16 week-old 129/SvJ
or C57BL/6 mice. Tissues were dissociated on ice, using a razor blade and blunt-end
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cell culture scrapers, and a small volume of PBS. The fine slurry of cells was irra-
diated 3 x 400 mJ / cm2 , pelleted, and frozen at -80 until cell lysis. For CLIP in
C2C12 myoblasts, monolayers of cells in 10 cm 2 dishes were washed with PBS, and
irradiated once with 400 mJ / cm2 on ice, under a layer of 4 ml PBS. Cells were
lysed in 10 mM Tris-HCl, 150 mM NaCl, 0.1% sodium deoxycholate, and 1% NP-40.
Cells from tissues were lysed with the aid of a hand-held homogenizer, followed by
brief sonication with a probe sonicator. The cell lysate was treated with DNase and
RNase; the high coverage C2C12 and 129/SvJ brain libraries were treated 1:100 with
RNase If (NEB) and the low coverage libraries were treated 1:10K with 10 mg/ml
RNase A (Fermentas), both for 10 minutes at 37 degrees. The ultracentrifugation
clearing step was replaced with a low speed, 10K x g spin in a benchtop centrifuge.
Immunoprecipitation was performed using a polyclonal antibody which does not ex-
hibit cross-reactivity with MBNL2 (personal communication, Tom Cooper). Washing
steps were performed with lysis buffer containing IM NaCl. Bis-tris SDS page gels
were used for vertical electrophoresis (Invitrogen), and wet transfer to nitrocellulose
was performed with BA-85 nitrocellulose (Protran). The 3' adapter was ligated on
bead, using a pre-adenylated DNA oligonucleotide terminated on the 3' end with a
dideoxy-C (IDT). Pre-adenylation was performed using in-house synthesized ImpA
(autocite Lau et al). Ligation of the 5' adapter was performed in solution using a
chimeric oligonucleotide, in which the 3' end is RNA and the 5' is DNA. The 5' adapter
for the C2C12 and 129SVJ Brain CLIP libraries contained two additional random nu-
cleotides at the 3' end, which were used to discriminate unique RNA molecules from
PCR duplicates.
Cellular fractionation for C2C12 mouse myoblasts Cells were grown in mono-
layers on 10 cm2 tissue culture dishes (Corning). The cytosolic lysis buffer contained
0.015% digitonin, the membrane lysis buffer 0.5% Triton X-100, and the cytoskeletal
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lysis buffer 1 M NaCl. Cells were washed with PBS, and incubated for 10 minutes at
4 degrees with 2 ml cytosolic lysis buffer, with gentle rocking. The cytosolic fraction
was removed and saved, and the membrane lysis buffer was added for 5 minutes at 4
degrees with gentle rocking. The membrane fraction was removed and saved, and the
cytoskeletal buffer was added. The plate was quickly rocked 4 times back and forth,
and the cytoskeletal fraction was removed and saved. Protein from each fraction was
prepared by heating in SDS page buffer (Invitrogen). RNA from each fraction was
prepared by adding guanidum isothiocyanate to 8 M, vortexing until clear, and sub-
sequent phenol/chloroform extraction. RNeasy mini columns (Qiagen) with DNase
treatment were used to further purify the RNA prior to standard Illumina library
construction. For fractionation experiments, Ribo-Zero columns (Epicenter Biotech-
nologies) were used to reduce ribosomal RNA abundance instead of oligo dT beads.
Cellular fractionation for fly S2 cells S2 cells were fractionated using hypotonic
lysis and ultracentrifugation. Cells were lysed in hypotonic buffer, homogenized by
dounce and spun briefly at 10OOg to clear nuclear and cell debris. The lysate was
collected and spun at 100,000g to obtain the cytosolic fraction as the supernatant.
The remaining pellet was resuspended in hypotonic buffer containing 1% Triton X-
100, homogenized, and spun again at 100,000g to obtain a membrane soluble fraction
in the supernatant, and a detergent insoluble fraction in the pellet. Ten percent of
the total cell sample was kept as an input control.
Immunoblotting Bis-tris SDS-PAGE gels (Invitrogen) were used to separate pro-
teins by molecular weight. Transfers were performed using the iBlot transfer ap-
paratus (Invitrogen). Nitrocellulose blots were blocked in 5% milk-PBS with 0.1%
Tween-20. Mouse antibodies against MBNL1 and MBNL2, MBla and MB2a, respec-
tively, were kind gifts from the Wolffson Center for Inherited Neuromuscular Disease,
and used at 1:300 dilutions. Rabbit Upfl antibody (Bethyl Laboratories) was used
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at 1:10K. Antibodies against Hsp90 (mouse), Calnexin (rabbit), and Tropomyosin
I (mouse) were used at dilutions of 1:1000. Femto-sensitive ECL reagent (Thermo-
Scientific) was used to detect activity of HRP-conjugated anti-mouse and anti-rabbit
secondary antibodies.
Cells, cloning, and luciferase assays C2C12 mouse myoblasts were cultured
in high glucose DMEM supplemented with 20% FBS and penicillin/streptomycin.
Knockdowns of MBNL1 and MBNL2 in mouse myoblasts were performed via polybrene-
assisted infection of lentivirus derived from the pLKO.1 vector, produced in 293T
cells, followed by puromycin selection starting 24 hours after infection. RNA and/or
protein was isolated from C2C12 mouse myoblasts 7 to 10 days after infection. The
Infusion system (Clontech) was used to clone fragments of Bgn and Fnl into the 3' of
Gaussia luciferase. The Bgn and Fnl fragments were amplified from mouse genomic
DNA, and the Fnl fragment contained the last intron of Fnl in addition to the 3'
UTR. For luciferase assays, C2C12 myoblasts were trypsinized and replated into 12-
well dishes. Liposome mixtures of 400 ng plasmid encoding Gaussia luciferase, 100
ng plasmid encoding Cypridina luciferase, and 100 ng of either of control (pLKO.1)
plasmid, a plasmid containing 960 CUG repeats (DT960), DT960 plus a plasmid
encoding the MBNL1 coding sequence were prepared using Trans-IT (Mirus). The
liposome mixtures were added to the media, and luciferase assays were performed 24
hours later. For the luciferase assays, 50 ul of media was removed from each well, and
2 x 10 ul was aliquoted into two 96-well flat clear-bottomed plates; one plate was as-
sayed for Gaussia activity, and the other for Cypridina activity (Targeting systems).
Significance between means was computed using the Mann-Whitney U test.
Analysis of gene and isoform expression levels Short reads were mapped
to the genome and a database of splice junctions using Bowtie (Langmead et al.
2009). Gene expression estimates were obtained by counting the number of reads
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mapping to constitutive exons for each gene, and dividing by the number of kilobases
of constitutive exon model per million uniquely mapped reads. For the fractionation
experiments, RPKM values across all cellular fractions were subsequently normalized
to prevent violation of the assumption that most genes are not differentially regulated
between samples, as described previously (Robinson and Oshlack 2010). Isoform level
estimates were obtained using MISO (Katz et al. 2010), run in single end mode.
Correlation between MBNL levels and total extent of splicing dysregula-
tion The set of cassette exon events for which sufficient expression (> 20 reads per
exon trio) was observed in all samples (brain, heart, muscle, and 3 C2C12 samples)
and where MBNL depletion led to a significant splicing change (Bayes Factor > 5) in
at least one sample was analyzed. The mean |I AT for these events was computed and
correlated to the extent of MBNL1, MBNL2, or total MBNL depletion. Analogous
analyses were performed for alternative 3' splice sites and alternative 5' splice sites.
Genome-wide correlation of CLIP density across samples The CLIP tag
density was computed in 5 nucleotide-long windows across 3' UTRs in the transcrip-
tome for genes highly expressed in whole brain and C2C12 mouse myoblasts (>100
RPKM) exhibiting high CLIP tag coverage (>100 tags per UTR). Pearson correlation
coefficients were computed for these densities between CLIP libraries performed in
different samples and for different proteins.
CLIP cluster motif analysis Motifs occurring in CLIP clusters from C2C12
mouse myoblasts were counted and compared to those found in randomly selected
clusters within the same genes. This procedure was repeated 100 times to derive
a Z-score for each motif, where the Z-score was defined as the number of standard
deviations away from the mean.
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Conservation analysis for cassette exons and 3' UTRs Conservation (30-way
phastCons, UCSC genome browser) of cassette exons with CLIP clusters within 1
kilobase of each splice site or within the exon itself was compared to a control set of
cassette exons found in similarly expressed genes. Conservation (30-way phastCons)
of 3' UTRs with CLIP clusters less than 1 kilobase upstream and less than 500 bases
downstream of constitutive transcript ends was compared to a control set of 3' UTRs
with similar length, in similarly expressed genes. For these analyses, CLIP clusters
and gene expression values from C2C12 mouse myoblasts were used.
Construction of RNA maps Cassette exons were separated into those with CLIP
tags within 300 nucleotides of the upstream intron, downstream intron, or within the
exon itself. Only exons which exhibited exclusive binding in a single region (< 2 tags
in any other region) were considered in the analysis. Exons were further subdivided
into those with varying CLIP tag densities, where density was defined as the number
of tags divided by logged gene expression and length of the intron or exon. The mean
AT of each subgroup was computed and displayed as bars.
Crosslink-induced substitution analysis The metric p(CIS) was defined as the
fraction of reads coverage a base supporting a base substitution differing from refer-
ence. Only positions with minimum read coverage above 10 were considered in this
analysis. Information content of each base flanking frequently substituted cytosines
was computed as -E[A,UC,G]f *ln(f), where f is the frequency of each base. The RNA
map using CLIP clusters containing highly substituted cytosines (p(CIS) > 0.3) was
constructed using only exons with this subset of CLIP clusters within 500 nucleotides
of the upstream and downstream 5' and 3' splice sites or within the cassette exon
itself. CLIP cluster density within the cassette exon was shrunken or stretched to
allow for display of variable length cassette exons, and cluster density in the entire
plot was smoothed using a kernel density function with a bandwidth of 30 nucleotides.
Chapter 3. Transcriptome Regulation by MBNLs 3.4. Methods
The RNA map inset using all CLIP tags was constructed using the same approach,
but individual CLIP tags rather than clusters were used.
Gene Ontology Cellular Component Analysis A permutation-based approach
was taken to identify cellular component categories enriched in genes with 3' UTR
CLIP binding. A foreground and background set of genes was defined, where the fore-
ground contained genes with 3' UTR CLIP binding and the background contained a
randomly selected set of genes matched for gene expression levels and 3' UTR lengths.
The proportion of foreground and background genes in each cellular component cate-
gory was recorded, and this process was repeated 100 times to generate distributions
for the foreground and background proportions. A "Bayes Factor" was derived to
determine whether the null hypothesis that the foreground and background distribu-
tions are identical should be rejected. The Bayes Factor was defined as the inverse
of the delta distribution evaluated at zero, where the delta distribution is the dis-
tribution derived from subtracting the background distribution from the foreground
distribution. CLIP binding for this analysis was defined as using CLIP clusters for the
high coverage brain and myoblast CLIP libraries, and CLIP tags for the low coverage
brain, heart, and muscle CLIP libraries.
Computational identification of CLIP clusters CLIP tags were first collapsed
to remove redundant sequences, and trimmed of adapters. These sequences were
mapped to genome and a database of splice junctions using Bowtie. To identify
CLIP clusters lying within genic regions, gene boundaries were first defined using
Refseq, Ensembl, and UCSC tables. For each window of 30 nucleotides covered by
at least one CLIP tag, a test was performed to assess CLIP density in the window
exceeded that which is predicted by a simple Poisson model which accounts for gene
expression and pre-mRNA length (Yeo et al. 2004).
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Simplex-based representation of cellular compartments Gene expression within
simplex space was obtained by computing the net vector resulting from the projec-
tion of gene expression values from each compartment onto unit vectors pointing
in the location of each compartment represented by the simplex. Using a simplex
centered at the origin with corner coordinates of [0, 1], [f, -j], [- E, -j] in Carte-
sian space, this is simply [RPKMcyt, * cos(1) + RPKMmem * cos(!'L) + RPKMis *
cos( 1), RPKMyto * sin(f) + RPKMmem* sin(7 ,) -+ RPKMiS * sin( )]. Simplex-
based coordinates were computed for control and MBNL-depleted cells, and the
"delta" vector [Xdepleted - Xcontrol, Ydepleted - Ycontroll was used to describe the change
in localization following MBNL depletion.
Analysis of mRNA localization of 3 UTR targets of MBNL The simplex
locations of genes with varying numbers of CLIP clusters within their 3' UTRs were
converted to a smoothed density. For each group of genes thresholded on CLIP
cluster number, the density was normalized such that the maximum density of any
bin within the simplex was set to the 100th percentile, and densities are displayed
as a topographical map with contours at 10th, 20th, 40th, and 80th percentiles.
Statistical analysis of the bias towards particular cellular components was performed
by Kolmogorov-Smirnov test, where the distribution of gene expression ratios between
cellular compartments was compared between genes with varying numbers of CLIP
clusters within their 3' UTRs.
Analysis of changes in mRNA localization following MBNL depletion The
set of "insoluble" genes was defined as those with coordinates in the simplex falling
below the y = V5x line, where the origin is the center of the simplex and corner co-
ordinates are as described above. The behavior of this set of genes following MBNL
depletion was subdivided into those with low, medium, or high CLIP cluster density
or UGCU motif density, and analyzed using two methods. In the first method, the
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behavior of each subgroup was plotted in a smoothed polar plot, where the radius of
the polar plot line at any given angle was defined as the number of genes exhibiting
a positive delta vector towards that angle following MBNL depletion. In the second
method, the behavior of each subgroup was quantified and displayed in bars by aver-
aging the projections of each subgroup's "delta" vectors onto each of the unit vectors
pointing in the cytosolic, membrane, or insoluble directions. For example, the height
of the bar describing behavior of genes with high CLIP density with respect to the
cytosolic compartment was computed as: E k [dxi, dyi] - [0, 1]. Error bars represent
standard error of the mean. Significance of the difference between the high CLIP den-
sity vs. low CLIP density subgroups or high UGCU density vs. low UGCU density
subgroups was computed using a Wilcoxon rank-sum test.
Analysis of alternative 3 UTR events Custom 3' UTR annotations were used
to define alternative polyadenylation (pA) and cleavage events (N. Spies), and 3'
UTRs with exactly two pA sites were used in this analysis. The fraction of genes
exhibiting preference for distal pA site usage was computed by considering only those
events with sufficient read coverage (> 20 reads in both samples), and significance
of the bias in this fraction was assessed using a binomial test, where the background
probability was defined as the fraction of non-significant events (BF < 5) preferring
the distal pA site. Significance was the change in bias following MBNL depletion was
assessed similarly, but in this case the binomial background probability was defined
as the fraction of genes preferring the distal pA site in control cells.
3.4. MethodsChapter 3. Transcriptome Regulation by MBNLs
3.5 References
Adereth, Y, V Dammai, N Kose, R Li, and T Hsu (Dec. 2005). "RNA-dependent inte-
grin alpha3 protein localization regulated by the Muscleblind-like protein MLP1."
In: Nat Cell Biol 7.12, pp. 1240-7. DOI: 10.1038/ncb1335 (cit. on pp. 70, 76).
Artero, R, A Prokop, N Paricio, G Begemann, I Pueyo, M Mlodzik, M Perez-Alonso,
and MK Baylies (Mar. 1998). "The muscleblind gene participates in the organiza-
tion of Z-bands and epidermal attachments of Drosophila muscles and is regulated
by Dmef2." In: Dev Biol 195.2, pp. 131-43. DOI: 10. 1006/dbio. 1997.8833 (cit.
on p. 62).
Begemann, G, N Paricio, R Artero, I Kiss, M Perez-Alonso, and M Mlodzik (Nov.
1997). "muscleblind, a gene required for photoreceptor differentiation in Drosophila,
encodes novel nuclear Cys3His-type zinc-finger-containing proteins." In: Develop-
ment 124.21, pp. 4321-31 (cit. on p. 62).
Bergeron, JJ, MB Brenner, DY Thomas, and DB Williams (Mar. 1994). "Calnexin: a
membrane-bound chaperone of the endoplasmic reticulum." In: Trends Biochem
Sci 19.3, pp. 124-8 (cit. on p. 70).
Cenik, C, HN Chua, H Zhang, SP Tarnawsky, A Akef, A Derti, M Tasan, MJ Moore,
AF Palazzo, and FP Roth (Apr. 2011). "Genome analysis reveals interplay be-
tween 5'UTR introns and nuclear mRNA export for secretory and mitochondrial
genes." In: PLoS Genet 7.4, e1001366. DOI: 10. 1371/journal . pgen. 1001366
(cit. on p. 73).
Csermely, P, T Schnaider, C Soti, Z Proha'szka, and G Nardai (Aug. 1998). "The
90-kDa molecular chaperone family: structure, function, and clinical applications.
A comprehensive review." In: Pharmacol Ther 79.2, pp. 129-68 (cit. on p. 70).
Du, H, MS Cline, RJ Osborne, DL Tuttle, TA Clark, JP Donohue, MP Hall, L Shiue,
MS Swanson, CA Thornton, and M Ares Jr (Feb. 2010). "Aberrant alternative
splicing and extracellular matrix gene expression in mouse models of myotonic
dystrophy." In: Nat Struct Mol Biol 17.2, pp. 187-93. DOI: 10. 1038/nsmb. 1720
(cit. on pp. 62, 64, 67, 76).
Fardaei, M, MT Rogers, HM Thorpe, K Larkin, MG Hamshere, PS Harper, and JD
Brook (Apr. 2002). "Three proteins, MBNL, MBLL and MBXL, co-localize in
vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells." In:
Hum Mol Genet 11.7, pp. 805-14 (cit. on p. 62).
Ffrench-Constant, C and RO Hynes (June 1989). "Alternative splicing of fibronectin
is temporally and spatially regulated in the chicken embryo." In: Development
106.2, pp. 375-88 (cit. on p. 67).
Ffrench-Constant, C, L Van de Water, HF Dvorak, and RO Hynes (Aug. 1989).
"Reappearance of an embryonic pattern of fibronectin splicing during wound heal-
ing in the adult rat." In: J Cell Biol 109.2, pp. 903-14 (cit. on p. 67).
Goers, ES, J Purcell, RB Voelker, DP Gates, and JA Berglund (Apr. 2010). "MBNL1
binds GC motifs embedded in pyrimidines to regulate alternative splicing." In:
Nucleic Acids Res 38.7, pp. 2467-84. DOI: 10. 1093/nar/gkp1209 (cit. on p. 67).
Chapter 3. Transcriptomne Regulation by MBNLs 3.5. References
Chapter 3. Transcriptome Regulation by MBNLs
Gunning, PW, G Schevzov, AJ Kee, and EC Hardeman (June 2005). "Tropomyosin
isoforms: divining rods for actin cytoskeleton function." In: Trends Cell Biol 15.6,
pp. 333-41. DOI: 10.1016/j.tcb.2005.04.007 (cit. on p. 70).
Hafner, M, M Landthaler, L Burger, M Khorshid, J Hausser, P Berninger, A Roth-
baller, M Ascano, AC Jungkamp, M Munschauer, A Ulrich, GS Wardle, S Dewell,
M Zavolan, and T Tuschl (2010). "PAR-CliP-a method to identify transcriptome-
wide the binding sites of RNA binding proteins." In: J Vis Exp 41. DOI: 10 .379
1/2034 (cit. on p. 68).
Hesketh, J (May 1994). "Translation and the cytoskeleton: a mechanism for targeted
protein synthesis." In: Mol Biol Rep 19.3, pp. 233-43 (cit. on p. 71).
Hino, SI, S Kondo, H Sekiya, A Saito, S Kanemoto, T Murakami, K Chihara, Y Aoki,
M Nakamori, MP Takahashi, and K Imaizumi (Dec. 2007). "Molecular mechanisms
responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1." In:
Hum Mol Genet 16.23, pp. 2834-43. DOI: 10. 1093/hmg/ddm239 (cit. on p. 67).
Holt, I, V Jacquemin, M Fardaei, CA Sewry, GS Butler-Browne, D Furling, JD Brook,
and GE Morris (Jan. 2009). "Muscleblind-like proteins: similarities and differences
in normal and myotonic dystrophy muscle." In: Am J Pathol 174.1, pp. 216-27.
DOI: 10.2353/ajpath.2009.080520 (cit. on p. 70).
Jagannathan, S, C Nwosu, and CV Nicchitta (2011). "Analyzing mRNA localization
to the endoplasmic reticulum via cell fractionation." In: Methods Mol Biol 714,
pp. 301-21. DOI: 10. 1007/978-1-61779-005-8_19 (cit. on p. 70).
Kanadia, RN, KA Johnstone, A Mankodi, C Lungu, CA Thornton, D Esson, AM Tim-
mers, WW Hauswirth, and MS Swanson (Dec. 2003a). "A muscleblind knockout
model for myotonic dystrophy." In: Science 302.5652, pp. 1978-80. DOI: 10. 112
6/science.1088583 (cit. on pp. 62, 63).
Kanadia, RN, CR Urbinati, VJ Crusselle, D Luo, YJ Lee, JK Harrison, SP Oh,
and MS Swanson (Aug. 2003b). "Developmental expression of mouse muscleblind
genes Mbnll, Mbn12 and Mbnl3." In: Gene Expr Patterns 3.4, pp. 459-62 (cit. on
p. 62).
Katz, Y, ET Wang, EM Airoldi, and CB Burge (Dec. 2010). "Analysis and design of
RNA sequencing experiments for identifying isoform regulation." In: Nat Methods
7.12, pp. 1009-15. DOI: 10.1038/nmeth.1528 (cit. on pp. 63, 81).
Kishore, S, L Jaskiewicz, L Burger, J Hausser, M Khorshid, and M Zavolan (July
2011). "A quantitative analysis of CLIP methods for identifying binding sites of
RNA-binding proteins." In: Nat Methods 8.7, pp. 559-64. DOI: 10. 1038/nmeth. 1
608 (cit. on p. 68).
Konig, J, K Zarnack, G Rot, T Curk, M Kayikci, B Zupan, DJ Turner, NM Luscombe,
and J Ule (2011). "iCLIP-transcriptome-wide mapping of protein-RNA interac-
tions with individual nucleotide resolution." In: J Vis Exp 50. DOI: 10. 3791/2638
(cit. on p. 65).
Langmead, B, C Trapnell, M Pop, and SL Salzberg (2009). "Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome." In: Genome
Biol 10.3, R25. DOI: 10.1186/gb-2009-10-3-r25 (cit. on pp. 63, 66, 80).
Licatalosi, DD, A Mele, JJ Fak, J Ule, M Kayikci, SW Chi, TA Clark, AC Schweitzer,
JE Blume, X Wang, JC Darnell, and RB Darnell (Nov. 2008). "HITS-CLIP yields
3.5. References
genome-wide insights into brain alternative RNA processing." In: Nature 456.7221,
pp. 464-9. DOI: 10. 1038/nature07488 (cit. on pp. 62, 67).
Lin, X, JW Miller, A Mankodi, RN Kanadia, Y Yuan, RT Moxley, MS Swanson,
and CA Thornton (July 2006). "Failure of MBNL1-dependent post-natal splicing
transitions in myotonic dystrophy." In: Hum Mol Genet 15.13, pp. 2087-97. DOI:
10. 1093/hmg/ddl132 (cit. on p. 62).
Miller, JW, CR Urbinati, P Teng-Umnuay, MG Stenberg, BJ Byrne, CA Thornton,
and MS Swanson (Sept. 2000). "Recruitment of human muscleblind proteins to
(CUG)(n) expansions associated with myotonic dystrophy." In: EMBO J 19.17,
pp. 4439-48. DOI: 10. 1093/emboj /19.17.4439 (cit. on p. 62).
Moore, MJ and NJ Proudfoot (Feb. 2009). "Pre-mRNA processing reaches back to
transcription and ahead to translation." In: Cell 136.4, pp. 688-700. DOI: 10. 10
16/j cell.2009.02.001 (cit. on p. 70).
Nakajima, Y, K Kobayashi, K Yamagishi, T Enomoto, and Y Ohmiya (Mar. 2004).
"cDNA cloning and characterization of a secreted luciferase from the luminous
Japanese ostracod, Cypridina noctiluca." In: Biosci Biotechnol Biochem 68.3,
pp. 565-70 (cit. on p. 73).
Pachter, JS (1992). "Association of mRNA with the cytoskeletal framework: its role in
the regulation of gene expression." In: Crit Rev Eukaryot Gene Expr 2.1, pp. 1-18
(cit. on p. 71).
Palazzo, AF, M Springer, Y Shibata, CS Lee, AP Dias, and TA Rapoport (Dec. 2007).
"The signal sequence coding region promotes nuclear export of mRNA." In: PLoS
Biol 5.12, e322. DOI: 10.1371/journal.pbio.0050322 (cit. on p. 73).
Pyhtila, B, T Zheng, PJ Lager, JD Keene, MC Reedy, and CV Nicchitta (Mar.
2008). "Signal sequence- and translation-independent mRNA localization to the
endoplasmic reticulum." In: RNA 14.3, pp. 445-53. DOI: 10. 1261/rna. 721108
(cit. on pp. 71, 73).
Robinson, MD and A Oshlack (2010). "A scaling normalization method for differential
expression analysis of RNA-seq data." In: Genome Biol 11.3, R25. DOI: 10. 118
6/gb-2010-11-3-r25 (cit. on p. 81).
Squillace, RM, DM Chenault, and EH Wang (Oct. 2002). "Inhibition of muscle dif-
ferentiation by the novel muscleblind-related protein CHCR." In: Dev Biol 250.1,
pp. 218-30 (cit. on p. 62).
Sundell, CL and RH Singer (Sept. 1991). "Requirement of microfilaments in sorting
of actin messenger RNA." In: Science 253.5025, pp. 1275-7 (cit. on p. 71).
Tannous, BA, DE Kim, JL Fernandez, R Weissleder, and XO Breakefield (Mar. 2005).
"Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in
culture and in vivo." In: Mol Ther 11.3, pp. 435-43. DOI: 10. 1016/j . ymthe. 200
4.10.016 (cit. on p. 73).
Teplova, M and DJ Patel (Dec. 2008). "Structural insights into RNA recognition by
the alternative-splicing regulator muscleblind-like MBNL1." In: Nat Struct Mol
Biol 15.12, pp. 1343-51. DOI: 10. 1038/nsmb. 1519 (cit. on p. 68).
Ule, J, K Jensen, A Mele, and RB Darnell (Dec. 2005). "CLIP: a method for identi-
fying protein-RNA interaction sites in living cells." In: Methods 37.4, pp. 376-86.
DOI: 10.1016/j .ymeth.2005.07.018 (cit. on p. 62).
Chapter 3. Transcriptomne Regulation by MBNLs 3.5. References
Vedeler, A, IF Pryme, and JE Hesketh (Feb. 1991). "The characterization of free,
cytoskeletal and membrane-bound polysomes in Krebs II ascites and 3T3 cells."
In: Mol Cell Biochem 100.2, pp. 183-93 (cit. on p. 70).
Wang, Z, J Tollervey, M Briese, D Turner, and J Ule (July 2009). "CLIP: construction
of cDNA libraries for high-throughput sequencing from RNAs cross-linked to pro-
teins in vivo." In: Methods 48.3, pp. 287-93. DOI: 10. 1016/j . ymeth. 2009 . 02. 021
(cit. on pp. 65, 77).
Yeo, GW, NG Coufal, TY Liang, GE Peng, XD Fu, and FH Gage (Feb. 2009). "An
RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein
interactions in stem cells." In: Nat Struct Mol Biol 16.2, pp. 130-7. DOI: 10. 103
8/nsmb.1545 (cit. on p. 66).
Yeo, G, D Holste, G Kreiman, and CB Burge (2004). "Variation in alternative splicing
across human tissues." In: Genome Biol 5.10, R74. DOI: 10. 1186/gb-2004-5-1
0-r74 (cit. on p. 83).
Zhang, C and RB Darnell (July 2011). "Mapping in vivo protein-RNA interactions
at single-nucleotide resolution from HITS-CLIP data." In: Nat Biotechnol 29.7,
pp. 607-14. DOI: 10. 1038/nbt. 1873 (cit. on p. 68).
Zhang, C, MA Frias, A Mele, M Ruggiu, T Eom, CB Marney, H Wang, DD Licat-
alosi, JJ Fak, and RB Darnell (July 2010). "Integrative modeling defines the Nova
splicing-regulatory network and its combinatorial controls." In: Science 329.5990,
pp. 439-43. DOI: 10. 1126/science. 1191150 (cit. on p. 66).
Zhao, J, L Hyman, and C Moore (June 1999). "Formation of mRNA 3' ends in eu-
karyotes: mechanism, regulation, and interrelationships with other steps in mRNA
synthesis." In: Microbiol Mol Biol Rev 63.2, pp. 405-45 (cit. on p. 70).
Chapter 3. Transcriptome Regulation by MBNLs 3.5. References
3.6 Figure Legends
Figure 3-1. Dependence of splicing changes on total MBNL levels by RNA-
seq analysis. (A) RNA-seq read coverage across a cassette exon in Trim55, from
wild type and MBNL1 knockout heart tissue. T as estimated by MISO is greater in
wild type as compared to MBNL1 knockout. (B) Global correlation of T values for
cassette exons. Correlations are greatest within tissue, followed by within genotype.
(C) The fraction of MBNL1, MBNL2, or total MBNL in knockout brain, heart,
muscle, and knockdown C2C12 myoblasts relative to control brain, heart, muscle,
and C2C12 myoblasts. (D) Total splicing dysregulation, or mean lAW|, correlates
best with the extent of total MBNL depletion, not the extent of MBNL1 depletion.
Figure 3-2. MBNL binding is conserved and associated with context-
dependent splicing activity. (A) MBNL1 and Nova CLIP tags derived from var-
ious tissues and cells are observed in the 3' UTR of Reticulon 4. CLIP densities corre-
late across genetic background, with slight differences for the same factor in different
cell types. (B) CLIP tag densities in 5 nucleotide bins across all 3' UTRs expressed in
brain and C2C12 myoblasts cluster primarily by protein CLIPped, then tissue type.
(C) Four-mers occurring most frequently in MBNL1 CLIP clusters from C2C12 my-
oblasts, relative to clusters chosen at random from identical genes. (D) Alternative
exons with MBNL1 CLIP clusters upstream or downstream of the exon are more con-
served than other alternative exons expressed at similar levels. (E) Fibronectin 1 exon
EIIIB is repressed by MBNLs, and inclusion levels correlate monotonically with total
levels of MBNL in C2C12 mouse myoblasts. MBNL1 binding is observed throughout
both introns flanking the alternative exon, but most densely in the upstream exon
and within the exon itself. (F) Sercal exon 22 is enhanced by MBNL1 binding. T in
MBNL1 knockout muscle is 2% and T in wild type muscle is 100%. MBNL1 binding
is observed downstream of the 5' splice site. (G) MBNL1 binding in the upstream
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intron (300 bases) and alternative exon is associated with splicing repression, and
binding in the downstream intron (300 bases) is associated with splicing activation,
both in a dose-dependent manner as inferred by CLIP density.
Figure 3-3. An RNA map of MBNL activity at nucleotide resolution.
(A) Examples of substitutions commonly observed in MBNL1 CLIP tags. The rate
of these crosslink-induced substitutions, p(CIS), is defined. (B) Cytosine exhibits
the greatest p(CIS) within MBNL1 CLIP clusters, and is most often sequenced as
thymine. (C) Cytosines exhibiting frequent substitutions are flanked by a UGCUU
motif. The strength of the motif increases with the frequency of cytosine substitutions.
(D) An RNA map for MBNL1 function at the nucleotide level constructed using
binding and functional data. The RNA map using p(CIS)c+r > 0.1 suggests that
MBNL1 splicing repression and activation are sharply separated by the 5' splice site.
An RNA map using all CLIP tags (inset) is noisier and exhibits a weak activation
peak.
Figure 3-4. MBNL binding in 3' UTRs is common and associated with in-
creased conservation and specific cellular compartments. (A) MBNL1 CLIP
density is found predominantly on the 5' side of the cleavage and polyadenylation (pA)
site, and increases as distance to the pA site decreases. (B) 3' UTRs with MBNL1
CLIP clusters are more highly conserved than 3' UTRs in genes with similar expres-
sion levels and UTR lengths. (C) 3' UTRs with MBNL1 CLIP clusters are enriched
for particular cellular components, across multiple cell and tissue types.
Figure 3-5. mRNA localization is associated with functional binding by
MBNL. (A) Cellular fractionation scheme in C2C12 mouse myoblasts and fly S2
cells. Adherent myoblasts were fractionated on tissue culture plates, while semi-
adherent S2 cells were fractionated using centrifugation, yielding "cytosolic", "mem-
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brane", and "insoluble" compartments. (B) Western blot of Hsp90, Calnexin, and
Tropomyosin I proteins for each compartment in control and MBNL knockdown my-
oblasts. (C) Simplex representation of mRNA expression of functional categories
in control myoblasts. mRNAs encoding "nucleosome" proteins are biased toward
the "cytosolic" compartment, whereas those encoding "integral membrane proteins"
or "proteinaceous extracellular matrix" proteins are biased towards the "insoluble"
compartment. (D) Density map of MBNL1 CLIP targets in control myoblasts. The
relative abundance of genes with 0, >4, >6, or >8 CLIP clusters is illustrated within
the simplex, and quantified for areas of the simplex delineated by the dashed line.
MBNL1 CLIP targets are enriched in the "insoluble" corner of the simplex. (E)
MBNL1 CLIP targets are significantly biased towards the insoluble and membrane
compartments relative to the cytosolic compartment, in a manner dependent on the
number of 3' UTR CLIP clusters.
Figure 3-6. MBNL binding is associated with regulation of mRNA local-
ization in mouse and fly, and may contribute to protein secretion. (A &
B) Change in mRNA localization following depletion of MBNLs in mouse myoblasts
and fly S2 cells. Arrows represent changes in mRNA localization, where the direction
change is encoded by color. (C & D) MBNL targets are depleted from the membrane
compartment and enriched in the insoluble compartment following MBNL depletion.
The aggregate behavior following MBNL depletion of the subset of genes biased to-
ward the insoluble compartment in control cells was analyzed and illustrated in a
polar plot, where the radius is defined by the number of genes moving toward any
given direction following MBNL depletion. Subdivision of genes by 3' UTR CLIP
cluster density reveals that MBNL binding is associated with localization of targets
to the insoluble compartment in a dose-dependent manner, where MBNL binding is
defined by CLIP clusters in mouse myoblasts and by UGCU frequency in fly S2 cells.
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The aggregate change in localization towards each compartment following MBNL de-
pletion for these genes is illustrated in bar plots. P-values denote the significance
of this effect when comparing the change in localization for MBNL targets vs. non-
targets (e.g. >2 vs. 0-0.5 for mouse myoblasts, and >8 vs. 0-4 for fly S2). (E)
Change in mRNA localization of Fibronectin 1 (Fn1) and Biglycan (Bgn) following
MBNL depletion in mouse myoblasts. The percent change in RPKM within each cel-
lular compartment is illustrated as bars, and MBNL1 CLIP tag density is illustrated
in the 3' UTR of each gene. (F) Heterologous secretion reporters demonstrate that
MBNL depletion by CUG repeats leads to a 10-20% decrease in secretion of Gaussia
luciferase containing the Bgn 3' UTR or the Fnl last intron plus 3' UTR, and that
this decrease can be partially rescued by MBNL1 overexpression.
Figure 3-7. MBNL regulates isoform-specific mRNA localization via bind-
ing to alternative 3 UTRs. (A) The fraction of transcripts using the Insig2 distal
cleavage and polyadenylation (pA) site (T) in each cellular compartment, in control
and MBNL-depleted mouse myoblasts. The distal pA site is favored in the mem-
brane and insoluble compartments relative to the cytosolic compartment in control
cells, but this bias is lost following MBNL depletion. (B) MBNL1 binds throughout
the 3' UTR of Insig2, and most notably in the distal 3' UTR. (C) Distal pA usage is
favored in the insoluble and membrane compartments relative to the cytosolic com-
partment in control mouse myoblasts. The fraction of genes favoring the distal pA
site in these comparisons is significantly different than that of those genes that do not
favor any site (BF < 5), and greatest when analyzing the most significantly regulated
alternative pA events. (D) The bias in distal pA usage is reversed following MBNL
depletion. Arrows originating from filled black circles and pointing towards colored
circles represent the change in distal pA bias from control to MBNL-depleted cells, re-
spectively. This change in bias is highly significant and strongest when analyzing the
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most significantly regulated alternative pA events. (E) The reversal in bias towards
distal pA usage following MBNL depletion is strongest for those alternative 3' UTRs
with evidence of MBNL binding. A subset of significantly regulated alternative pA
events (BF > 20) was subdivided into those with low, medium, and high CLIP cluster
density within the entire 3' UTR. Events with high CLIP cluster density exhibit the
greatest reversal in bias towards distal pA usage following MBNL depletion.
Figure 3-8. A model for splicing- and non-splicing functions of MBNL.
MBNLs perform both splicing repression and activation functions, and additionally
may first bind to 3' UTRs in the nucleus. Following nuclear export, the targeting of
mRNAs with signal sequences to the rough ER may be enhanced by MBNL binding
in 3' UTRs. Alternatively, transcripts may be targeted to the cytoskeleton or other
membrane-rich organelles via actin-, microtubule-, or intermediate filament-based
molecular motors. These organelles may include synapses, neuromuscular junctions,
or the plasma membrane, depending on cell type. Isoform-specific mRNA localization
may be mediated by MBNL, in which MBNL binding sites within distal 3' UTRs are
required for targeting to particular compartments.
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Figure 3-8: A model for splicing- and non-splicing functions of MBNL.
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Chapter 4
Conclusion
4.1 Summary
This thesis has described the development of a powerful new approach for studying
transcriptomes, and applied it to an important biomedical problem. Chapter 2 de-
scribed the development and characterization of RNAseq for studying gene expression
and isoform usage (Wang et al. 2008), and increased previous estimates of the extent
to which human genes are alternatively spliced, to virtually all multi-exonic genes.
With the improved dynamic range and higher resolution of RNAseq, we were able to
demonstrate that tissue-regulated alternative splicing occurs at least two or threefold
more frequently than individual specific alternative splicing. We were also able to
study alternative polyadenylation and cleavage (APA), a type of RNA processing not
specifically targeted by splice junction or exon microarrays, and uncovered patterns
of APA and splicing regulation which correlated across tissues and cell lines. Further
phylogenetic analysis of cis elements suggested that the regulation of APA and splic-
ing may be mediated by the same trans factors, whose expression and activity varies
in different contexts.
Chapter 3 described the application of RNAseq and associated sequencing ap-
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proaches such as CLIPseq towards the study of the Muscleblind-like (MBNL) pro-
teins, a highly conserved, developmentally regulated family of RNA binding proteins
that is functionally inactivated in myotonic dystrophy (DM) (Begemann et al. 1997;
Miller et al. 2000). By profiling brain, heart, muscle, and myoblasts with and with-
out MBNL family member proteins (Kanadia et al. 2003), we were able to identify
functional targets of MBNLs, observing that MBNL1 and MBNL2 likely co-regulate
hundreds of shared targets. By biochemically purifying UV crosslinked complexes
containing MBNL1 (Wang et al. 2009b), we were able to identify the transcriptome-
wide binding targets of MBNL1, and construct an RNA map for MBNL function, in
which binding upstream and on top of alternative exons leads to splicing repression,
and binding downstream leads to splicing activation. We uncovered a new global
function for MBNLs, in which the proteins regulate the localization of mRNAs via
binding to 3' UTRs, and generalized the role previously demonstrated for MBNL2
(Adereth et al. 2005). Cellular fractionation experiments revealed that mRNA targets
of MBNL1 are depleted from the membrane compartment following MBNL depletion
in myoblasts, and that secreted proteins whose mRNAs are localized by MBNL are
secreted less efficiently following MBNL inactivation by CUG repeat expression.
The results in Chapter 3 can be viewed as the application of techniques and bi-
ological insights derived from Chapter 2 on multiple levels. We characterized the
strengths and weaknesses of RNAseq for studying transcriptomes at a technical level,
and characterized alternative isoform usage biologically across different tissues and
cell types, establishing expectations for the extent and types of regulation that would
be observed in response to different biological perturbations. We revealed that regu-
lation of splicing and 3' end processing may be mediated by a common set of protein
factors, and as a result, regulation of these events may be coordinated across biolog-
ical conditions. We used all of these insights derived from Chapter 2 to design and
interpret the experiments performed in Chapter 3. Power analysis of the relationship
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between depth of sequencing and number of detectable events partly informed the
experimental design for RNAseq of mouse tissues and myoblasts depleted of MBNLs.
The dynamic range of splicing regulation observed across tissues, particularly of ex-
treme, "switch-like" exons, set expectations for the MBNL-dependent splicing changes
we might observe. Finally, the phylogenetic analysis performed in Chapter 2, which
uncovered increased conservation of CUG-containing motifs in both introns and 3'
UTRs, foreshadowed a role for the MBNL splicing factors in localizing mRNAs via 3'
UTR binding. This function, formally demonstrated by the application of RNAseq
to subcellular fractions, holds implications for the role of subcellular localization in
controlling downstream biological processes, the roles that splicing factors play in
non-splicing activities, and the diversity of mechanisms by which sequestration of
MBNL proteins can lead to DM symptoms.
4.2 Future Directions
To fully study the DM transcriptome and understand the roles that RNA binding
proteins play in disease pathogenesis, our studies would have to extend beyond the
MBNL protein family, as other RNA binding proteins such as the CELF family have
been implicated to play a role in disease pathogenesis (Cooper et al. 2009). Also, an
assessment of actual DM transcriptomes, along with phenotypic data across a wide
range of disease severities and expanded repeat lengths, will be required to understand
how transcriptome changes lead to physiological consequences, and how they can be
prevented by therapeutic interventions.
Towards this end, we have embarked on a large scale sequencing project over the
past two years to sequence transcriptomes of multiple mouse models of DM, and
transcriptomes of DM autopsy and biopsy tissue, along with associated normal and
unrelated disease controls. The mouse models comprise time courses in which CELFI
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or CELF2 have been over-expressed in heart or muscle (Wang et al. 2009a; Ward et al.
2010), or time courses in which expanded CUG repeats have been over-expressed in
the context of the DMPK 3' UTR (Wang et al. 2007). To date, we have generated
over 100 DM and normal human tissue transcriptomes, of which a substantial fraction
are associated with robust phenotypic and clinical data. By studying all of these
transcriptomes in an integrative fashion, we can attempt to assess the extent to
which each RNA binding factor contributes to disease pathology in DM. We may be
able to assess whether the perturbation of MBNLs and CELFs accounts for most of
the molecular changes in DM cells, and depending on the conclusion, be able to focus
our efforts on correcting those changes, or searching for new, important, pathways of
which we are not yet aware.
DM has served as a paradigm for a new class of RNA dominant diseases, in
which the expression of RNA with aberrant properties perturbs cellular metabolism
in harmful ways (Cooper et al. 2009). Analogously, we have provided a model for
how global approaches can be used to make fundamental, biological insights about
disease pathogenesis. Emerging with testable hypotheses and theories about biolog-
ical mechanisms remains a challenge in global studies, particularly of disease, but a
comprehensive approach effectively prevents unusual phenomena from generalizing to
the whole, and allows investigators to focus on general principles. The integration of
these types of approaches, with focused investigations of representative examples, will
eventually yield powerful insights into disease pathogenesis and biological processes,
and reveal opportunities that can be harnessed for the improvement of human health.
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Introduction
A fundamental question in molecular biology is how cells and
tissues differ in gene expression and how those differences specify
biological function. A related question is what part of the cellular
machinery represents housekeeping functions needed by all cells
and how many genes encode such functions. The transcriptomes
of mammalian tissues have been extensively studied using methods
such as reassociation kinetics (Rot) [1], serial analysis of gene
expression (SAGE) [2], microarrays [3,4], and sequencing of
expressed sequence tags (ESTs) and full length transcripts [5].
Reassociation kinetics was used early on to study and compare
global properties of tissue transcriptomes [1,6]. From those studies
it was concluded that -20,000 mRNAs are expressed in each cell
or tissue, and that roughly 90% of all mRNAs are common
between two tissues, drawing the first conclusions on tissue
transcriptome compositions [7]. Later studies of tissue transcrip-
tomes using SAGE [8] identified -- 1,000 ubiquitously expressed
genes (i.e. expressed in all cell types examined) and concluded that
tissue-specific transcripts make up roughly 1% of mRNA mass of
cells. Focusing on colorectal cancer cell lines, for which the deepest
coverage was available, it was estimated that half of all mRNA
transcripts in these cells came from the 623 most highly expressed
genes. Comparing mRNA expression levels across panels of
human and mouse tissues by microarrays, Su and coworkers
identified tissue-specific genes for each tissue, and estimated that
-6% of genes were ubiquitously expressed, and that individual
tissues express 30-40% of all genes [9]. Using additional
microarray data, expression of -8,000 genes was detected in
each tissue but as few as 1-3% of these were detected in all tissues
[10]. Similar conclusions were drawn from a second mouse tissue
atlas [11] that identified - 1,800 genes as ubiquitously expressed.
Altogether, microarrays and SAGE have been quite successful in
identifying tissue and cell specific genes [8-12]. However, the
discrepancy between estimates of the composition and character-
istics of tissue transcriptomes obtained by microarray and SAGE
methods on the one hand and reassociation kinetics studies on the
other has not been explained.
Deep sequencing of RNAs (RNA-Seq) has recently been used to
quantify gene and alternative isoform expression levels [13-17]. In
RNA-Seq, all RNAs of a sample (or, more often, polyA* RNAs)
are randomly fragmented, reverse transcribed, ligated to adapters
and then these fragments are sequenced. Gene expression levels
can then be estimated from the number of sequence reads deriving
from each gene [15]. Expression estimates from RNA-Seq are
quantitative over five orders of magnitude and replicates of mouse
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tissues are highly reproducible [13]. Compared to microarrays,
RNA-Seq is more sensitive, both in terms of detection of lowly
expressed and differentially expressed genes [15,18], and expres-
sion values from RNA-Seq correlate better with protein levels
[19]. The greater accuracy and coverage of the expressed
transcriptome makes this method suitable for addressing global
features of transcriptomes.
We recently studied alternative isoform expressions across
tissues using RNA-Seq and found both a very high frequency of
alternative splicing and extensive tissue regulation of the
expression of alternative mRNA isoforms [14]. Here we instead
focused on a gene-centric analysis of transcript composition and
complexity. The highly quantitative nature of RNA-Seq has
motivated us to revisit the longstanding questions regarding the
composition of tissue transcriptomes, as well as the expression of
long non-coding RNAs, the variability in 3'UTR length, and the
association between these features and gene function.
Results
Excluding 3' UTR reads yields more accurate gene
expression estimates
We investigated the transcriptomes of a diverse collection of
human and mouse tissues and five breast and breast cancer cell
lines that were recently sequenced at a depth of roughly 20 million
short reads per sample using RNA-Seq protocols (Table S 1). Gene
expression was initially estimated by calculating read density as
'reads per kilobase of exon model per million mapped reads'
(RPKM) [13]. These estimates are typically performed using
common gene annotations (e.g., RefSeq) with the entire annotated
transcript representing the 'exon model'. These expression level
estimates may however be confounded by the expression of shorter
isoforms due to alternative cleavage and polyadenylation (Figure
SlA and SlB). We found that excluding annotated 3'UTRs -
which will sometimes vary between mRNA isoforms as a result of
alternative cleavage and polyadenylation - enabled estimation of
expression levels that correspond more closely with quantitative
RT-PCR measurements (Figure S1C). We noted that removing
the 3'UTR from calculation of gene expression yields a >2-fold
change for over one thousand genes (Figure SID), and that the
effect of 3'UTRs on expression estimates does not seem to be a
technical issue caused by secondary structure in the 3'UTR
(Figure S2). We therefore advocate excluding UTRs from such
estimates, and all subsequent gene expression estimates described
here excluded 3 'UTR regions.
Ubiquitous expression of -8,000 human genes
We next sought to answer how many genes are expressed in a
tissue or cell type. A comparison between the expression levels of
exons and intergenic regions was used to first find a threshold for
detectable expression above background (Figure IA, algorithm in
Figure S3), yielding a threshold RPKM value of 0.3 which balances
the numbers of false positives and false negatives. For individual
samples, we obtained threshold values between 0.2 and 0.8. As it is
difficult to identify untranscribed DNA regions with confidence
[20,21], it is very possible that the background was overestimated.
Applying the threshold 0.3 RPKM, the number of genes expressed
in most human and mouse tissues varied from 11,000 to 13,000,
corresponding to roughly 60-70% of RefSeq protein-coding genes
(Table 1). These gene number estimates were stable across different
sequencing depths (Figure 1 B) and therefore represent bona fide
tissue differences. Testis was a clear outlier, expressing more than
15,000 different genes (84% of RefSeq genes). As many as 7,897
genes (42%) were observed to be expressed in all tissues and cell lines
(Dataset S1). The corresponding number for Ensembl annotation
was 8,214, or 38% of protein-coding genes (Ensembl is an
automated gene annotation system, whereas RefSeq is manually
curated). Each ubiquitous gene was typically expressed at roughly
the same order of magnitude in all tissues, suggesting that there were
few problems with genes being considered ubiquitous when they
were really specific to one or a few tissues but had a leaky, non-
functional expression elsewhere (Figure S4). While we observed
small numbers of reads for 8 genes known to have leaky
transcription [22,23] in several tissues, these genes were all too
weakly or narrowly transcribed outside their main tissue to be
detected as ubiquitous. The estimated number of ubiquitously
expressed genes appeared to plateau as the number of samples used
was increased to the full set of 24 (Figure 1 C). The detection
threshold used affects the number of genes detected (Table 1), and
the number of detected ubiquitous genes can vary by up to -2,000
genes depending on threshold used. The number of samples is large
enough that background is unlikely to cause relatively tissue-specific
genes to be detected in every sample. These differences between
thresholds therefore most likely reflect the presence of low-
abundance RNA species. The number of ubiquitous genes we
detected is much greater than the -1,000 shared genes identified by
SAGE [8] and the 1-6% of genes from microarrays [9-11], but is in
relatively good agreement with the - 10,000 shared genes estimated
by reassociation kinetics [6] and the 3,140 to 6,909 estimated from
ESTs [24] (the higher number came from a cutoff of presence in 16
out of 18 tissues, used to remedy uneven EST sequencing across
tissues). The increased number of ubiquitously expressed genes
compared to SAGE and microarrays most likely results from the
increased depth of mRNA-Seq data and improved detection of
lowly expressed genes [22]. The number of genes expressed in a
tissue ranged from 11,199 to 15,518 genes (Table 2), so a majority of
the genes expressed in a specific tissue or cell type are ubiquitously
expressed genes. These genes contribute -75% of the polyA* RNA
molecules in most tissues (Table 3), although this fraction was higher
in the cancer cell lines, perhaps as a result of their elevated
metabolic rate.
Functions of ubiquitous and non-ubiquitous genes
To characterize the set of ubiquitously expressed genes we had
identified, we looked for functional enrichment compared to genes
expressed only in a subset of the tissues analyzed (hereafter called
non-ubiquitous). The protein products of human ubiquitously
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Figure 1. Functions of ubiquitous genes. (A) False discovery and negative rate for the detection of genes as a function of detection threshold
used, demonstrating how a threshold of 0.3 RPKM was chosen. (B) The number of genes detected (>0.3 RPKM) at different sequencing depths. Each
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Table 1. Number of expressed and ubiquitous genes for
various minimum expression thresholds.
Threshold RPKM In all 24 samples on average per sample
0.1 9,205 14,011
0.3 7,897 12,859
0.5 6,946 12,170
0.7 6,176 11,633
0.9 5,618 11,189
2 3,510 9,432
4 1,931 7,493
doi:10.1371/journal.pcbi.1000598.tOO1
expressed genes were more likely to have intracellular localization
and to be involved in metabolism and other core cellular functions
such as macromolecule synthesis, general transcription and vesicles
(Figure 1E). Genes that were expressed in only one or a few tissues
Table 2. Number of human genes expressed per tissue.
Number of Fraction of Ensembl
Tissue/Cell genes* genes* genest
Liver'3  11,392 0.61 12,191
MB435 4  11,847 0.64 12,726
T47D4  12,205 0.66 12,983
MCF74 12,281 0.66 13,216
Colon 13,016 0.70 14,052
Kidney 13,235 0.71 14,177
Breast 13,406 0.72 14,537
Testes 15,518 0.84 16,869
*annotations from RefSeq, protein-coding genes.
tnumber of protein-coding genes, annotations from Ensembl.
number of genes detected in mouse: skeletal muscle 11,799; liver 11,201; brain
13,626.2
standard deviation for samples from different individuals: 106.3
mean number for different individuals.
4breast cancer cell line.
5human mammary epithelial cell line.
doi:10.1371/journal.pcbi.1000598.t002
Table 3. Fraction of mRNA pool by copy number from
ubiquitous human genes.
Tissue/Cell Fraction ubiquitous
Heart 0.66
HME 4 0.75
Skeletal muscle 0.76
Testes 0.77
Adipose tissue 0.81
Lymph node 0.84
MB4353  0.89
BT474 3 0.90
'standard deviation for samples from different individuals: 0.01.2
mean number for different individuals.
3breast cancer cell line.
"human mammary epithelial cell line.
doi:10.1371/journal.pcbi.1000598.t003
were more often secreted or membrane-bound (Figure 1 E; Dataset
S2 and S3), suggesting that cellular contacts and communication are
mediated more often by specialized tissue-specific components.
Interestingly, an exception to this inside-outside rule was sequence-
specific DNA binding proteins, which are nuclear yet seldom
ubiquitously expressed. Among these transcription factors we found
that POU, homeobox and forkhead genes had the fewest
ubiquitously expressed members, consistent with roles in specifying
cell and tissue identity [25], whereas e.g. basic-leucine zipper factors
were more often ubiquitous (Table 4). Functional characterization
of housekeeping genes has been done in the past [26,27] (and
indirectly by [28]), with comparable results, although transporters
were found to be relatively tissue-specific in one study [26]. Rather
than looking at ubiquitous expression, that study compared the
mean number of tissues where the genes were expressed, which
could explain the difference. Ubiquitous genes often had CpG
islands near their promoters (Figure 1D), as has been observed
previously for ubiquitous and developmental genes [29]. The set of
ubiquitous genes with CpG-poor promoters were not enriched for
any GO category compared to all ubiquitous genes, nor were those
with CpG-rich promoters. These observations suggest that
ubiquitous expression is a better indicator of housekeeping functions
than promoter CpG content. Together, these analyses suggest that
much of the internal cytoplasmic machinery and most nuclear
functions are common to most or all tissues, and that a large portion
of the differences between tissues lie primarily in expression of
receptors and ligands that mediate communication, and in a subset
of sequence-specific DNA binding transcription factors.
Estimating the fraction of the transcriptome devoted to
specific functions
As RNA-Seq expression measurements are highly quantitative,
we also explored tissue transcriptome composition in terms of
113
Appendix A. Abundance of Ubiquitously Expressed Genes
Table 4. Expression of sequence-specific transcription
factors.
Transcription factor Number of Fraction non-
classification genes ubiquitous
Homedomain 239 0.89
ETS 28 0.71
p53 family 42 0.67
Nuclear hormone receptor 47 0.66
High mobility group 39 0.59
Basic-leucine zipper 53 0.42
'IPT: Immunoglobin-like fold shared by Plexins and Transcription factors; TIG:
Transcription factor ImmunoGlobin.
doi:10.1 371/journal.pcbi.1000598.t004
mRNA abundance classes [1] and the extent to which mRNA
populations are dominated by a few highly expressed genes. Genes
were sorted according to their expression and the fraction of the
total cellular polyA* RNA pool devoted to the most highly
expressed genes was determined. This analysis showed that
mRNA expression in both tissues (Figure 2A) and cell lines
(Figure 2B) followed a continuous distribution rather than
separating into distinct abundance classes as reported in previous
studies (e.g. [1,6]).
In muscle and liver transcriptomes, a small number of genes
contributed a large fraction of the total mRNA pool, e.g. the ten
most highly expressed genes in liver and muscle made up roughly
20-40% of the mRNA population. Other tissue transcriptomes
were more complex, with the ten most highly expressed genes
contributing only 5-10% of the mRNAs in brain, kidney and
testis. The remaining tissues had intermediate levels of complexity
(Figure 2A). The breast cancer cell lines had similar or greater
complexity than normal breast tissue (Figure 2B). Biological
replicates in both human and mouse tended to have highly similar
complexity distributions (Figure 2C, 2D). Mouse tissues had
somewhat similar profiles to corresponding human tissues
(Figure 2D), although a much higher expression of several acute-
phase genes in both human liver samples shifted their curves
toward lower complexity compared to mouse liver. We conclude
that kidney, testes and brain tissues have more complex
transcriptomes due to the expression of more genes and with less
dominance of a few highly expressed genes, whereas liver and
muscle tissues are the least complex and express fewer genes, with
more dramatic contributions of highly expressed genes.
We next asked what fractions of total cellular mRNA are
allocated to genes involved in different biological processes across
the different tissues and cell lines. For this purpose, we developed a
tool called FRACT (Functional Relative Allocation of Transcripts)
that assesses relative gene expression from RNA-Seq read density
for arbitrary sets of genes or broad gene ontology (GO) categories
(results for a subset of tissues are shown in Figure 3A). This analysis
provided a perspective on the functional priorities of cells in each
tissue, since allocating a large fraction of the polyA* RNA content
in a cell (and likely of translational capacity) to one functional
category represents a major investment of cellular resources. For
some categories, including 'metabolic process', 'transport', and
also 'regulation of cell proliferation', FRACT allocation varied
relatively little across the tissues and cell lines (as measured by the
coefficient of variation, CV, of the transcriptome fraction),
consistent with the expected 'housekeeping' functions of these
gene categories. Other categories had a far higher fraction of
transcripts allocated to them in one tissue than in others, e.g.
immune response (high in lymph node), muscle contraction, heart
development and electron transport (all high in heart), and signal
transduction and G protein-coupled receptor signaling (both high
in brain). These examples, representing more specialized activities
expected to be of increased importance in the corresponding
tissues, provided a molecular-level validation of the integrity of the
tissue samples and protocol used. In some cases, differences not
readily apparent from the broad GO categorization shown in
Figure 3A, could be detected by finer sub-classification of
categories - an example is shown in Figure 3B.
We also investigated the expression of thousands of large non-
coding RNAs (ncRNAs). These genes were found to contribute a
small fraction of transcripts to polyA* transcriptomes compared to
mRNAs (Figure 4A) as a result of their considerably lower
expression levels (Figure 4B). These levels are lower than for
mRNAs for all degrees of tissue-specificity (Figure 4C).
Tissue-specific gene expression is fairly well conserved
Muscle and brain tissues from human and mouse were observed
to have similar expression and FRACT distributions (Figure 2D
and data not shown), raising the question of the extent of
conservation of tissue-specific expression patterns. We compared
global gene expression levels between human and mouse tissues
and observed high correlations between expression of orthologous
genes between human and mouse (Pearson correlation 0.76 for
muscle, 0.77 for liver and brain). When different tissues were
compared (e.g. human brain vs. mouse muscle) substantially
weaker correlations were observed (Pearson correlations in the
range 0.47 to 0.61). These observations indicate a fairly strong
overall conservation of gene expression levels between mouse and
man, consistent with previous studies based on microarrays [30].
3' UTR length varies 3-fold between different functional
groups of genes
The lengths of mRNAs were studied by mapping the reads to
coding and untranslated regions. Using RefSeq annotations, the
density of reads in untranslated regions was lower than in coding
regions (Figure 5A), suggesting that expression of mRNAs with
UTRs shorter than or distinct from those annotated in RefSeq is
common. We therefore estimated the lengths of the UTRs as their
relative number of reads to coding regions using the annotated
coding region length. Mouse data from [13] was chosen for this
analysis as this dataset had little 3' bias (Figure S5). In all three
mouse tissues studied, significant negative correlations were
observed between expression level and transcript lengh (-0.31
in liver and muscle, -0.16 in brain; all tissues p<10 8 ), showing
that shorter mRNAs tend to be expressed at higher levels
(Figure 5B). This result agrees with that from reassociation kinetics
data [31]. Weighting each gene by the expression level to obtain
length estimates for the bulk mRNA population in tissues to obtain
the average mRNA length in each tissue, we found that brain
mRNAs have longer 3'UTRs on average than liver and muscle
mRNAs, by 300-400 nucleotides (Figure 5C).
To assess the protein functions encoded by transcripts with long
or short UTRs, we calculated the median length of 5' and 3'UTRs
of genes associated with each GO biological process category
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Figure 2. Complexity of tissue transcriptomes. (A) The fraction of all mRNAs derived from the most highly expressed genes for a number of
mouse and human tissues. For example, the 10 most expressed genes in mouse liver contribute 25% of all mRNAs in that tissue. (B) Same as A, but
with cell lines from breast. HME is a transformed cell line from normal mammary epithelium, breast is the normal tissue, the others are breast cancer
cell lines from invasive ductal carcinoma. Gray lines are the tissues in A. (C) Same as B, but with 2 human livers and 6 human cerebellar samples from
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tissues from mouse.
doi:1 0.1371/journal.pcbi.1000598.g002
(Figure 6B and data not shown). Transcripts coding for proteins
involved in metabolism and RNA processing had the shortest
UTRs (medians below 500 bp), while the longest median UTR
lengths were observed in transcripts encoding proteins involved in
development, morphogenesis and signal transduction (Figure 6A).
The median lengths in the longest categories ranged between 1000
and 1500 nt, i.e. two- to three-fold longer than for typical
metabolism- or RNA processing-associated transcripts. Some of
these differences might reflect an increased role for 3'UTR
sequences in localization of proteins to specific membrane
locations, likely to be more common for proteins involved in
signal transduction and morphogenesis than for metabolic or RNA
processing-associated proteins, which are typically cytoplasmic or
nuclear, respectively. These differences could also reflect differ-
ences in the complexity of translational regulation among these
classes of genes.
Discussion
A surprise in our analysis was the large number of ubiquitous
genes found expressed in all tissues and cell lines, and that these
genes account for a majority of the mRNA pool. This pattern
suggests that tissue identity derives less from expression of distinct
sets of genes in different tissues than was previously thought.
Ubiquitous genes can still vary in relative expression levels
between tissues however, and in expression of alternative mRNA
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isoforms [14]. Although a still limited set of tissue and cell lines was
available for this meta-analysis (24 in total), the observation
appears robust to inclusion of additional tissues (Figure 1 C). Many
genes had a low and rather constant expression across tissues. This
could mean our expression detection was affected by subpopula-
tions of cells, limiting the extent our conclusions can be
extrapolated to single cells, but it could also indicate the existence
of a large population of lowly but universally expressed genes. One
subpopulation that could potentially impact these estimates would
be organism-wide cell types. For example, blood-related cells may
be found in all vascularized tissues and genes specific to these cells
may be detected as ubiquitous. Our study limited this effect by
requiring ubiquitous genes to also be detected in cell lines. Future
analyses of pure cell populations could definitely assess the
contributions of common cell types. When single-cell transcrip-
tomes (like [32]) are available for multiple cell types, it will be
possible to identify the core set of genes expressed in every
mammalian cell. Still, our analyses of tissue transcriptomes points
to a higher number of core genes even in individual cells than
previously inferred.
Transcriptome complexity varied substantially across tissues,
with brain, kidney and testis having higher complexity in that they
expressed more genes and had more diverse mRNA populations.
This increased transcriptome complexity may stem from the
presence of more heterogeneous cell types in brain and testis or
from a need for more diverse protein repertoires. The lower
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complexity observed in liver, muscle and heart presumably reflects
more specialized functions of these tissues. Our FRACT analysis
estimated the fraction of mRNA populations devoted to biological
processes that are more specific for muscle and liver cells, such as
muscle contraction, metabolism, electron transport and acute-
phase response. At this point we have only static pictures of the
functional allocation of mRNA resources across tissues and cell
lines. Following the dynamic regulation of mRNA allocations
during developmental or disease progression would therefore be of
great interest, and might lead to robust gene expression signatures
that are diagnostic of cellular state.
Many studies (e.g. [33,34]) cite the existence of three distinct
abundance classes of mRNAs, originally observed by reassociation
kinetics [1,6] (reviewed in [7]). Although we detected mRNA
expression levels that varied across several orders of magnitude, we
observed no separation of mRNAs into distinct expression level
classes, instead finding a continuum of expression levels. Similarly,
no separation into distinct expression classes was observed in
SAGE data (Figure 4 in [35]), although the authors discussed the
larger impact of sequencing errors. This discrepancy with
reassociation kinetics analyses may result from the limited number
of data points used in these earlier studies, in conjunction with line
fitting algorithms that could artificially add inflection points [1,36].
Previous studies using ESTs and microarrays have found a bias
towards the usage of longer 3'UTRs in brain tissues [14,37] and
found that 3'UTR length can be dynamically regulated in
response to activating and mitogenic signals [38]. The short read
sequencing data allowed us to estimate the average lengths of
transcripts in different tissues and we found that brain expressed
mRNAs with 3'UTRs 300-400 bp longer on average than in
other tissues. An important factor seems to be the brain-specific
expression of genes with long 3'UTRs (data not shown). Perhaps
this is required in a tissue where many mRNAs are transported far
away from the nuclei, or the variety among neurons requires a
large regulatory capacity housed in the UTRs. Interestingly,
transcripts coding for specific protein functions seem to require
longer 3'UTRs and 5'UTRs, including proteins involved in axon
guidance which have on average almost three times the UTR
length of ribosome biogenesis genes [39], suggesting extensive
UTR-based regulation, e.g. of translation and/or mRNA
localization, in this class of genes [40,41].
It was striking how many protein-coding genes were expressed
in all samples studied, even including many transcription factors.
This pattern could help in identifying determinants of cell identity
and responses, as ubiquitous genes are less interesting candidates
and could be discarded or separated when clustering samples by
gene expression. It could also make it easier to select candidate
disease genes after genetic linkage or association studies as
ubiquitous genes are less involved in hereditary diseases [42].
Furthermore, it accentuates the importance of cell communication
as a regulatory mechanism, as these components are mostly
restricted to particular tissues and cell types and play a role in
'calculating' what state a cell should have [43], information that is
then transmitted through a relatively static interior of the cell.
These components have relatively recent origins as a result of their
importance in multicellular organisms [28,44], and sit on the
periphery of the protein interaction network, conveying informa-
tion directly to and from the center consisting of highly connected
and generally ubiquitously expressed genes [45-47].
Methods
Short-read RNA sequence data
We used short read data from human tissues from [14]
(SRA002355.1) and [18], mouse tissues from [13] (downloaded
from http://woldlab.caltech.edu/html/rnaseq), mouse embryonic
cell and body data from [16] (http://grimmond.imb.uq.edu.au/
mESEB.html) and cerebellum data from non-schizophrenic
humans from [48]. See respective papers for details on library
preparation, sequencing and general read mapping statistics. The
data from [18] were mapped to build hgl8 with bowtie [49] with
setting -best and ambiguous reads were removed. Two human
brain samples were used. The sample with lower sequencing depth
from a mix of individuals was used in the comparison with RT-
PCR data, while the deeper sample was used everywhere else.
Gene expression estimates
We mapped read positions onto gene models and estimated
gene densities as the number of reads divided by the number of
read start positions. We used only reads that mapped uniquely to
the genome, and only positions where a read could potentially
map uniquely counted toward exon length. For testing different
ways of measuring gene expression (by removing different parts of
the gene structure), we selected a set of genes with >2 exons and
only one annotated isoform in RefSeq whose expressions had been
measured by the MicroArray Quality Control project [50] in the
same two samples, UHR (universal human reference) RNA and
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brain. Cleavage and polyadenylation sites are from [51,52].
RefSeq or Ensembl gene annotations without 3'UTRs were then
used for all gene expression estimates. For genes with multiple
splice variants, we fitted an RPKM value to each variant by least
square regression and used the sum of the expression of all
isoforms (Figure S6). Isoforms that did not overlap directly but
were grouped only through overlap with a third isoform were not
considered to represent the same gene. All Pearson correlations
were calculated based on log-transformed expression. False
discovery and false negative rates were estimated using the
algorithm presented in Figure S3, which seeks to correct for the
presence of spurious reads mapping to non-expressed genes. The
extent of leaky ubiquitous transcription by comparison of the
ubiquitous set of genes to shuffled controls (Figure S4).
Gene ontology and CpG content
For three mouse tissues, we calculated RPKM values in the
same way as had been done for the human ones. Mouse genes
were matched to human orthologs using Entrez Gene. A list of
acute-phase genes was taken from http://www.informatics.jax.
org. DAVID [53] was used for finding enriched gene ontology
categories. Categorization of promoters by CpG content was
performed as described in [29]. Transcription factor annotations
are from [54].
Non-coding RNA
RefSeq gene annotation was used for protein-coding RNA (i.e.
accessions starting with NM_) and curated non-coding RNA
(NR_). We used the liftOver tool from the UCSC genome browser
to obtain human positions for lincRNA regions from [21].
Transcriptome analysis with FRACT
GO annotations for Ensembl transcripts were downloaded from
Ensembl (BioMart). The read density for each transcript in each
tissue was distributed among its annotated GO categories (total
transcript density/no. GO categories for the transcript). GO
categories were sorted by the total transcriptome density across
tissues and cell lines, and the 400 categories with greatest density
(accounting for 94% of total density) were aggregated into 17
broad classes; the remaining categories (6% of total transcriptome
density) were aggregated into an "other" class (see Dataset S4 for
mappings). The total density of transcripts devoted to each class in
each tissue was tabulated. The coefficient of variation in the
fraction of each transcriptome devoted to different classes was
computed, and a Z-score for each class was computed to identify
particular tissues which devote a significantly different fraction of
the transcriptome to particular classes (I Z-score I >2).
Length of the untranslated regions
The UTR lengths were calculated as the number of reads in a
UTR divided by the number of reads in CDS multiplied by the
CDS length. For the expression weighted average gene lengths, we
used the CDS length from Refseq gene annotation, but weighted
according to the expression of each gene. To see the correlation
between mRNA length and abundance, we took the CDS length
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Splice site strength-dependent activity and genetic
buffering by poly-G runs
Xinshu Xiao",3, Zefeng Wang",3, Minyoung Jang', Razvan Nutiul, Eric T Wang",2 & Christopher B Burge'
Pre-mRNA splicing is regulated through the combinatorial activity of RNA motifs, including splice sites and splicing regulatory
elements. Here we show that the activity of the G-run (polyguanine sequence) class of splicing enhancer elements is -4-fold
higher when adjacent to intermediate strength 5' splice sites (ss) than when adjacent to weak 5' ss, and -1.3-fold higher relative
to strong 5' ss. We observed this dependence on 5' ss strength in both splicing reporters and in global microarray and mRNA-Seq
analyses of splicing changes following RNA interference against heterogeneous nuclear ribonucleoprotein (hnRNP) H, which
cross-linked to G-runs adjacent to many regulated exons. An exon's responsiveness to changes in hnRNP H levels therefore
depends in a complex way on G-run abundance and 5'ss strength. This pattern of activity enables G-runs and hnRNP H to buffer
the effects of 5' ss mutations, augmenting both the frequency of 5' ss polymorphism and the evolution of new splicing patterns.
Certain other splicing factors may function similarly.
Genetic changes that perturb pre-mRNA splicing are commonly asso-
ciated with human genetic diseases, whereas other splicing altera-
tions have contributed to evolutionary innovations". Splicing may
be disrupted either by mutation of sequence motifs present in every
intron, namely the core 5' ss, 3' ss or branch point, or by mutation of
exonic or intronic splicing regulatory elements (SREs). Such changes
frequently result in skipping of exons or other major alterations to
the mRNA and the encoded protein, but they may be compensated
for during evolution by strengthening of other elements 5. In a recent
study, reciprocal compensatory evolution was observed for most pairs
of splicing elements in humans and mice, with weakening of element
A associated with strengthening of element B and vice versa, suggest-
ing that most elements that define exons may contribute additively to
exon recognition6 . However, for the the 5' ss and the 'G triplet' (that
is, three consecutive guanines) intronic splicing enhancers (ISEs; see
below), compensatory evolution was unidirectional, suggesting that
this pair of elements might have a special functional relationship 6.
G-runs have central roles in splicing of a number of important
cellular and viral genes, and they commonly function through recruit-
ment of splicing regulators of the hnRNP F/H gene family7-15 . Just
three consecutive guanines, a G triplet, are required for binding
of hnRNP F/H proteins and for splicing activity16 . G triplets are
extremely abundant in mammalian introns, where they commonly
function as ISEs, increasing the usage of adjacent splice sites. G triplets
are most highly enriched within the -70 nucleotides (nt) downstream
of the 5' ssi (Fig. la and Supplementary Fig. 1). The extremely
high density of G triplets located just 20-30 base pairs (bp) from the
5' ss, and the asymmetric coevolutionary relationship between these
motifs suggested that there might be strong functional links between
the 5' ss motif and the adjacent G-run ISEs. Here we explore this
possibility using a battery of classical and high-throughput molecu-
lar genetic approaches in human cells, uncovering an unexpected
but highly consistent pattern of functional interdependency that has
important genetic and evolutionary implications.
RESULTS
G triplets are more conserved near intermediate 5' ss
The 5'ss sequences of mammalian introns vary greatly in the degree
of complementarity to Ul small nuclear RNA (snRNA) and in their
intrinsic activity in pre-mRNA splicing". Using statistical models
that capture mono- and dinucleotide composition at pairs of 5' ss
positions, log-odds scores can be assigned to 5'ss motifs that reliably
predict function 19 . Using the MaxEnt model, scores of natural 5' ss
typically range between 0 bits (occasionally below zero) and 12 bits,
with the median around 9 bits. Increased density of G-rich and C-rich
sequences adjacent to mammalian exons with weak 5'ss or weak 3' ss
has been observed' 1,20.
Grouping orthologous pairs of human and mouse introns by their
5' ss scores, we observed that G triplets in the downstream intron
were more conserved than control trinucleotides (3-mers) in all splice
site strength groups, consistent with common ISE activity (Fig. 1b).
However, significantly greater conservation was seen for G triplets
located adjacent to intermediate-strength 5' ss (4-8 bits) than for
those adjacent to strong (>8 bit) or weak (<4 bit) 5' ss (P < 0.05; Fig.
1b). In these and subsequent analyses, the boundaries between higher
versus lower activity seemed to fall at 5' ss scores of 4 bits and 8 bits,
respectively, corresponding to the fourth and thirty-third percentiles
of constitutive exon splice site scores (that is, one-third of 5' ss are
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weaker than 8 bits). Here our analyses included only G-runs located
in the region + 11 to +70 relative to the 5' ss, where G triplets are
most enriched. The region +1 to +10 was excluded because G-runs
that overlap with the 5' ss motif tend to suppress rather than acti-
vate splicing of the upstream exon 21. Weaker exons are expected to
be more dependent on enhancers. Therefore, the more pronounced
conservation of G triplets adjacent to intermediate 5' ss relative to
weak 5' ss was unexpected, and it suggested the hypotheses that the
ISE activity of G-runs might vary depending on 5' ss strength and
that constitutive introns with weak 5' ss might depend more heavily
on other types of ISEs.
G-run ISE activity depends on 5' ss strength
To test this hypothesis, we assessed G-run ISE activity as a function of
5' ss strength and sequence using splicing reporter minigenes trans-
fected into cultured human cells (Fig. 1c). MaxEnt 5' ss scores corre-
lated well with splicing activity, as assessed by the fractional inclusion
of a test exon (Supplementary Fig. 2). Here we used the 'percent
spliced in' (PSI or T) value, the fraction of mRNAs that include an
exon as a proportion of mRNAs that contain the flanking exons22 , as
determined by quantitative reverse-transcription PCR (qRT-PCR).
Insertion of G-runs totaling 3 nt (G3), 6 nt (G6 ) or 9 nt (G9 ) down-
stream of the test exon consistently enhanced exon inclusion, with
increased enhancement associated with longer G-runs. Splicing acti-
vation was particularly pronounced for intermediate-strength 5' ss:
T values increased by 70%, from -20% to -90%, following insertion
of G9 in three reporters with 5-7-bit 5' ss (Fig. Ic and Supplementary
Table 1). Splicing enhancement by runs of G6 or G9 was more modest
for exons with weaker (P = 3.6 x 10-6) or stronger (P = 0.03) 5' ss.
Figure 1 Abundance, conservation and 5' ss strength-dependent activity
of G-run ISEs. (a) Excess count of GGG in introns downstream of human
constitutive exons. Excess count is defined as the difference between the
observed count and the expected count (0 - E; Supplementary Methods).
Each point represents the center of a 30-nt window, with a 3-nt offset
between successive windows. Black bars show the s.e.m. (b) Mean and
s.e.m. of the conservation rate (CR) ratio, calculated as O/C (observed/
control) conservation for GGG in positions +11-70 downstream of exons
12 conserved between humans and mice. The intermediate 5' ss bins (4-6,
tel 6-8 bits) had significantly higher CR, and the very strong bin (10-12
bits) had significantly lower CR (all P< 0.05, Bonferroni corrected)
than control sets sampled from the other 5' ss strength bins to match
GGG counts. (c) ISE activity of G-runs in modular splicing reporters (See
Online Methods). Below, change in T value (qRT-PCR) of the test exon of
selected splicing reporters (Supplementary Table 1) with different
5' ss (listed at right) containing runs of three, six or nine guanine residues
inserted in the downstream intron relative to the corresponding reporters
with control inserts. Error bars indicate the range of the replicated
experiments. Above, increase in T value of a test exon with inserted
G-runs relative to control insert (mean ± s.e.m.), normalized by the
number of guanines in the inserted G-runs. Splicing reporters were
ore (bits) grouped into weak (w), intermediate (i) and strong (s) bins according
0.3 to 5' ss score of the test exon. P-values were calculated by the Wilcoxon
0.6 rank-sum test.
0.7
(Enhancement did not differ significantly for G3.) Considering all of
the data, we observed an increase in T value of -20% per inserted
G triplet on average for intermediate 5' ss, -1.3-fold greater than the
mean enhancement for strong 5' ss and some 4-fold higher than the
mean for weak 5' ss (Fig. 1c, above).
ISE activity was much more dependent on 5' ss strength than
specific sequence, with similar ISE activity observed for different
5' ss sequences of similar score (Fig. Ic and Supplementary Table 1).
The dependence of ISE activity on 5' ss strength was robust to differ-
ences in the starting T value, that is, the ' value before insertion of
G-runs (Supplementary Fig. 3a). We found no consistent pattern of
dependence of ISE activity on 3' ss strength (Supplementary Fig. 4a).
These observations suggested that G-run ISEs located downstream of
an exon recruit factor(s) that enhance splicing at a step closely associ-
ated with 5' ss function, such as 5' ss recognition by U 1 small nuclear
ribonucleoprotein (snRNP) or progression from U 1-5' ss recognition
to formation of the exon definition complex 23 (see Discussion).
Intermediate 5' ss exons are more responsive to hnRNP H
hnRNP H is the most highly expressed member of the G-run-binding
hnRNP F/H protein family in HEK 293T cells24 . RNA interference
(RNAi) directed against hnRNP H resulted in substantial (around
threefold to fourfold) reductions in target mRNA and protein levels
by qRT-PCR and western analysis, 72 h after initial transfection of
the small interfering RNA (siRNA) (Supplementary Fig. 5). We did
not observe any compensatory upregulation of closely related fac-
tors25 : expression of the gene encoding hnRNP F, HNRNPF, was also
reduced by the siRNA used, whereas HNRNPH2 (encoding hnRNP
H') (which showed approximately five-fold lower expression than the
gene encoding hnRNP H) was unaffected and HNRNPH3 (encoding
hnRNP 2H9) was not detectably expressed (see Online Methods).
To assess the activity of G-runs in regulation of endogenous exons,
we assessed changes in exon inclusion following hnRNP H knock-
down by deep sequencing of mRNAs (mRNA-Seq) using the Illumina
platform and by Affymetrix all-exon microarrays. We estimated the
P values of exons from mRNA-Seq read densities as described 26.
Analysis of mRNA-Seq read densities identified 214 exons whose -
values changed significantly, at a cutoff corresponding to a 5% false
discovery rate (FDR). Of these, 79% (169 of 214) had >3 guanines
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Figure 2 hnRNP H knockdown and mRNA-Seq analysis of G-run activity. (a) Change in V (mean ± s.e.m.; 30
control - hnRNP H knockdown) of exons grouped by number of guanines in downstream intronic G-runs 15
(for example, the bin labeled 6 includes exons with six to eight guanines in G-runs). Data were obtained
from mRNA-Seq analysis of total RNA following RNAi directed against hnRNP H. (b) Change in T (mean 1
± s.e.m.) of exons with 6 guanines in G-runs in downstream introns grouped by 5' ss score relative to 2
control exons lacking exonic or intronic G-runs (0 - E). The relative change was significantly higher for .9 9
the intermediate-strength 5' ss (4-6 bit) and significantly lower for the strong (8-10 bit) 5' ss bins (both 0 6
P< 0.05, Bonferroni corrected) relative to control sets sampled from the other 5' ss bins to match the
distribution of numbers of guanines in runs G3 or longer. No significant differences in flanking nucleotide 3
frequency were detected between 5' ss bins. (c) Same as a for exons with different numbers of guanines 0 4 6 8 10 12
in G-runs in the exons, excluding those with upstream or downstream intronic G-runs. (d) Same as b for
exons with 61 guanines in exonic G-runs. The relative change was significantly lower for the strong (10-12 bit) 5' ss bin relative to control sets sampled
from the other 5' ss bins (P< 0.05, Bonferroni corrected). (e) Change in 'P (0 - E, same as b) of all exons grouped both by the number of guanines in
downstream intronic G-runs and the 5' ss score.
in G-runs, and 61% (131 of 214) had 6 guanines in G-runs within
70 bp of the 5' ss, both values being significantly higher than levels
in control exons whose P values did not change (P < 1.7e- 8 and P <
1.2e1, respectively; Fisher's exact test). Furthermore, GGG was the
most enriched 3-mer within 70 bp 3' of the 214 exons (not shown),
consistent with widespread reduction in ISE activity of G-runs
following RNAi against hnRNP H.
Similar or greater ' value changes were associated with intronic
GGGG motifs than with other 4-mers containing GGG, with no
other significant differences observed between GGGN and NGGG
4-mers (Supplementary Fig. 6), suggesting that G-run length rather
than the flanking nucleotide context is the primary determinant of
ISE activity in this system. We observed similar T value changes for
exons flanked by G-runs independent of the initial ' value or 3' ss
strength (Supplementary Figs. 3b and 4d), and for GGGs located at
different positions within the range +11 to +70 relative to the 5' ss,
to the extent that we could assess this variable using the available data
(Supplementary Fig. 6).
Larger changes in P value were associated with larger numbers of
guanines in intronic G-runs in both the mRNA-Seq and exon array
analyses (Fig. 2a and Supplementary Fig. 7b), with better fit to a
linear (additive) rather than multiplicative model of G-run ISE
activity (Supplementary Fig. 7d,e). This relationship paralleled that
observed for the splicing reporters (Fig. Ic and Supplementary Fig. 3a).
Grouping expressed exons with downstream G-runs by 5' ss strength,
the largest decreases in ' value following RNAi were observed for
exons with intermediate-strength (4-8 bit) 5' ss (P < 0.05; Fig. 2b).
Thus, three independent lines of evidence--evolutionary conservation,
splicing reporter analyses and RNAi mRNA-Seq and exon array analyses
(Supplementary Fig. 7c)-all supported the conclusion that G-run
ISE activity is sensitive to 5' ss strength, with higher activity for exons
containing intermediate-strength 5'ss.
Conversely, ' values of exons with internal G-runs tended to
increase following hnRNP H knockdown, consistent with pre-
vious observations that exonic G-runs commonly function as
ESSs27 s2 8 .Again, the change in ' value increased proportionally to
the total length of the G-run (Fig. 2c). We also observed effects of
5' ss strength for exons containing internal G-runs, with the highest
inferred ESS activity for exons with strong or weak 5' ss, and little
or no ESS activity detected in the context of intermediate-strength
5' ss (Fig. 2d), a relationship inverse to that observed for the ISE
activity of intronic G-runs. Measurement of ' values for a subset
of exons by qRT-PCR yielded a good correlation with ' values
estimated by mRNA-Seq (Supplementary Fig. 8) and identified a
high-confidence set of hnRNP F/H-responsive exons, including
exons in the ATXN2, MADD and TARBP2 genes (Supplementary
Fig. 8 and Supplementary Table 2).
For the RNAi and mRNA-Seq experiment, we were able to map
the full spectrum of G-run ISE activity, as inferred from change in
' value, for exons with varying 5' ss strength, yielding a smoothly
varying pattern (Fig. 2e). It is clear from this representation that an
exon's responsiveness to hnRNP H is not just a function of the den-
sity of G-runs but is actually a function of both G-run length and
5' ss strength. The bivariate nature of this function is expected to
result in finer regulatory discrimination between subsets of exons
(for example, between exons with strong, intermediate and weak
5' ss) in their responsiveness to changes in hnRNP H levels. Such
changes may occur under developmental or physiological conditions
or in disease states in which hnRNP H activity is altered, such as
myotonic dystrophy29 ,3 0 .
The concordance between the activities of G-runs observed in the
splicing reporter assays and in the hnRNP H knockdown experiment
suggested that a substantial proportion of the effects observed in these
systems were the result of direct effects of hnRNP H protein bound
to intronic G-runs. Data from cross-linking/immunoprecipitation/
sequencing (CLIP-Seq) experiments using antibodies against hnRNP
H in HEK 293T cells further supported this idea. The CLIP-Seq data
set, generated as part of a separate study of untranslated region
(UTR)-associated functions of hnRNP H, constituted 2.9 million
32-bp CLIP tag sequences that could be mapped uniquely to the
human genome. In these CLIP tag sequences, guanine was highly
enriched, and GGG was the most abundant 3-mer, enriched more
than five-fold relative to the average 3-mer (Supplementary Table 3).
Thus, these transcriptome-wide in vivo binding data were consistent
with the high affinity of hnRNP H for runs of three or more guanines
that was observed previously in vitro.
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Figure 3 Genetic buffering by G-runs. (a) G-runs as an evolutionary buffer to 5' ss mutations. Exon inclusion data from reporters s2 and 3 in
Figure 1c. Dashed white line represents percent inclusion that would result if the G-run activity were no greater for intermediate-strength 5' ss
exons than for strong 5' ss exons. Cb) Higher SNP density in 5' ss of exons with downstream (+11-70) G-runs. Mean and s.e.m. are shown of the ratio
(O/E) between the fraction with 5' ss SNPs among exons with G-runs and that in control exons lacking G-runs but with matched compositional bias
(*P< 0.001, rank sum test). Inset shows results for in-frame and out-of-frame exons separately for exons with >6 guanines in G-runs. (c) Larger change
in 5' ss strength between orthologous human (h) and mouse (m) exons with conserved downstream G-runs. The O/E ratio was defined similarly as in b,
but the absolute change in MaxEnt 5' ss scores was calculated (*P< 0.001). (d) Higher fraction of exons with different splicing phenotypes in human
and mouse (constitutive (constit.) in human, alternative (alt.) in mouse) in exons with ancestral downstream G-runs. Data were grouped by number of
guanines in ancestral G-runs in positions +11-70. Mean and s.e.m. are shown of the ratio (O/E) of the fraction with different splicing phenotypes among
exons with ancestral G-runs and that of control exons lacking G-runs but matched for base composition, conservation and EST coverage in mouse
(*P< 0.001). Inset shows in-frame and out-of-frame exons separately. (e) Same as d for exons with ancestral exonic G-runs.
Grouping introns by G-run density downstream of the 5' ss,
we observed an approximately linear increase in CLIP tag density
(normalized by gene expression) as a function of the number of
guanines in G-runs (Supplementary Fig. 9a). This linear increase in
binding paralleled the approximately linear increase in ISE activity
as a function of G-run density observed in the splicing reporter and
hnRNP H knockdown experiments. Exons whose expression changed
following hnRNP H knockdown were substantially more likely to
have associated CLIP tags than were control exons (Supplementary
Fig. 9b). Thus, both the overall pattern of linear increase in binding
and activity associated with total G-run length and the change in
the association between binding and splicing following knockdown
provided further support for direct effects of hnRNP H being of
primary importance in the observed pattern of G-run ISE activity.
The set of exons whose T values changed following hnRNP
H knockdown and the associated CLIP tag counts are provided
in Supplementary Table 4.
Genetic buffering of 5' ss mutations by G-runs
The 5' ss strength-dependent activity of G-run ISEs and ESSs uniquely
equips these elements to serve as'genetic buffers'that can suppress the
phenotypes of 5'ss-weakening mutations that would otherwise cause
substantial exon skipping. For example, in the absence of intronic
G-runs, a mutation altering a strong (9.2-bit) 5' ss to intermediate
strength (6.1-bit) reduced reporter exon inclusion from 56% to 21%
(Fig. 3a). However, insertion of a G9 run in the downstream intron, in
addition to enhancing exon inclusion, made inclusion of the exon tol-
erant to the same 5' ss-altering mutation, as a result of the increased
ISE activity in the presence of an intermediate-stength rather than a
strong 5' ss, with the P value actually increasing marginally from 90%
to 93%. The presence of a downstream G-run ISE can therefore make
an exon much less sensitive to 5' ss-altering mutations, with only the
most drastic changes (for example, strength reduction to <4 bits)
likely to result in substantially increased exon skipping. Many human
exons are potentially affected by this mechanism. For example, more
than 14,000 constitutive human exons (-17% of the data set used)
had 5' ss with scores of >8 bits and at least six guanines in G-runs
within 70 bp downstream of the 5' ss, and approximately one-third of
randomly generated point mutations of these 5' ss reduced strength
to the 4-8 bit range (data not shown). This buffering mechanism is
therefore applicable to a substantial proportion of 5' ss mutations
in many thousands of human exons. Additional exons are probably
buffered by G-run ESSs, as the splice site strength-dependence of
G-run ESS activity also acts in a direction that tends to buffer the
effects of mutations from strong to intermediate-strength 5' ss.
Equilibrium models of the evolution of cis-elements affect-
ing exon splicing confirmed our expectation that the presence of
ISEs tends to relax constraints on the 5' ss and that the sort of 5' ss
strength-dependent ISE activity that is observed for G-runs relaxes
the selective pressure on 5' ss more than would 5' ss-independent
ISE activity (Supplementary Fig. 10 and Supplementary Methods).
These models predict that the 'flux' (that is, the number of changes
occurring in the population per unit of time) of neutral 5' ss muta-
tions should be higher in constitutive exons flanked by G-run ISEs
and that these exons should therefore accumulate increased (neutral)
genetic variation in their 5' ss sequences. Consistent with this predic-
tion, a significantly higher frequency of single-nucleotide polymor-
phisms (SNPs) was observed within the 5' ss consensus motifs of
constitutive human exons with downstream G-runs of total length
6 than for control exons (Fig. 3b). This observation suggested that
downstream intronic G-runs have buffered (suppressed the pheno-
typic effects of) a substantial fraction of 5' ss mutations in recent
human evolution.
Orthologous human and mouse exons flanked by conserved G-runs
diverged more in their 5' ss scores than did control pairs of ortholo-
gous exons (Fig. 3c). The presence of intronic G-runs was therefore
also associated with longer-term evolutionary change in 5' ss strength,
as expected from the genetic buffering model.
An important but poorly understood evolutionary process is the
evolution of alternative splicing patterns31 . New alternative exons
may sometimes derive from exons that were previously constitutively
spliced or vice versa. Given the effects of G-runs on 5' ss variation,
we asked whether the presence of G-runs accelerated evolutionary
changes in splicing patterns.
When G-runs totaling 6 guanines were present ancestrally in the
downstream intron, we observed an -30% higher frequency of alter-
native splicing in the mouse orthologs of constitutively spliced human
exons than in control mouse exons (Fig. 3d and Supplementary
126
Appendix B. Splice site strength-dependent activity and genetic buffering by poly-G runs
a included-conserved exons (ICEs)
- 5' ss 0-4 bits
- 5' ss 4-8 bits
5' ss 8-12 bitsI
50 0 50 100
Exonic/intronic position (bp)
8 GUGG |
CCAGA IGAAA
4 UUAGA -JCAGCC
UAGAC
0 -ACACU
GAGUU
-4 uUUU AUCAG
-8
-8 -4 0 4 8
Intron MCS, 5'ss 0-2 bits
AL. .UGUGUbU~UU
8 buuucu8 ACACA 0GGUGUG
AGCGC -
*AAAGC
40AC
_4 CCAUGU
-4 IT-CGGuI CCCCG
-8- 1- -*
-8 -4 0 4 8
Intron MCS, 5' ss 4-6 bits
d Alternative-conserved exons (ACEs)
50 0 50 100
Exonic/intronic position (bp)
f
,9UGCAUG aGCAUG
*CUAAC 16 |
8 ACUAA 12 1ACAA AU
4 AGAGC UAU8 GCU
.. I- . % - -. GGCAG UAACC
0 { ACAUA o , GCUUU
] GA C UGGUC
-4 GGUUU c AGUAG
-4 0 4 8 -4 0 4 8 12 16
Intron MCS, 5'ss 0-4 bits Intron MCS, 5'ss 4-8 bits
Figure 4 Sequence conservation flanking exons is dependent on 5' ss strength. (a) Conservation profile (mean and 95% confidence interval of
PhastCons scores49) of exons and flanking introns for orthologous human and mouse ICEs grouped by 5' ss score (bits). (b) Motif conservation
scores (MCS, Supplementary Methods) of 5-mers in downstream introns (11-70 nt from 5' ss) of ICEs with indicated 5' ss scores. Dashed lines
show cutoff of significant MCS determined based on randomly shuffled data. Black dots represent motifs that are significantly conserved in more
than one 5' ss groups. Motifs with more significant MCS in one group than all other groups are represented by colored dots in the same color scheme
as in a. Inset, histogram of the t-statistic of 4-mers between the two indicated 5' ss groups. UUUU was the most significant in the 0-2 bits group.(c) Same as b for the 5' ss groups of 4-6 bits and 8-12 bits. (d-f) same as a-c, respectively, for ACEs. Scatter plots are shown for the downstream
intronic region 11-200 nt from the 5' ss. Because the number of exons was smaller in this analysis (-3,000), only three bins of 5' ss strength
were used (0-4 bits, 4-8 bits and 8-12 bits).
Table 5). We also observed an acceleration of splicing level evolution
when the conserved G-runs were located in the exon rather than in
the downstream intron (Fig. 3e). Some of these mouse-specific exon-
skipping events are expected to generate severely truncated proteins
that are likely to lack function (for example, in the MYEF2 gene) but
may serve to downregulate expression, whereas others are expected to
generate isoforms missing one or more specific domains, for example,
an isoform of BMP-binding endothelial regulator protein (BMPER)
that is predicted to lack just the central VWD domain, suggesting
altered interaction properties (these and other examples are shown
in Supplementary Fig. 11).
Regulation by hnRNP H and G-runs
Genes rich in intronic G-runs were more likely than control genes
to encode proteins involved in a number of gene ontology categories
related to development, membrane localization and signal transduc-
tion; genes containing hnRNP H-responsive exons were enriched for
similar functions (Supplementary Table 6).
Cell type-specific and tissue-specific regulation of alternative
splicing is thought to involve both highly tissue-specific factors,
such as Noval and Nova2, and tissue-specific differences in the
levels or activities of ubiquitously expressed factors, such as hnRNPs.
Because exons with intermediate-strength 5' ss are more responsive
to changes in hnRNP H levels than are other exons, we expected that
bioinformatic analyses of tissue-specific G-run enrichment should
have greater statistical power in the subset of exons with intermediate
5'ss. This expectation was confirmed by analysis of G-run enrichment
in sets of exons expressed tissue specifically (Supplementary Fig. 12),
suggesting increased activity of hnRNP H in testis, consistent with
western analysis32 , and also in adipose and MB435 cells.
Intronic sequence conservation varies with 5' ss strength
Whether the activities of other SREs are similarly sensitive to splice site
strength remains largely unexplored, with only a handful of reports
addressing this issue (for example, ref. 33). By grouping exons by 5'ss
strength, we observed marked differences in patterns of evolutionary
conservation (Fig. 4). Notably, increased sequence conservation was
observed adjacent to exons with weak 5' ss compared to those with
stronger 5'ss. This pattern was observed both for exons constitutively
spliced in humans and mice ('included-conserved exons' or ICEs;
Fig. 4a) and for exons alternatively spliced in both species ('alternative-
conserved exons' or ACEs; Fig. 4d), which showed much higher
intronic conservation overall than did ICEs34 . These observations
suggested that 5' ss strength fundamentally alters exon recognition
and regulation, with intronic SREs having a far greater role in splicing
of exons with weak or intermediate 5' ss than in splicing of strong
5' ss exons. This idea is consistent with the high conservation of 5' ss
strength observed in ACEs35.
Some sequence motifs were highly conserved in intronic regions
irrespective of 5' ss strength, suggesting that their activity does not
depend on it (Fig. 4). This pattern was observed for 5-mers matching
the consensus binding motifs of the Fox1/Fox2 and STAR families
of splicing factors (UGCAUG and ACUAAC, respectively36 ) and a
few others.
Other motifs including UUUU were highly conserved only when
adjacent to ICEs with weak (0-2 bit) 5' ss, suggesting increased activ-
ity specifically in splicing of this class of exons. Consistent with this
expectation, increased activity of U-run ISEs (which may act through
the TIA-1 and/or TIAR splicing factors37 ) was observed in splicing of
reporter exons with weak 5'ss (Supplementary Fig. 13). Previous stud-
ies of exonic motifs have observed increased density of certain exonic
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splicing enhancers (ESEs) in exons with weaker splice sites38. However,
we identified only one exonic motif as having differential conservation
dependent on 5' ss strength (Supplementary Table 7), suggesting that
5' ss strength-dependent activity is more common for intronic SREs.
In addition, a diverse set of motifs were preferentially conserved
adjacent to strong, intermediate or weak 5' ss ICEs (Supplementary
Table 7). Besides G triplets (Fig. 1b), these motifs included GUGUG
and UGUGU, which resemble the binding motifs of CELF family
splicing factors39 and were conserved adjacent to ICEs and ACEs
with intermediate-strength and strong 5' ss, but not adjacent to weak
5' ss (Fig. 4b,c,f).
DISCUSSION
Here we present the first comprehensive study of the relationship
between splicing regulatory activity and 5' ss strength. The sensitivity
of the splicing regulatory activity of G-runs to 5' ss strength suggests
that G-run ISEs recruit factor(s) that enhance splicing at the step of
initial 5' ss recognition by U1 snRNP or soon thereafter. Both U 1-5' ss
recognition and subsequent formation of the exon definition complex
are important points of regulation4 0 .
Several scenarios can be imagined that could account for the 5' ss
strength-dependent activity of G-run ISEs. One possibility ('differ-
ential binding') is that the factor(s) responsible for splicing activation
might bind more strongly to G-runs adjacent to intermediate strength
5' ss than to those near weak or strong 5' ss, with stronger binding
leading to increased splicing activation. An issue with this scenario
is that it is unclear how G-run binding would be affected by a motif
located tens of bases away.
Another possibility ('differential activation') is that it is not binding
to the pre-mRNA but activity in promoting splicing that varies for
G-run-binding proteins, depending on 5' ss strength. Such variation
might occur if the pathway of spliceosome assembly were dependent
on 5' ss strength, for example, if activation occurred through interac-
tion with U1 snRNP and if exons that have weak 5' ss and therefore
low affinity for U 1 snRNP were often spliced in a manner independent
of U1 snRNP binding4 14. G-run activity might also vary depending
on 5' ss strength for exons whose splicing is regulated kinetically, if
activation occurred at a step that is rate-limiting for intermediate 5' ss
exons, but a distinct step became rate-limiting for weak 5' ss exons. In-
depth biochemical analyses are clearly needed to distinguish among
these or other possible mechanisms.
The observed pattern of 5' ss strength-dependent ESS activity of
exonic G-runs could potentially be explained through a combina-
tion of two competing activities of hnRNP H when bound to exonic
G-runs: (i) a splicing inhibitory activity (for example, involving
inhibition of exon definition complex formation between the down-
stream 5' ss and the upstream 3' ss) that occurs independently of
5' ss strength; and (ii) a splicing-activating function that is similar or
identical to that which is associated with intronic G-runs. Combined,
these two activities might yield a pattern similar to that observed in
Figure 2d, with the inhibitory activity dominant in the case of weak
or strong 5' ss but roughly balanced by the more potent activating
activity in the context of an intermediate 5' ss. Again, there are other
possible scenarios.
The increased frequency of 5' ss polymorphism observed adjacent
to G-run ISEs supports a common role for this motif as a buffer
of genetic variation in the 5' ss. Such a buffering role could protect
genes (presumably including disease genes) from some mutations that
would otherwise disrupt their function, analogous to the buffering
by some chaperones of mutations that would otherwise cause
protein misfolding44 .
Increased accumulation of neutral 5' ss polymorphisms involving
intermediate and strong 5' ss allele pairs flanked by G-runs might con-
tribute to evolution of alternative splicing. A straightforward pathway
would involve reduction in the expression or activity of hnRNP H
through mutation of the hnRNP H locus or other means. The 5' ss
strength dependence observed for G-run ISEs and ESSs (Figs. 1 and 2)
will tend to magnify differences between strong and intermediate 5' ss
alleles when hnRNP H activity is reduced, thereby unmasking previ-
ously latent 5' ss variation as alternative splicing alleles, providing a
substrate for natural selection. In the event that an allele generating an
alternative splice of a formerly constitutive exon were advantageous
or neutral, subsequent selection could act to tune the regulation,
for example, to bring it under the control of appropriate cell type-
specific or condition-specific factors. Such a model would be directly
analogous to the model of 'evolutionary capacitance', by which the
chaperone Hsp90 is proposed to accelerate evolutionary change45 .
Changes in alternative splicing have been proposed as a major driver
of phenotypic change in the mammalian lineage 46,4 7, and G-runs
and/or other motifs with the potential to act as evolutionary capaci-
tors of splicing change are likely to have accelerated these changes.
The presence of intronic G-runs was not associated with an increase
in the relative rate of nonsynonymous substitutions (Supplementary
Fig. 14), as would occur under the alternative 'reduced selection pres-
sure' model4 8 .
Preferential conservation of a range of motifs adjacent to interme-
diate and weak 5' ss suggests that the activities of a number of differ-
ent splicing factors may also have 5' ss strength-dependent activity,
as seen for G-runs and hnRNP H. In addition to potential roles in
genetic buffering and effects on alternative splicing evolution, sensi-
tivity to 5' ss strength may provide a general mechanism for tuning
the responsiveness of distinct sets of exons to changes in the levels of
a splicing factor, contributing to tissue-specific or environmentally
regulated splicing.
METHODS
Methods and any associated references are available in the online
version of the paper at http://www.nature.com/nsmb/.
Accession Codes. Gene Expression Omnibus: mRNA-SEQ reads have
been submitted the to the GEO short read archive with accession
code GSE16642. Microarray data have been submitted to GEO with
accession code GSE12386.
Note: Supplementary information is available on the Nature Structural & Molecular
Biology website.
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ONLINE METHODS
Library preparation for Illumina sequencing. We used two rounds of selection
with Poly-T capture beads to isolate mRNA from 10 jig of total RNA. We generated
first-strand cDNA using random hexamer-primed reverse transcription and subse-
quently used it to generate second-strand cDNA using RNase H and DNA polymer-
ase. Sequencing adapters were ligated using the Illumina Genomic DNA sample
prep kit. Fragments of -200 bp were isolated by gel electrophoresis, amplified by
16 cycles of PCR and sequenced on the Illumina Genome Analyzer. Further details
regarding the mRNA-Seq protocol can be found in ref. 50.
Splicing reporter constructs. To assess the activity of ISEs in the context of differ-
ent splice sites, we used a'modular'splicing reporter system described previously6 .
This reporter contains three exons with the test exon in the middle flanked by
two green fluorescent protein (GFP) exons28. Splice site sequences were altered
by site-directed mutagenesis at each splice site using primers covering the corre-
sponding splice site (Supplementary Table 1). To insert sequences into the second
intron of the splicing reporter, we used a reverse primer containing a Sal) site and
the desired insert sequence (for example, G9 ) at its 5' end and a forward primer
at the beginning of the upstream intron containing a HindIll site to mutate
and amplify the test exon and its downstream intron via PCR. The sequences of
the reverse primer were: 5'-CACGTCGACNNNNNNNNNNNGTTGGAAAA
CAATAAAGAC-3' (SalI site underlined and ISE region represented by N), and
the forward primer was 5'-GAAACAAGGATGCTGTTAGAG-3'. The resulting
PCR product contains an ISE (or control) sequence 25 nt downstream from the
5' ss of the test exon and is inserted into the reporter backbone digested with
SalI and HindIl. The control sequence used was 5'-CGTGCAAATCAA-3'
(designated Go because it lacks G-runs). Nucleotides in the control sequence
were replaced with different numbers of G-runs to generate ISE sequences
5'-CGTGCGGGTCAA-3' (designated G3), 5'-CGGGCGGGTCAA-3' (G6), and
5'-CGGGGGGGGGAA-3' (G9). All constructs were sequenced before transfection
to confirm that the insert was correct.
Cell culture, transfection, RNA purification and quantitative RT-PCR. We
cultured HEK 293T cells with DMEM medium supplemented with 10% (v/v)
FBS. The splicing reporter constructs were transfected (0.8 pg per well) with
Lipofectamine 2000 (Invitrogen) in 12-well culture plates according to manu-
facturer instructions. Total RNA was purified from transfected cells using Trizol-
chlorophorm extraction followed by isopropanol precipitation and RNeasy
column purification (Qiagen). The reverse transcription reaction was carried
out using 2 jig total RNA with SuperScript III (Invitrogen). One-tenth of the
product from the reverse transcription reaction was used for PCR (20 cycles of
amplification, with a trace amount of ca-32P-dCTP in addition to nonradioactive
dNTPs). Quantitation of splicing isoforms was conducted as described 51.
RNA interference. We conducted knockdown of hnRNP H (H-KD) in four bio-
logical replicates (no. 1-3 for exon array experiments and no.4 for mRNA-Seq; see
below), as was the control knockdown using control siRNA. The double-stranded
RNA used for H-KD (IDT DNA) had the following sequences5 2: 5'-/5Phos/
rArArCrUrUrGrArArUrCrArGrArArGrArUrGrArArGrUrCAA-3'; 5'-rUrUr
GrArCrUrUrCrArUrCrUrUrCrUrGrArUrUrCrArArGrUrUrCrA-3'. As a control,
we used the double-stranded RNA Negative Control (DS ScrambledNeg) provided
by IDT: 5'-/Phos/rCrUrUrCrCrUrCrUrCrUrUrUrCrUrCrUrCrCrCrUrUrGrUGA-3';
5'-rUrCrArCrArArGrGrGrArGrArGrArArArGrArGrArGrGrArArGrGrA-3'. The
siRNA sequence for hnRNP H is partially complementary (at bases 1-19 from the
5'end of the siRNA, with a mismatch at position 7) with the mRNA of the related
gene, HNRNPF. In HEK 293T cells, hnRNP H is known to be expressed at much
higher levels than hnRNP F, as shown by western analysis 24. From the analysis
of mRNA-Seq (Supplementary Methods), we detected downregulation at the
mRNA level of both hnRNP H and hnRNP F (about three-fold) following siRNA
transfection, considering only the reads specific for each of these two closely
related genes. Similar analyses using Affymetrix exon arrays (Supplementary
Methods) yielded approximately twofold downregulation for both hnRNP H
and hnRNP F.
We used two different protocols in the knockdown experiments. Protocol 1,
used for H-KD 1 and control 1 was as follows. On day 0, we plated cells in 10-cm
dishes. On day 2, we transfected cells with 20 nM siRNA with Lipofectamine 2000
(Invitrogen). On day 3, the cells were harvested. Protocol 2, used for H-KDs 2, 3
and 4 and controls 2, 3 and 4 was as follows. On day 0, we plated cells in 10-cm
dishes. On day 1, we transfected cells with 20nM siRNA using Dharmafect 1
(Dharmacon) as a transfection reagent. On day 2, we transfected the cells with
50 nM siRNA using Dharmafect 1 (Dharmacon) as the transfection reagent. On
day 4, the cells were harvested. Transfections were conducted using protocols sug-
gested by the manufacturer of the transfection reagent. After cell harvest, three-
quarters of each dish was used for RNA extraction (using Trizol-chlorophorm
extraction followed by isopropanol precipitation and RNeasy column purifica-
tion (Qiagen)) and one-quarter was used for protein extraction. The quality of
the recovered RNA was verified by Bioanalyzer analysis (Agilent). Samples for
mRNA-Seq were processed and sequenced at Illumina Inc. Samples for exon array
analysis were labeled, hybridized to the Affymetrix GeneChip Human Exon 1.0
ST exon microarrays and scanned at the Massachusetts Institute of Technology
BioMicro Center following the manufacturer's instructions. The extent of
H-KD was assessed both at the mRNA (real-time PCR) and protein levels (western
blotting), as described in Supplementary Methods.
Analyses of organism- and tissue-specific alternative splicing. For Figure 3e, we
considered changes in splicing pattern where constitutive splicing was observed
in humans and alternative splicing in mice, rather than the reverse, because the
higher coverage of the human transcriptome in available expressed sequence tags
(ESTs) and mRNA-Seq data sets enabled more confident identification of consti-
tutive exons in humans than in mice. For Supplementary Figure 12, we observed
significant enrichment of G-runs downstream of exons with high T values in
three tissues (adipose, testis and the cell line MB435) in the set of intermediate
5'ss exons, whereas no significant enrichment for any tissue was observed in the
strong 5' ss exon set, despite its larger size, and G-run enrichment was reduced
to slightly below the Bonferroni-corrected P-value cutoff in the complete set of
exons. This analysis suggested a higher activity of hnRNP H in testis, consist-
ent with the high levels of hnRNP H protein detected by western analysis32 ,
and also in adipose and MB435 cells. More generally, these observations suggest
that subdividing exons on the basis of splice site strength will provide greater
statistical power to detect activity when considering SREs that have splice site
strength-dependent activity.
50. Schroth, G.P., Luo, S. & Khrebtukova, . Methods Mol. Biol. (in the press).
51. Wang, Z., Xiao, X., Van Nostrand, E. & Burge, C.B. General and specific functions
of exonic splicing silencers in splicing control. Mo!. Cell 23, 61-70 (2006).
52. Kim, D.H. et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and
efficacy. Nat. Biotechnol. 23, 222-226 (2005).
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Analysis and design of RNA sequencing experiments
for identifying isoform regulation
Yarden Katz",2, Eric T Wang2'3 , Edoardo M Airoldi4 & Christopher B Burge2,5
Through alternative splicing, most human genes express
multiple isoforms that often differ in function. To infer
isoform regulation from high-throughput sequencing of cDNA
fragments (RNA-seq), we developed the mixture-of-isoforms
(MISO) model, a statistical model that estimates expression
of alternatively spliced exons and isoforms and assesses
confidence in these estimates. Incorporation of mRNA fragment
length distribution in paired-end RNA-seq greatly improved
estimation of alternative-splicing levels. MISO also detects
differentially regulated exons or isoforms. Application of
MISO implicated the RNA splicing factor hnRNP H1 in the
regulation of alternative cleavage and polyadenylation, a role
that was supported by UV cross-linking-immunoprecipitation
sequencing (CLIP-seq) analysis in human cells. Our results
provide a probabilistic framework for RNA-seq analysis,
give functional insights into pre-mRNA processing and yield
guidelines for the optimal design of RNA-seq experiments for
studies of gene and isoform expression.
The distinct isoforms expressed from metazoan genes through
alternative splicing can be important in development, differen-
tiation and disease'. For example, the pyruvate kinase gene pro-
duces two distinct tissue-specific spliced isoforms that differ in
their enzymatic activity, allosteric regulation and ability to sup-
port tumor growth 2. Conservative estimates predict 2-12 mRNA
isoforms for most mammalian genes (Supplementary Fig. 1),
though some genes, including neurexins, may express more than
1,000 isoforms each 3.
Recently, high-throughput sequencing of short cDNA frag-
ments, RNA-seq, has emerged as a powerful approach to char-
acterizing the transcriptome. RNA-seq data have recently been
used to show that the vast majority of human genes are alter-
natively spliced and that most alternative exons show tissue-
specific regulation4 . To date, RNA-seq analysis methods have
focused mostly on estimation of gene expression levels and
discovery of novel exons and genes4 -6, assembly and annota-
tion of mRNA transcripts5 7 , and estimation of the expression
levels of alternative exons 4. Two recent methods, Cufflinks and
Scripture, can produce de novo annotations of transcripts in
metazoan genomes using RNA-seq data alone8 -io
Accurate quantification of alternative-exon abundance and
detection of differentially regulated exons and isoforms remain
challenging. Paired-end RNA-seq protocols, in which both ends of
a cDNA fragment are sequenced, are paving the way for isoform-
centric rather than exon-centric analyses. Here we have developed
the MISO model, a probabilistic framework that uses information
in single-end or paired-end RNA-seq data to enable more compre-
hensive and accurate analysis of alternative splicing, at either the
exon or isoform level. MISO provides confidence intervals (CIs)
for estimates of exon and isoform abundance, detects differential
expression and uses latent information to improve accuracy. We
applied MISO to analyze isoform regulation by the splicing factor
hnRNP H. Using MISO, we showed how the mean and variance
of the library insert length affects the information obtained about
splicing events in paired-end RNA-seq data, yielding guidelines
for the design of RNA-seq experiments.
RESULTS
Quantifying alternative splicing with MISO
To detect alternative splicing using RNA-seq data, MISO and
other methods use sequence reads aligned to splice-junction
sequences that are either precomputed from known or predicted
exon-intron boundaries, or discovered de novo by spliced align-
ment to the genome (Online Methods). In the most common
type of alternative splicing in mammals, an exon is included or
excluded from the mature mRNA; 'percentage spliced in' (PSI or
"I)"I denotes the fraction of mRNAs that represent the inclusion
isoform. Reads aligning to the alternative exon or to its junctions
with adjacent constitutive exons provide support for the inclusion
isoform, whereas reads aligning to the junction between the adja-
cent constitutive exons support the exclusion isoform; the relative
read density of these two sets forms the standard estimate of IF,
denoted I3Sj (Fig. 1 and Supplementary Fig. 2)4.
This estimate ignores reads that align to the bodies of the flank-
ing constitutive exons, which could have derived from either
isoform. Nevertheless, these constitutive reads contain latent
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Figure 1 I More accurate inference of splicing
Levels using MISO. (a) Generative process for
MISO model. White, alternatively spliced exon;
gray and black, flanking constitutive exons.
RNA-seq reads aligning to the alternative exon
body (white) or to splice junctions involving
this exon support the inclusive isoform, whereas
reads joining the two constitutive exons (black-
gray exon junction) support the exclusive
isoform. Reads aligning to the constitutive
exons are common to both isoforms.
(b) The sj estimate uses splice-junction and
alternative exon-body reads only. (c) The MISO
estimate, '1 MIso (derived here analytically),
also uses constitutive reads and paired-end
read information; orange lines connect reads in
a pair; the insert length distribution is shown
at right. (d) Comparison of Nia and I'MISo
estimates from simulated data. Reads were
sampled at varying coverage, measured in RPK,
from the gene structure shown at top right,
with underlying true W= 0.5. Mean values from
3,000 simulations are shown (±s.d.) for each
coverage value. Percentiles of gene expression
values are shown for a data set assuming
25 million mapped paired-end (PE) read pairs
(25M PE; blue, extrapolating from an Illumina
GA2 run that yielded 15 million mapped
read pairs) and for a data set of 78 million
mapped read pairs from an Illumina HiSeq
2000 instrument (78M PE; red), both obtained
from human heart tissue.
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information about the splicing of the alternative exon, as higher
expression of the exclusion isoform will generally increase the
density of reads in the flanking exons relative to the alternative
exon, and lower expression of the exclusion isoform will decrease
this ratio of densities. MISO captures this, as well as the infor-
mation in the lengths of library inserts in paired-end data, by
recasting the analysis of isoforms as a Bayesian inference problem.
Our approach is related to the alternative-splicing quantification
method 2 , which does not use paired-end information.
MISO samples reads uniformly from the chosen isoform, then
recovers the underlying abundances of isoforms (Wfand 1 - 'Fin the
case of a single alternative exon) using the short read data (Fig. 1 a
and Supplementary Fig. 3). As a result of mRNA fragmentation
in library preparation, mRNA abundance and length contribute
roughly linearly to read sampling in RNA-seq. This effect is treated
by rescaling the abundances 'Iand 1 - W of the two isoforms by
the number of possible reads that could be generated from each
isoform, respectively. In the model, reads from a gene locus are
produced by a generative process in which an isoform is first chosen
according to its rescaled abundance, and a sequence read is then
sampled uniformly from possible read positions along the mRNA
(Online Methods). For the exon-centric analyses involving a single
alternative exon we derived an analytic solution to the inference
problem, whereas for isoform-centric analyses and estimation using
CIs we developed an efficient inference technique based on Monte
Carlo sampling (Online Methods). Our new estimator, 'EMIso,
uses all of the read positions used in 'PSj, plus reads aligning to the
adjacent exons (Fig. Ib,c) and information about the library insert
length distribution in paired-end RNA-seq. Both Wsj and WMIso
are unbiased estimators of IF.
An improved measure of exon expression
Simulating read generation from an alternatively spliced gene, we
observed that the WMISO estimate had consistently much lower
variance and error than IPsj (Fig. id). For reference, the dis-
tribution of read-coverage values at depths typically obtained
from one lane of sequencing on an Illumina Genome Analyzer 2
(GA2) and on a HiSeq 2000 are shown, in units of reads per
kilobase of exon model (RPK). For a gene with median cover-
age in the GA2 data set (-220 RPK), the s.d. of the estimated 'P
value was reduced more than twofold, from 0.21 for 'Psj to 0.09
for 'PMIso.
Validation of MISO estimates
To assess the uncertainty in the splicing estimates for each exon,
we calculated CIs for W (Online Methods) from moderate-depth
breast cancer RNA-seq data (Supplementary Table 1; examples
are shown in Fig. 2a,b). Comparing 'PMIso estimates for 52 alter-
native exons to corresponding quantitative reverse-transcription
PCR (qRT-PCR) values",13 yielded a Pearson correlation
r = 0.87 (Fig. 2c and Supplementary Table 2; a bias in the
RT-PCR data was analyzed in Supplementary Figs. 4-6).
Restricting the analysis to exons with 95% CI width <0.25
increased the correlation with qRT-PCR data considerably, to
r = 0.96 (Fig. 2d). Thus, MISO CIs identify exons whose
RNA-seq-based 'P-value estimates are more reliable.
Detection of differentially expressed isoforms
Differential splicing of alternative exons entails a difference in
'Pvalues, A I, and can be evaluated statistically using the Bayes
factor (BF), which quantifies the odds of differential regulation
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Figure 2 | MISO CIs for I values and qRT-PCR validation. qRT-PCR
measurements from ref. 13 for a set of 52 alternatively skipped exons were
compared to MISO posterior mean estimates of IF, denoted MIso-
Full listing of events is given in Supplementary Table 1. (a,b) The IF
posterior distributions obtained by sampling and 95% CIs are shown for
two representative exons, one with a wide (NFYA, exon 3) and one with a
narrower (ZNF207, exon 6) CI. qRT-PCR 4I measurements are indicated in
red. (c) Scatterplot of MISO and qRT-PCR W estimates for the full set of
52 events. (d) Scatterplot of MISO and qRT-PCR estimates for the subset
of 23 high-confidence events, for which CI width <0.25. One exon was
excluded from this plot because of expressed sequence tag (EST) evidence
of an alternative isoform expected to confound the qRT-PCR analysis
(Supplementary Fig. 6).
occurring. MISO is used to calculate the posterior probability
distributions of 'Iand A'Ffor the two samples. The latter distribu-
tion is used to calculate the BF, defined as the ratio of the posterior
probability of the alternative hypothesis,A'F 0, to that of the null
hypothesis, A F= 0 (Online Methods); thus, higher values of the
BF indicate increased confidence in differential regulation.
In a recent study we used RNA-seq to characterize transcriptome
changes after RNA-interference knockdown of the splicing factor
hnRNP H in cultured human cells' 4 .This factor is known to bind
polyguanine (poly(G)) runs, typically activating splicing when
binding in introns flanking an exon and repressing splicing when
binding in exons (Fig. 3a,b). An example of BF calculation for a
gene with moderately high read coverage is shown in Figure 3c.
When we compared RNA-seq to qRT-PCR data, we found that
100% of exons (6 of 6) with BF 20 were detected as differentially
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regulated by qRT-PCR, compared to 21% of exons (4 of 19) with
BF < 20 (P < 0.0004, Fisher's exact test), and the magnitude of A W
showed good agreement (Supplementary Fig. 7). Overall, 15%
of alternative exons changed with BF 2 20 (Fig. 3d); similarly
widespread changes in splicing have been observed by all-exon
microarray analysis".
Genome-wide vaidation of isoform reguLation by CLIP-seq
To identify events directly regulated by hnRNP H and further
validate the BF analysis, we performed CLIP-seq analysis of
hnRNP H1 under the same conditions as in ref. 14 to identify
RNA binding sites of hnRNP H transcriptome-wide. Notably,
the percentage of exons with CLIP tags in their flanking introns
whose splicing was enhanced by hnRNP H (AV> 0 between con-
trol and knockdown conditions) increased from 60% to over 90%
as the BF threshold was increased, approaching a plateau at a
BF = 5 (Fig. 3e), corresponding to 5:1 odds of regulation. This
effect was stronger for hnRNP H binding in the downstream intron
Figure 3 | Bayes factor analysis of hnRNP H regulation of exon splicing.
0O (a) CLIP tag density (H CLIP; green) and RNA-seq read densities in hnRNP
H-knockdown and control conditions (H KD and H Ctrl; light and dark
blue, respectively) for an alternative exon in human C17orf49. Number of
guanines in poly(G) runs in upstream and downstream introns is shown.
(b) Model of hnRNP H function in splicing regulation: binding of poly(G)
runs (G,) adjacent to an exon enhances the exon's splicing (+ arrows);
100 binding in exon body represses splicing (- arrow). A 250-nt window
in flanking introns was used to count CLIP tags in analyses. (c) BF for
exon 2 of PRMT2 gene. Gray dashed line, distribution over A'F under the
null hypothesis; black solid line, posterior distribution. (d) Cumulative
distribution of BFs using hnRNP H RNA-seq data for exons with sufficiently
high read coverage. Inset, fraction of differentially regulated exons (A'W
2 0.15 by qRT-PCR), grouping exons by BF (n = 25 exons). (e) Percentage
of exons enhanced by hnRNP H (AW > 0), plotted against increasing BF
thresholds, for exons with CLIP tags in downstream or upstream introns
but not in exon body (red and orange curves), for exons with CLIP tags in
exon body but not in flanking introns (blue curve) and for exons with no
0 CLIP tags (dotted black line). (f) Guanines in poly(G) runs in downstream
intron, plotted against increasing BFs.
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Figure 4 | Bayes factor analysis a NFATC4 b H shortens UTR
implicates hnRNP H in alternative No change
cleavage and polyadenylation. (a) CLIP [0l
tag density (H CLIP; green) and RNA-seq 0
read densities in hnRNP H control and HCtri
knockdown conditions (H Ctrl and H KD; 0 4- 0
light and dark blue, respectively) along 0the 3' UTR of the NFATC4 gene. Core and 1.
extension poly(A) sites for NFATC4 are 0 1 S a 0.15
shown, with a model illustrating the Core poly(A) site Ext. poly(A) site 0
effect of hnRNP H effect on poly(A) site 0
selection. (b) Number of CLIP tags per z 0.05
kilobase normalized by expression (RPKM) 0
for exons with shortened and lengthened 0 2 5
UTRs between hnRNP H control and 23,916,800 23,917,800 23,918,648 Bayes factor
knockdown conditions (red and blue Chromosome 14
curves, respectively). Values plotted are
averages of subsampLed mean densities (n =100 subsamplings) where exons were matched for expression (RPKM). Error bars show s.e.m.
CLIP tag density for UTRs not differentially regulated (BF < 1), as shown by dotted gray Line.
and was reversed for events with exonic CLIP tags, consistent
with previous studies (for example, ref. 14 and references therein);
virtually no bias was detected, on average, for exons not associated
with CLIP tags. Further evidence that BF values reflect regu-
lated exons came from the observation that exons with larger
BFs had more guanines in poly(G) runs in their downstream
introns (Fig. 3f).
A possible roLe for hnRNP H in alternative polyadenyLation
We used a similar approach to examine whether hnRNP H also
has a role in regulating tandem alternative cleavage and poly-
adenylation (APA), in which cleavage at distinct polyadenylation
sites (PASs), without intervening splicing, results in mRNAs with
longer or shorter 3' untranslated regions (UTRs), often affecting
mRNA stability, localization or translationi5 . Evidence that
hnRNP H1 and its paralogs hnRNPs F and H2 affect the effi-
ciency of constitutive cleavage and polyadenylation has been
described16,17, but regulation of alternative 3' UTR events by this
factor has not previously been reported. Notably, we observed that
increased density of CLIP tags just upstream of the core (5') PAS
correlated with greater use of this site in control conditions than
in the hnRNP H knockdown, suggesting a role for hnRNP H in
promoting core PAS use.
For example, a high density of hnRNP H CLIP tags was
observed upstream of the core PAS of the NFATC4 gene, and
RNA-seq data indicated greater use of this site in control condi-
tions than in knockdown conditions (Fig. 4a). Because MISO
encodes isoforms in a general way as lists of exon coordinates,
APA events can be analyzed similarly to alternative splicing
events (Online Methods). Applying MISO to RNA-seq data
from control and hnRNP H knockdown cells, we observed that
genes with higher expression of the shorter 3' UTR isoform
in the presence of hnRNP H-particularly those with large BF
values-had higher CLIP tag density near the core PAS (Fig. 4b).
Together, these analyses implicate hnRNP HI in widespread
regulation of APA in human genes by activation of the core
PAS when bound nearby. Elevated levels of hnRNP H1 have
been observed in certain cancers 18, and it would be of interest
to determine whether hnRNP H1 contributes to the widespread
'3' UTR shortening' (preferential expression of upstream PASs)
that occurs in cancer cells'9, 20.
RNA-seq design: paired-end reads and insert Length
A size-selection step is used in RNA-seq library preparation to
control the mean length of inserted cDNA fragments. In paired-
end sequencing, the full distribution of the lengths of these inserts
can be measured precisely from read pairs that map to large con-
stitutive regions such as 3' UTRs, which are typically intronless.
This length distribution can then be used to make qualitatively
new types of inferences about alternative isoforms. For example,
when the reads in a pair map upstream and downstream of an
alternatively spliced exon, the inclusion and exclusion isoforms
will typically imply different intervening insert lengths, often
enabling the isoform from which the read was generated to be
inferred with high confidence.
These considerations led us to compare the fraction of reads
that are 'assignable'-that is, consistent with only one of the two
isoforms-in simulations of paired-end and single-end sequenc-
ing, varying the mean, y, of the insert length distribution (Fig. 5).
To assess the amount of splicing information present in the length
distribution, we considered read pairs that were 20 times more
likely to have derived from one isoform than the other under the
insert length distribution to be 'probabilistically assignable', with
a'false read assignment' (FRA) frequency of 1/20 = 5%. In Figure
5d, the insert length distribution has a mean -260 ± 10 nucle-
otides (nt), making it far more likely that the read pair shown
derived from the inclusion isoform.
Variability in the insert length distribution influences the confi-
dence with which read pairs can be assigned to isoforms. Varying
the s.d., a, of the insert length distribution by a dispersion factor,
d (where a = dVp), we observed that even for a relatively broad
insert length distribution (d = 2), inclusion of the 5% FRA reads
substantially increased the fraction of assignable reads for a gene
containing a (typically sized) 100-nt alternative exon (Fig. 5b).
For tighter length distributions (d = 1 or d = 0.5), the fraction of
assignable reads increased markedly, from -15% when ignoring
insert length information to >50% when considering insert length
for large mean lengths, indicating that paired-end data with low-
dispersion length distributions can potentially increase the yield
of information about splicing by threefold or more at a given
sequencing depth. Obtaining a length distribution with d near 1
requires care in library preparation but is achievable in practice
(the libraries used in this study had d values between 0.6 and 1.5).
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Figure 5 | Improved estimation of isoform
abundance using paired-end reads.
(a) Representative gene model with 100-nt
first exon, 100-nt skipped exon (exon 5, in
white), 150-nt constitutive exons and 600-nt
Last exon. (b) We simulated reads from the
two-isoform gene model shown in a while
varying the mean, y, of the insert length
distribution, setting the s.d. a- = p to adjust
for the higher variability expected in the
size selection for longer fragments. Fraction
of 1-bit (assignable to only one isoform)
paired and single-end reads is plotted (±s.d.).
(c) Distribution of errors for paired-end and
single-end estimation as coverage increases
(measured in RPK). (d) Histogram shows
library insert length distribution computed
from read pairs mapped to long constitutive
3' UTRs in a human testes RNA-seq data set.
In the example exon trio shown (similar to
that in Fig. 1d), the insert length distribution
assigns a higher probability to the top
(inclusion) isoform than to the bottom
(exclusion) isoform, for which the inferred
insert length is improbably small. (e) Fraction
of assignable 2-bit and 1-bit reads (±s.d.)
for paired-end and single-end reads as
a function of the number of intervening
constitutive exons, k.
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For d < 1.5, the proportion of assignable reads increased steadily
with insert length (Fig. 5a), as larger inserts make it more likely
that reads from a pair will fall on opposite sides of an alternative
exon and be probabilistically assignable. Thus, if dispersion is kept
near or below 1, use of longer insert lengths should yield more
information about splicing. However, changing mRNA fragment
size can have other effects on RNA-seq experiments, potentially
affecting the priming and reverse-transcription steps and the
sampling of mRNAs of different lengths.
To assess the nature and extent of these effects, we generated
libraries with mean insert lengths of-100 nt and -280 nt from the
same RNA sample, derived from control mouse myoblasts, and
generated similar libraries from myoblasts depleted of the splic-
ing factor CUGBP1 (Supplementary Fig. 8a). Gene expression
estimates were relatively unaffected by insert length for mRNAs
1 kilobase (kb) or longer, but, as expected, read coverage of very
short mRNAs only a few hundred bases in length was reduced by
-20-40% in the longer-insert libraries (Supplementary Fig. 8b).
The precise pattern of fluctuations in read coverage along consti-
tutive regions differed between libraries with different insert sizes
but was highly correlated between libraries generated with similar
insert sizes (Supplementary Fig. 8c). The reproducibility of the
patterns of local fluctuations indicated that they are primarily
determined by fragment size21-which could affect RNA second-
ary structure and therefore the priming and reverse-transcription
steps-rather than by technical noise. Because such fluctua-
tions could affect analysis of alternative splicing, comparisons
made between RNA-seq data sets prepared using similar library
insert lengths will be most accurate. Changes in gene expres-
sion resulting from the knockdown of CUGBP1 were detected
highly reproducibly at the two different library insert sizes (r ~
0.9; Supplementary Fig. 8d), indicating that library insert size
can be varied at least over this range without affecting the ability
to detect changes in expression. The overall magnitude of read-
coverage fluctuations was only modestly greater for the 100-
nt-insert library than for the library with 280-nt inserts
(Supplementary Fig. 8e), but further tests of longer insert librar-
ies will be needed to determine the magnitude and impact of the
expected increases in local read-coverage fluctuations. Overall,
the optimal insert size to use in an RNA-seq experiment will
depend on the importance one places on outputs such as detection
of splicing changes relative to efficient capture of short mRNAs.
More accurate I-vaLues using insert Length information
Insert length information is incorporated in MISO by probabil-
istic assignment of read pairs to isoforms that are consistent with
both individual reads, weighting the assignment of read pairs
by the relative probability of observing the given insert length,
according to the structure of each isoform. To quantify the impact
of the increased assignability of reads on accuracy of 'IFestimates,
we simulated paired-end reads from a typical gene model con-
taining an alternative exon (Fig. 5a). Use of paired-end reads
with insert length information markedly increased the accuracy
of estimates of IFin simulations, reducing the error by a factor of
-2-5 (Fig. 5c). With a typical gene model containing a typically
sized alternative exon, applying the NPMIso estimation method
that makes use of paired-end length information, rather than the
standard PMIso estimate, reduced the error in estimated IF from
about 8% to -4% for a gene with RPK of 200, and the error was
further reduced to -2% at higher coverage values.
Applications to complex alternative splicing
Paired-end data can also be used to make inferences about iso-
form levels for genes that contain multiple alternative splicing
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events. To assess how much information can be gained about
splicing by paired-end sequencing in these cases, we simulated
reads from a gene model containing a pair of alternative exons
while varying the number of exons, k, separating the two alterna-
tive exons (Fig. 5e). In this gene model, 2 bits of information are
required to uniquely specify an isoform: 1 bit to indicate whether
the first alternative exon was included or excluded, and 1 bit to
describe the splicing of the second alternative exon. Reads that
can be uniquely assigned to one of the four isoforms are there-
fore considered '2-bit reads, whereas reads that are assignable
to exactly two of the four isoforms are considered '1-bit reads'
(Fig. 5e). When k = 0, a single read may overlap the junction of
the two alternative exons or the junction between the flanking
constitutive exons, providing 2 bits of information. For k 1,
no 2-bit reads occurred for the typical read and exon lengths
used in the simulation, but read pairs can sometimes provide 2
bits of information-for example, if the two reads derive from
the two alternative exons or from junctions that are informative
about the splicing of these exons, though this is fairly rare. When
insert length information is used and probabilistically assignable
reads are considered, far more read pairs yield 1 or even 2 bits of
information (Fig. 5c and Online Methods), indicating that short-
read data has some potential to address more complex alternative
splicing events.
The MISO model generalizes to the isoform-centric case
in which genes express arbitrarily many isoforms through
alternative splicing (Supplementary Note and Supplementary
Figs. 9-11); an application of MISO to estimate the abun-
dance of four isoforms from the GRIN) gene is shown in
Supplementary Figure 12. However, sequencing methods
involving longer reads, longer library insert lengths or both
are needed to quantify isoforms in genes with multiple distant
alternative splicing events.
DISCUSSION
Alternative splicing is highly regulated during development and
differentiation, and misregulation of RNA processing underlies
a variety of human diseases2 ,2 2. Because individual alternative
exons typically represent only a few percent of the length of the
mRNA, analysis of splicing requires greater sequencing depth
and more powerful statistical methods than are needed to study
gene expression. The MISO model introduced here represents a
detailed probabilistic model of RNA-seq, and it has a variety of
advantages, including improved accuracy and the ability to ana-
lyze all major types of alternative pre-mRNA processing at either
the exon level or the isoform level.
This study also has important implications for the design of
RNA-seq experiments. Our analyses indicate that paired-end
sequencing yields far more information about alternative exons
and isoforms than single-end sequencing does. This informa-
tion derives primarily from cases in which the reads in a pair
flank an alternative exon, so that the inclusion and exclusion
isoforms imply different intervening mRNA lengths. Use of
somewhat longer mRNA fragments, of 300 bases or more, in
library preparation should generally enhance isoform inference
by increasing the occurrence of such read pairs, with tradeoffs
related to the capture of very short mRNAs and changes in the
pattern and extent of local fluctuations in read coverage along
exons. Our analyses of read-coverage fluctuations strongly imply
that RNA-seq-based comparisons of expression and splicing
will be most accurate when the insert lengths of the libraries
being compared are similar. In some cases a mixed experimen-
tal design involving use of different library insert sizes from
a single sample may be appropriate-for example, combining
one lane of paired-end sequencing from a longer-insert RNA-
seq library for inference of mRNA isoform abundance together
with a lane of shorter-insert single-end sequencing for analysis
of gene expression.
METHODS
Methods and any associated references are available in the online
version of the paper at http://www.nature.com/naturemethods/.
Accession codes. Gene Expression Omnibus: GSE23694.
Note: Supplementary information is available on the Nature Methods website.
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ONLINE METHODS
Software availability. All software implementations used in this
paper are available at http://genes.mit.edu/burgelab/miso.
Cell culture and CUG-BP1 RNA-seq experiments. Control and
CUG-BP1 knockdown C2C12 myoblasts23 were a generous gift of
Carol Wilusz (Colorado State University). Cells were cultured at
37 *C, 5% CO 2 in Dulbecco's modified Eagle's Medium contain-
ing 20% (v/v) FBS and maintained in subconfluency conditions.
Total RNA was isolated from cells at 50-60% confluency by lysis
with Trizol, followed by chloroform extraction, precipitation and
cleanup plus DNase treatment on RNeasy columns (Qiagen). Total
RNA was poly(A)-selected using poly(T) Dynabeads (Invitrogen)
and prepared for Illumina sequencing. After adaptor ligation,
libraries were agarose gel purified; two 1-mm-thick bands cen-
tered at -250 and -400 nt were excised with razor blades. These
gel-purified products were amplified by 11 cycles of PCR using
adaptor primers and subjected to a final gel purification to main-
tain a tight size distribution.
Mapping and processing of RNA-seq reads. Reads were aligned
to the genome and to a precomputed set of splice junctions (as
described 4 ) using the Bowtie alignment program 24 . Reads were
required to map with two mismatches or fewer, and junction reads
were required to include four bases or more from each spanning
exon. For simplicity, we considered only reads that map uniquely
to the union of the genome and splice junctions, and correct
for differing uniqueness of different regions by excluding non-
unique positions from the analysis; for an alternative treatment,
see ref. 25. Alternative exons used in all analyses were derived as
described 4, by considering an exon as skipped if it is supported by
one or more annotated ESTs or cDNAs. Alternative poly(A) sites
were compiled from PolyA DB26 . Here we used a precomputed
junction database, but an alternative is to discover splice junctions
de novo using one of several available tools for junction discov-
ery and transcript annotation (for example, refs. 8,9,27-32). The
human heart and testis RNA-seq data listed in Supplementary
Table 1 were provided by G. Schroth (Illumina) and are available
upon request. The breast cancer RNA-seq data were generated by
R. Nutiu (MIT) from tissue provided by S. Abou Elela (University
of Sherbrooke). Read data relevant to Figure 2 will be provided
upon request.
Notation and model. After aligning reads to the genome and
splice junctions, we considered only reads that map uniquely to
genes for both exon-centric and isoform-centric analyses.
Assuming N reads that align to a given gene with Kisoforms, each
read R, (where 1 5 n N) is associated with a vector with com-
ponents RI through RK indicating its compatibility with the K
different isoforms: if the nth read maps to the kth isoform of the
gene, then Rk is set to 1, and 0 otherwise. Given a set of uniquely
aligning reads, we seek to infer the 'percentage spliced isoform'
values T', representing the relative abundances of the gene's iso-
forms. Here, Wk denotes the fraction of mRNAs corresponding
to the kth isoform (and thus IWk =1). Faithfully modeling the
k
physical process of fragmentation and subsequent size selection
is not yet feasible, but the general effect of these processes on the
data is that the probability of sampling a read from an mRNA
increases approximately linearly with the mRNA's length. To cap-
ture this effect, we rescale the isoform abundances IF, through
Wk by the numbers cl through c. of reads of length RL that could
be generated from these isoforms: if lk is the length of the kth
isoform, then ck = ik- RL + 1. In the two-isoform case, this rescal-
ing yields the values
Ph - c and Wf2 Tfl [1]
ci'Fi + c2'F2
corresponding to the expected proportion of reads generated
from each isoform. Let In be a variable representing the isoform
from which the nth read was sequenced, where 1 n N. The
rescaled abundances then correspond to the probability that the
nth read was generated from the kth isoform, denoted P(I IW),
accounting for fragmentation. Given the assignment of the nth
read to the kth isoform, we then define the probability of observing
a specific read from that isoform. This probability will depend
on a set of fixed parameters 0 of the experiment, such as the
length of a read (RL) and the minimum overhang length for reads
that span splice junctions. To account for uniqueness of reads
in the alignment, let m(RL, I) be the number of mappable read
positions in some isoform In for an experiment where the read
length is RL. For convenience, only reads and read positions that
satisfy the overhang constraint are considered mappable. The
probability of observing read Rn from the kth isoform, denoted
P(Rn I In = k, 0), is defined to be uniform over the number of reads
observable from isoform k-that is, Rk equals 1 with probability
1/m(RL, In), and is 0 otherwise. Our goal is to invert the genera-
tive process by which reads are produced and infer the under-
lying isoform abundances that best explain the observed reads.
Formally, this is achieved by computing a probability distribution,
called the 'posterior, over the unobserved random variable (f),
given the RNA-seq data. This is done using Bayes' rule, which
states how the posterior distribution can be computed in terms of
two quantities: (i) the probability of the data given a setting of the
variable, referred to as the 'likelihood' of the data, and (ii) our a
priori expectation about the values of this variable, referred to as
the 'prior' distribution. The relationships between the prior, likeli-
hood and posterior distributions are depicted in Supplementary
Figure 3. In our case, the prior specifies our expectation about
the value of 'P before observation of reads (we use a prior that is
unbiased, not favoring any particular abundance value), and the
likelihood specifies the probability of observing a set of reads
given a 'I value. The posterior describes the probability of V'I
given a set of reads. Given a set of N reads R1:N the posterior
distribution denoted P( I R1:N), Bayes' rule gives
P(T) 
- P(RI:N I
Intuitively, this equation states that the probability of a set of abun-
dances given the reads are proportional to our a priori expectation
about the values of these abundances (the prior), weighted by how
likely reads we observed are to have been produced from these
abundances (the likelihood). To compute the posterior, we need to
consider all possible assignments of every read to each isoform and
use the probabilities defined above to score these assignments:
K K N
P(#IR:N) I --- I f P(Rn I1]:N> 1')(':N I'P)P('p)
I=1 IN=
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where I. indicates the isoform from which the nth read was gen-
erated. For exon-centric analyses where there are only two iso-
forms, we use a prior distribution uniform over [0, 1], which is
a special case of the Beta distribution commonly used as a prior
in Bayesian statistics 33. In this case, our model is a variant of the
well-studied 'Beta-Bernoulli' model 33 . Whereas in the general
case of many isoforms inference is performed using approxi-
mate techniques 34,35 , an analytic solution can be obtained in the
two-isoform case under certain assumptions about the prior dis-
tribution (Supplementary Note). We can extend the model to
isoform-centric analyses (where there are many isoforms) using
the Dirichlet-Multinomial distributions 3 3, which are the multi-
variate generalization of the Beta-Bernoulli distributions used in
the exon-centric case. The general model is specified as follows:
I - Dirichlet(a) once for every gene g,
In -~ Multinomial (1, Yu) for everyread n that maps to gene g,
Rn P(R IIn, 0) for every read n that maps to gene g
where the corrected abundances that account for the lengths of
multiple isoforms are now defined as a vector if, and where an
entry
K
yf k = (ck k Y- C cj)j=1
corresponds to the probability of sampling a read from the kth iso-
form. As above, we consider a symmetric Dirichlet distribution with
all parameters equal to encode a uniform prior over !, not favoring
any particular distribution of isoforms. As in the exon-centric case, we
seek the posterior distribution P(I R lN), which can be obtained by
Bayes' rule. A graphical model representation of MISO summarizing
the relations between all these variables is shown in Supplementary
Figure 9, where variables are indicated by nodes and probabilistic
dependencies are indicated as edges between the nodes.
Quantitation of diverse classes of alternative pre-mRNA
processing events. By representing alternative pre-mRNA
processing events generically as a mixture of isoforms, with each
isoform defined by a list of exon coordinates, it is possible to
quantify diverse classes of events can, including alternative 5' and
3' splice sites, alternative first and last exons, tandem APA sites,
mutually exclusive exons and retained introns. Different event
types will be supported by distinct types of reads-for example,
tandem APA events are currently quantified using reads that are
unique to the extended isoform and reads that map to the core
region shared by both isoforms. The 'Pvalue in this case is defined
as the ratio of the abundance of the long isoform relative to the
sum of the abundances of long and short isoforms. Intuitively,
MISO uses the density of reads in the extended region relative
to that in the core region to estimate this quantity. Similarly, the
absolute and relative sizes of alternative regions will affect the read
coverage and the power to reliably quantify isoform abundances
(for example, alternative 3' splice sites can differ by as few as three
bases, whereas tandem APA events typically differ by -1 kb).
Incorporation of paired-end information. In single-end sequenc-
ing, it is sufficient to represent a read by the set of isoforms it could
have been derived from. For paired-end reads, it is also neces-
sary to incorporate information about the insert lengths that are
consistent with each read. We represent a paired-end read with a
pair of parameters, (Rn, A,), where the first element, Rn, is a binary
vector representing the alignment of reads to isoforms as in the
single-end case: R = 1 if the nth read aligns to the kth isoform;
Rk = 0 otherwise. The second element, An, is a vector of observed
inserted fragment lengths, where A2 is set to the length of the
insert implied by isoform k for the nth read pair, assuming the
read was consistent with isoform k and is undefined otherwise.
To score how likely observed insert lengths are and use this infor-
mation to assign reads to isoforms, we modeled the distribution
of isoform lengths in the mRNA-seq sample. This distribution is
computed empirically by mapping read pairs to long constitu-
tive 3' UTRs, whose size is much larger than the expected insert
length selected during the sample library preparation. The mean
(p) and variance (a2) of this distribution are then used to com-
pute the probability that a read pair came from each isoform, if
it is consistent with more than one. The probability of assigning
the nth read pair to the kth isoform given IF depends on both the
lengths of the isoforms 11 through lk and the mean of the insert
length distribution, y,
P(In = k| N,p) =A + 1)ykK
X ( 3 -up+ )T4j=1
The probability of observing a paired-end read (Rn, A) given its
assignment to an isoform k and the experiment's parameters 0,
denoted with P(Rn, An I = k, 0), is assumed to be uniform over
the number of fragments of the relevant size that can be gener-
ated from isoform k; that is, Rk = 1 with probability 1I/m(A, Ia),
and it is 0 otherwise. We modeled the empirical fragment length
distribution P(An I y, a) as a discretized normal distribution, with
mean y and s.d. a. The two parameters y, a can be set to fit the
empirical distribution of insert lengths in any RNA-seq sample
before the MISO inference procedure is run. All paired-end simu-
lations were conducted with two 36-nt reads, where insert lengths
were sampled from a discretized normal distribution whose mean
y and dispersion d were varied as described in the main text.
Analytic estimates of Win exon-centric analyses. In exon-centric
analyses we have two isoforms. In this case, we derive the maxi-
mum a posteriori estimate of IF, "MISo, using single-end reads
(a complete derivation is provided in the Supplementary Note).
lyMIso is a function of five main parameters: the numbers of
inclusion, exclusion and common reads (N, NE, Nc) and the fixed
conditional probabilities of a read given its assignment to the first
and second isoforms (p, and p 2, respectively). Under the assump-
tion of a uniform prior on IF, it is sufficient to define an estimate
for 'I- and transform to get an estimate of IF, using the inverse of
equation (1). The derivation of 7I' is then reduced to solving a
quadratic equation, whose relevant solution is
A- B+C
I D
(described fully in Supplementary Note). We then obtain an esti-
mator for qNMISo by plugging i into the inverse of equation (1).
Our estimate is compared to 'A 3Ss and the qfsJ estimates from
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ref. 4 in Supplementary Figure 2. Calculation of these measures
and proofs of unbiasedness are given in the Supplementary Note.
Estimates of W in isoform-centric analyses. To estimate the full
posterior distribution over abundances in either exon- or isoform-
centric analyses, analytic solutions are not available, and approxi-
mate inference techniques must be used instead 3 5.The correction
of isoform abundances needed to account for the fragmentation
step leads to violations of the mathematically convenient con-
jugacy properties of traditional Dirichlet-Multinomial mixture
models, which are required for standard methods of performing
inference in such models, such as Gibbs sampling 33 . To perform
efficient inference in our model, we devised a Markov chain Monte
Carlo (MCMC) inference scheme based on a novel proposal dis-
tribution. We use a hybrid MCMC sampler that combines the
Metropolis-Hastings (MH) algorithm with a Gibbs sampler 34 . In
MH, a proposal distribution Q is used to estimate the target dis-
tribution P(x), where P can be evaluated up to proportionality on
any set of states but cannot easily be sampled from. Transitions to
different states of P are repeatedly proposed from Q, and these are
stochastically accepted or rejected according to the MH ratio, a:
a= min rP(xt + i)Q(xt;xt + 1
P(xt)Q(xt + 1;Xt) )
In our case, P is the joint distribution on 'P and the latent assign-
ment of reads to isoforms I.N* A substantial challenge for infer-
ence in our model is to construct a proposal distribution Q that
efficiently proposes high-probability i values under P while
respecting the constraint that 'P must sum to 1. To achieve this,
we use the logistic-normal distribution 36 to construct a random
walk in the simplex space by drifting over the parameters of
the Beta distributions from which qj values are drawn. See
Supplementary Note for a full derivation of the inference scheme
and Supplementary Figure 11 for the resulting algorithm.
Computation of Bayesian confidence intervals. Given a pos-
terior distribution over 'P obtained with the proposed MCMC
sampler, a Bayesian CI for Wk is computed using the method
described3 7 . The 100(1 - a)% Bayesian CI is an interval (a, b)
where the probability of a value for Wk being contained in (a, b) is
100(1 - a)%. Let S = {}= 1 be a set of n posterior samples for ak i (a/2)ngiven Wk. The 100(1 - a)% interval (a, b) is computed as: Yk
( - a12)n), where y a/2)n is the (a/2)nth smallest sample in S,
and V ( - a/2)n is the (1 - a/2)nth smallest sample in S. Such an
interval is a consistent estimator of the Bayesian CI37 .
Statistical test for differential isoform expression using Bayes
factors. To detect the differential expression of an isoform between
two samples A and B, we use a two-sided point null hypothesis
test. Let 3= 'PA - 'PB, where 'PA, 'PB correspond to the expres-
sion levels of the isoform in samples A, B, respectively. The null
hypothesis (H.) states that 3 = 0, and the alternative hypothesis
(HI) that # 0. To choose between the two competing hypotheses,
we compute the BF38, which can be interpreted as the weight of
the evidence in the data D in support of Hi over HO:
BF = P(D Hi)P(HI)
P(D HO)P(Ho)
The BF can be accurately estimated using the Savage-Dickey den-
sity ratio 33-that is, by calculating it as a ratio of the posterior
density at 3= 0 under Hi and the prior density under Hi at the
same point:
BF = P(8 = 0 1Hi)
P(6 = 0| D,Hi)
We assume a uniform prior over 'PA and 'PB, which yields a prior
distribution that peaks where 3 = 0, corresponding to the case
of no differential regulation between the conditions (that is,
a 'triangular prior' where P(6= 0 | HI) = 1). This reduces the BF
calculation to 1/P(3= 0 | H, D) = 1.
Analysis of quantitative reverse-transcription PCR data. Only
alternative exons meeting the coverage criteria outlined above
were used. To ensure detectable alternative splicing of the exon
in the breast cancer sample, we required that the qRT-PCR
value be greater than 0 and smaller than 1. To correct for the
length bias in the qRT-PCR data when computing the overlap
between qRT-PCR data and MISO CIs, we used an out-of-sample
cross-validation scheme to calculate an adjusted qRT-PCR value
(as described in Supplementary Note).
hnRNP H CLIP-seq experiment and data analysis. CLIP-seq
for hnRNP H was performed as described14 . Read fragments of
size 15-30 nt were aligned to the human genome (hg18) and a pre-
computed set of splice junctions. CLIP tag densities were normalized
by RPKM values estimated from the hnRNP H control condition.
For analyses of alternative and constitutive exons, only tags in the
exon body and in the intronic region upstream and downstream
of exons (using at most 250 nt of half the intron proximal to the
exon) were considered. For analysis of tandem 3' UTRs, a window
of -250 to 500 nt relative to the core poly(A) site (based on PolyA
DB annotation) was used, excluding regions that are less than 500 nt
away from the extension poly(A) site. Plotted values in Figure 4b are
means of mean CLIP tag densities from 100 subsamplings of exons
with corresponding BF values, matched for their gene's RPKM to
control for the inherent correlation between BF and expression level.
Error bars are means of standard errors from subsamplings.
Simulations of single-end and paired-end reads. All single-end
read simulations were performed with reads 36 nt long having an
overhang constraint of 4. Paired-end simulations were peformed
with two 36-nt reads, with varying mean insert lengths (p) and
dispersion (d), as described in the main text. Coverage was mea-
sured in reads per kilobase (RPK) of constitutive exons of a gene
model. For GRINI, reads were simulated from the four described
isoforms at 1,000-RPK coverage, using the exon sizes given in
the UCSC Known Genes table for the mouse genome (mm9).
All sampler results were run for 10,000 iterations using a burn-
in of 500 iterations and a 10:1 thinning ratio. Posterior marginal
distributions were averaged across 50 independent chains and runs
of the sampler.
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ABSTRACT
Recent genome-wide analyses have elucidated
the extent of alternative splicing (AS) in mammals,
often focusing on comparisons of splice isoforms
between differentiated tissues. However, regulated
splicing changes are likely to be important in bio-
logical transitions such as cellular differentiation,
or response to environmental stimuli. To assess
the extent and significance of AS in myogenesis,
we used splicing-sensitive microarray analysis
of differentiating C2C12 myoblasts. We identified
95 AS events that undergo robust splicing transi-
tions during C2C12 differentiation. More than half
of the splicing transitions are conserved during dif-
ferentiation of avian myoblasts, suggesting the
products and timing of transitions are functionally
significant. The majority of splicing transitions
during C2C12 differentiation fall into four temporal
patterns and were dependent on the myogenic
program, suggesting that they are integral compo-
nents of myogenic differentiation. Computational
analyses revealed enrichment of many sequence
motifs within the upstream and downstream
intronic regions near the alternatively spliced
regions corresponding to binding sites of splicing
regulators. Western analyses demonstrated that
several splicing regulators undergo dynamic
changes in nuclear abundance during differenti-
ation. These findings show that within a develop-
mental context, AS is a highly regulated and
conserved process, suggesting a major role for AS
regulation in myogenic differentiation.
INTRODUCTION
Current estimates are that ~95% of multi-exon genes in
humans are subject to alternative splicing (AS), greatly
expanding the transcriptome (1). AS also serves a crucial
regulatory role by altering the function, localization and
expression level of gene products, often in response to the
activities of key signaling pathways (2-5). Misregulation
of AS is implicated in the pathogenic mechanisms of
several diseases (6-9). Splicing regulatory proteins are
subject to multiple levels of regulation during develop-
ment (10-12) and AS regulation has been shown to
occur during a number of developmental processes
including heart development (13), neurogenesis (14-16)
and T-cell differentiation (17). Despite increased recogni-
tion of the prevalence of AS and its relevance to develop-
ment, tissue identity and disease, little is known about the
mechanisms that regulate natural splicing transitions. In
addition, the broad biological relevance of the extensive
transcript diversity generated by AS continues to be
debated (18-21).
Recent efforts to examine splicing on a global scale using
high-throughput techniques such as splicing sensitive
microarrays (22,23) and deep sequencing (1,24,25) have
focused primarily on comparing splicing patterns in adult
tissues or examining events affected by depletion of trans
acting factors. Other studies have used purely computa-
tional approaches to ascertain the global impact of AS
(20,26), often relying on EST databases, which are
heavily biased towards transcripts derived from brain
and cancer tissues (27,28). By restricting global AS
analyses to adult tissues, temporally regulated aspects of
AS biology are overlooked. Analysis of global AS transi-
tions during key biological transitions such as development
provides an experimental system in which to identify the
regulatory mechanisms and biological relevance of AS.
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AS is enriched in skeletal muscle (22), as are several
splicing factors, such as the FOX and Muscleblind-like
(MBNL) families (29,30), suggesting that myogenesis is
accompanied by high levels of AS regulation. The
C2C12 mouse myoblast cell line is a subclone of a cell
line derived from adult muscle satellite cells (31,32). The
cells are committed to the myogenic pathway and are
highly proliferative when maintained in high serum/low
confluence conditions. Exposing confluent C2Cl2 cells
to low serum conditions induces differentiation. Cultures
up-regulate the myogenic transcription factor myogenin
within 24h, exit the cell cycle within 36h and myoblasts
fuse within 72h to form multinucleated myotubes that
exhibit morphological and biochemical similarities to
immature skeletal muscle tissue (Figure IA) (33,34).
Our goal was to utilize myogenic differentiation as a
model system to study developmentally-associated AS
regulation. We specifically set out to define networks of
AS transitions that occur during myogenic differentiation
and to identify cis-acting elements and trans-acting factors
that control these regulatory networks. Using splicing sen-
sitive microarrays we identified ~100 alternatively spliced
regions that undergo robust splicing transitions during
C2Cl2 differentiation. Most of the strongly regulated
splicing transitions tested are conserved during differenti-
ation of mammalian and avian myoblasts and are depend-
ent on the myogenic program. Computational analysis
identified multiple sequence motifs that are significantly
enriched and conserved within the intronic regions sur-
rounding the regulated alternative regions. Many of
these motifs were significantly associated with specific
temporal subsets of splicing transitions. The identified
motifs included binding sites for known splicing regulators
such as FOX, CELF, hnRNP L, TIA and PTB. A large
number of novel sequence motifs were also enriched near
regulated regions. Furthermore, many of the splicing regu-
lators with enriched and conserved binding motifs exhibit
changes in nuclear abundance during C2Cl2 differenti-
ation, either due to apparent nuclear/cytoplasmic transi-
tions (MBNL2 and MBNL3) or changes in total
steady-state levels (MBNL1, CUGBPl and CUGBP2,
PTB, FOXI and hnRNP C), while other splicing regula-
tors exhibit relatively constant nuclear steady-state levels
(FOX2). These results reveal regulatory networks
controlling natural splicing transitions that are likely to
be directly relevant to physiological changes associated
with muscle differentiation.
MATERIALS AND METHODS
Cell culture
C2Cl2 myoblasts (ATCC) were maintained in
high-glucose DMEM, supplemented with 10% FBS, 1%
penicillin/streptomycin and 1% L-glutamine (all
Invitrogen). C2Cl2 cells were differentiated at -95% con-
fluence by adding differentiation media containing
high-glucose DMEM, supplemented with 2% horse
serum (Invitrogen), 1% penicillin/streptomycin and 1 %
L-glutamine. Low-passage (<10 passages) cells were used
for all experiments. QM7 cells (ATCC) (35) were
maintained in Earle's M199 basal medium, supplemented
with 10% fetal calf serum, 10% Tryptose phosphate
broth (both Difco), 1% penicillin/streptomycin and 1%
L-glutamine. QM7 cells were differentiated at -95% con-
fluence in Earle's M199 basal medium, 0.01% fetal calf
serum, 1% penicillin/streptomycin and 1% L-glutamine.
QM7 cells were allowed to differentiate for 96h, at
which point large numbers of myotubes were visible. All
cell lines were maintained in a humidified, 370 C incubator
with 5% C02.
BDM treatment
A 5M stock solution of 2,3, butanedione monoxime
(BDM; Sigma) dissolved in DMSO was added to C2Cl2
differentiation media to a final concentration of 15 ptM,
(or an equal volume of DMSO; vehicle control). The
treated media was then added to -95% confluent
C2Cl2 cells (Hour 0 of differentiation). Fresh treated dif-
ferentiation media was added to cultures every two days.
C2Cl2 cells were allowed to differentiate for up to 120h.
RNA and whole-cell protein lysate were collected as
described below at -24, 0, 24, 72 and 120 relative to dif-
ferentiation induction.
Splicing sensitive microarray, RNA preparation
and hybridization
Splicing arrays were designed and RNA isolation and hy-
bridization performed as previously described (13).
Briefly, the array design included probes to 10 111 genes
expressed in muscle or heart. Optimized 60-nt probes were
designed to monitor each exon, and 36-nt probes were
centered across each exon-exon junction (36). Exons
<60nt were monitored by using shorter probes attached
to T-stilts. In total, 248 316 oligonucleotide probes,
including 110 367 exon and 93 382 junction probes were
synthesized on a six-array set. Total RNA for splicing
microarray analysis was prepared from C2Cl2 cultures
at -24 and 120h relative to differentiation induction
using RNeasy kits (Qiagen), and the RNA quality was
assessed spectrophotometrically (Agilent) at the micro-
array core facility at Baylor College of Medicine. Cy dye
labeling, hybridization and array analysis was performed
as described earlier (13).
RT-PCR validation and quantification of
splicing transitions
For RT-PCR assays, total RNA was extracted using
TRIzol (Invitrogen). RT-PCR primers were designed
complementary to constitutive exonic regions flanking
the predicted alternative regions. One-Step RT-PCR reac-
tions were performed using specific primers on 0.5 tg of
total RNA samples isolated from C2C12 or QM7 cells at
various time points throughout differentiation. After
gene-specific reverse transcription at 42'C for 35 min, the
resulting cDNA was subjected to 18-25 cycles of 95'C for
45 s, 570C for 45 s and 72'C for 60 s, then separated using
PAGE, followed by ethidium bromide staining, imaging
and molecular weight-corrected quantification using the
Kodak Gel logic 2200 and Molecular Imaging Software.
Alternative region percent inclusion was quantified by
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C2C12 mouse mvoblast Differentiation
24hr 48hr 72hrtChange in percent included 220 230 240 250
Number of validated
splicing transitions 95 71 49 31
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actin binding cytoskeletal kinase
Figure 1. Characterization of validated splicing transitions associated with C2C12 myoblast differentiation. (A) Phase-contrast micrographs showing
a time course of C2C12 differentiation. (B) The number of splicing events (out of 117 total validated events) that undergo splicing transitions of >20
percentage points. (C) Summary of the different types of validated splicing transitions included within the data set of 117 splicing transitions. (D) GO
analysis for significantly (P < 0.05) enriched molecular functions in validated splicing transitions of >20 percentage points.
adjusting band intensity for length of the PCR product,
dividing the intensity the band including the regulated al-
ternative region by the total product [inclusion band/(in-
clusion + exclusion band) x 100]. All bands of interest
were gel-isolated, amplified and confirmed by sequencing.
Gene ontology analysis
Gene ontology (GO) analysis was performed using
PANTHER according to the instructions provided at
www.pantherdb.org/. Validated splicing transitions from
C2C 12 or QM7 data sets were analyzed against a reference
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list (10 111 genes on the microarray) for significant enrich-
ment of molecular function terms, calculated using
binomial testing with Bonferroni correction for multiple
testing as described earlier (37) Only processes with a sig-
nificant (P < 0.05) enrichment were discussed in this
article.
Computational analysis of motif enrichment
and conservation
Significantly enriched pentameric motifs within flanking
introns of AS regions undergoing splicing transitions
>10% across all time points were detected according to
a GC-content controlled first-order Markov model. The
intronic regions analyzed consist of the first and last 250 nt
of the upstream and downstream introns, relative to the
regulated alternative region, excluding the first 9 and last
30 nt of the intron which contain the conserved 5' and 3'
splice sites, respectively. Sequences were binned according
to their G+C content into 10 groups. Expected pentamer
frequency was calculated for each pentamer by using the
first-order Markov model in introns of each GC group
respectively. Pentamer enrichment was then evaluated by
comparing the occurrence frequency of each pentamer to
the overall expected frequency calculated by summing up
the expected counts of all G+C groups. A P-value was
calculated by using the binomial distribution. All results
were subjected to false discovery rate filter (Benjamini-
Hochberg, FDR < 0.05). Significantly conserved penta-
meric motifs among splicing transitions changing >10%
across all time points were identified within the above
intronic regions using alignments to seven other mamma-
lian genomes that have at least 5x sequence coverage in
the UCSC 28-way multi-genome alignment. A conserva-
tion rate (CR) was calculated as the fraction of aligned
and conserved motif occurrences. The significance of the
CR for each pentamer was evaluated by comparing to 10
other pentamers with similar expected CR, according to a
first-order Markov model. P-values were obtained using
binomial distribution, and subjected to a false discovery
rate filter (Benjamini-Hochberg, FDR <0.05).
Motif regression analysis
Regression analysis was performed on motifs determined
to be significantly enriched or conserved, discovered using
introns flanking events which change >10% across all
time points, events which increase >10% across all time
points, and events which decrease <10% across all times
points. The percent of alternative region inclusion at
each time point (i) of a C2C12 differentiation time
course (-24, 0, 12, 24, 72 and 120h relative to differenti-
ation induction) was compared to every other time point
(j), to obtain different vectors of splicing changes (yiy),
where the length of the vector was proportional to the
number of splicing events within the validated data set.
For each of the above mentioned intronic regions (r)
flanking each regulated splicing event, the density of
motifs (x,) was regressed against each vector of splicing
changes (yij = A x.+ b). Significant correlations (P <0.05)
were noted and plotted in a heat map format
(Supplementary Figure Sl) in which colors denote -log10
(P-value) for P-values <0.05, with darker colors represent
increasing significance. Red shades denote a positive
coefficient (A), where presence of the motif is associated
with an increase in alternative region inclusion
(NTime2 - *Timei > 0), and blue shades denote a negative
coefficient (A), where presence of the motif is associated
with an increase in alternative region skipping
(WTimc2 ~ qTime1 < 0).
Clustering analysis
Affinity propagation analysis was performed to identify
similar clusters of splicing transitions, (38) using a
matrix of all pair wise comparisons between all splicing
events. To obtain the similarity matrix, the Pearson cor-
relation coefficients was computed between the raw inclu-
sion levels of regulated alternative regions for each pair of
splicing events across time points -24, 0, 12, 24, 48, 72
and 120 of C2C12 differentiation. Various affinity propa-
gation preference levels were tested; preference values of
0.25-0.5 yielded the same number of clusters, and these
clusters are shown in Figure 6 and Supplementary
Table S5. Clustering graphs illustrate splicing profiles of
a cluster of splicing events across time points; the y-axis
represents inclusion levels at various time points,
normalized so that means and SDs are uniform. Each
cluster contains an 'exemplar' (shown in red) which best
'exemplifies' the cluster, according to the affinity propaga-
tion algorithm. Splicing profiles of the other events in each
cluster are plotted in various shades of gray, where darker
gray represents a larger maximum difference in inclusion
level across all time points. Motif enrichment and conser-
vation analysis was performed for the events within each
cluster in a manner identical as that described earlier.
Nuclear, cytoplasmic and whole-cell protein extraction
Nuclear and cytoplasmic protein fractions were prepared
from C2Cl2 cells by washing cells three times in ice cold
PBS, scraping in fractionation buffer [10mM HEPES
(pH 7.5), 10mM MgCl2, 5mM KCl, 0.1mM EDTA,
0.1% Triton X-100, 0.2mM PMSF, 1mM DTT,
1 x Complete Protease Inhibitor Mixture (Roche)] and
passing cells through a 27 gauge needle 10 times. The re-
sulting lysate was then centrifuged at 600g for 15 min at
4'C to pellet nuclei. The cytoplasmic fraction was acetone
precipitated overnight and resuspended in lysis buffer
[10mM HEPES (pH 7.5), 0.32M sucrose, 1% SDS,
5 mM MG132 and 5 mM EDTA with protease inhibitors].
The nuclear pellet was washed two times in fractionation
buffer, and then resuspended in lysis buffer. Both nuclear
and cytoplasmic fractions were sonicated and total protein
was quantified using the BCA assay (Pierce). All samples
were stored at -80"C.
Western blot analysis
Thirty micrograms of nuclear, cytoplasmic or total protein
was fractionated on a 10% Tris-glycine SDS-PAGE gels
and transferred onto PVDF membranes (Immobilon). The
protein loading and transfer quality were confirmed by
Ponceau S red staining (Sigma). Membranes were
blocked in TBST with 5% non-fat milk, then incubated
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with the primary antibody overnight at 4'C, washed in
TBST, incubated with the appropriate secondary
HRP-conjugated antibody at room temperature for 2h,
washed in TBST and visualized using an HRP chemilu-
minescence system (Pierce). The following primary
antibodies were used: monoclonal anti-CUGBPI
antibody (1:1000; 3B1; Upstate), monoclonal anti-
CUGBP2 [1:500; 1H2 (39) conjugated with HRP], poly-
clonal anti-MBNL1 [1:1000 (40)], monoclonal
anti-MBNL2 (1:1000; and monoclonal anti-MBNL3
(1:1000; both generously provided by Glenn E. Morris)
(41), monoclonal anti-FOX-1 [1:500; generated in-house
(13)] polyclonal anti-FOX-2 [1:120 000; generated
in-house (13)], monoclonal anti-PTB (1:1000; R164; gen-
erously provided by Doug Black), monoclonal anti-
Myogenin (1:500; F5D Abcam), monoclonal
anti-hnRNP L (1:50000; 4D11l; Abcam), monoclonal
anti-hnRNP C (1:10000; Sigma), polyclonal Anti-p27
(1:500; sc-518; Santa Cruz) monoclonal anti-TBP
(1:1000; ab818; Abcam), and monoclonal anti-GAPDH
(1:10000; Biogenesis). Secondary antibodies used were
HRP-conjugated goat anti-rabbit (1:50000; Calbiochem)
and HRP-conjugated sheep anti-mouse (1:5000; Jackson).
RESULTS
Skeletal muscle differentiation is associated with a large
number of AS transitions
AS transitions during C2C12 differentiation were
identified using a previously described custom splicing
sensitive microarray (13) as well as from the literature
focusing on exons found to be preferentially included
in adult mouse skeletal muscle tissue (23,42). Overall,
117 splicing transitions were identified, 66 of which were
detected using splicing-sensitive microarrays, and the re-
maining events were found by performing EST
comparisons and through the literature. All events were
validated by RT-PCR using total RNA collected from
C2C12 cells 24h before differentiation induction (-24h)
and 5 days post differentiation induction (120 h). The
identities of the predominant (>10% of total) RT-PCR
products were confirmed by sequencing. To define the
kinetics of splicing transitions, validated events were
further analyzed by RT-PCR in a series of time course
experiments, using total RNA collected at -24, 0, 12, 24,
72 and 120h relative to differentiation induction
(Supplementary Table Sl). AS is expressed as the
percent of mRNA that includes the variable region and
splicing transitions are expressed as the change of percent
of mRNAs containing the variable region between time
points; thus an event that changes from 20 to 50% inclu-
sion is a 30% point change. At least two biological repli-
cates were performed for all time points of all events
analyzed in the time course. In addition, all events were
tested in at least two additional biological replicates at the
-24 and 120 time points. The magnitude of most splicing
transitions was highly consistent between biological
replicates.
Of the 117 validated splicing events, 95 exhibited strong
transitions of >20 percentage points with 49 of these
exhibiting a change of 40 percentage points or more
(Figure lB and Supplementary Table Sl). Sixteen events
changed between 10 and 20 percentage points and six
events displayed changes <10 percentage points. Of the
95 strong events, the average alternative region length
was 96 nt, with a SD of 49 nt. A total of 69 of the
95 strong events (73%) showed increased inclusion
during differentiation, and the remaining 26 (27%)
showed increased skipping. Among all 117 validated tran-
sitions, there were 100 cassette exons (85%), including 16
multiple cassette exons, 8 mutually exclusive exons (7%)
and 9 alternative 3' or 5' splice sites (7%) (Figure IC).
Ninety-six of these 117 events (82%) are predicted to
retain the reading frame. In addition, 38 of the 117
events (32%) underwent an average fold change >2.0 in
gene expression.
To assess the biological roles of the transcripts under-
going AS transitions during C2C12 myoblast differenti-
ation, we performed comparative GO analysis (37,43).
The 95 strong events were compared against a reference
set of ~10000 transcripts expressed in mouse striated
muscle. Genes expressing transcripts undergoing
AS transitions were significantly enriched for GO
molecular function terms relating to cytoskeletal, actin
binding, cell junction and nucleotide kinase molecular
functions (Figure 1 D), as well as a significant
(P = 0.021) over-representation in integrin signaling
pathway components, consistent with other muscle
specific splicing data sets (23,42). Overall, this data set
represents a large cohort of validated, robustly regulated
splicing transitions that occur in several temporally
coordinated patterns (see below) during myogenic
differentiation.
AS transitions associated with muscle differentiation are
conserved in mammalian and avian cultures
To asses the biological relevance of the splicing transitions
during muscle differentiation, we examined their conser-
vation between the murine C2Cl2 line and the
quail myoblast cell line QM7 (35). From a set of 77
strongly regulated alternative exons from the validated
data set, we identified 48 orthologous exons in the pub-
lished chicken genome (build 2.1). A total of 38 (79%) of
these were detected by RT-PCR (Figure 2A and
Supplementary Table S2) of which 22 (57%) were
regulated similarly to mouse, three (8%) were oppositely
regulated and 13 (34%) were alternatively spliced but
showed little or no regulation during QM7 differentiation
(Figure 2B). We used GO analysis to define the molecular
functions of the 25 genes containing exons regulated in
both quail and mouse and found that 7 (30%) were
within transcripts encoding RNA-binding proteins, a stat-
istically significant enrichment (P = 1.39 x 10-4), while 6
(24%) were within transcripts encoding cytoskeletal com-
ponents. The high level of conservation of regulated
AS transitions in avian and mammalian muscle differen-
tiation strongly suggest that AS regulation plays a bio-
logically significant role and that RNA-binding proteins
are conserved targets of splicing regulation.
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Figure 2. Most AS events common to mouse and quail myoblasts undergo conserved transitions during differentiation. (A) Representative RT-PCR
results for seven splicing transitions conserved between C2C12 (mouse) and QM7 (quail) myoblast differentiation. Undifferentiated (U) and
differentiated (D) cultures are indicated. The percentage alternative exon inclusion (% inclusion) is indicated in undifferentiated and differentiated
C2C12 and QM7 cells. (B) Summary of splicing transitions conservation between C2C12 and QM7 cells. See Supplementary Table S2 for a full list of
all events tested between C2C12 and QM7 cells.
The majority of regulated splicing transitions in C2C12
are dependent on the myogenic differentiation program
Myogenic differentiation in culture is induced by a com-
bination of reduced growth factors and high cell density
and is preceded by cell-cycle exit (33,44,45). To determine
whether AS regulation is an integrated component of the
myogenic program or simply a result of growth factor
withdrawal and cell-cycle exit, we used 2,3, butanedione
monoxime (BDM) to induce cell-cycle exit and simultan-
eously block myogenic differentiation (46). As expected,
C2C12 cultures treated with 15 pM BDM failed to
undergo morphological changes associated with differen-
tiation, including cell alignment and formation of
myotubes (Figure 3A). In addition, BDM-treated
cultures showed no increase in cell number over time
(data not shown), exhibited upregulated expression of
the cell-cycle inhibitor p27, and failed to upregulate ex-
pression of the myogenic transcription factor myogenin
(Figure 3B). We examined 21 splicing events that
undergo strong (>20 percentage points) differentiation-
induced splicing transitions in cells treated at time 0 with
BDM compared to cells treated with the DMSO vehicle
alone. The majority of these events (13) showed little or no
change (<25% of that seen in control cells) (representative
events are shown in Figure 3Ci and 3Cii). Of particular
interest are the several splicing transitions that occur pre-
dominantly between -24 and 0 h of differentiation. These
events are initiated much earlier than the appearance of
transcriptional markers of myogenesis or overt morpho-
logical changes indicative of differentiation. Most of these
events revert toward the level of inclusion observed at
-24 h when BDM is added at time 0, suggesting depend-
ence on the myogenic differentiation program despite the
transition initiating before addition of differentiation
media (Figure 3Cii). Four events showed a moderate
degree of regulation in the presence of BDM (>25% but
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Figure 3. Most splicing transitions are dependent upon myogenic differentiation. (A) Phase-contrast micrograph of vehicle (DMSO) and BDM
(15 iM) treated C2C12 cells 120h following induction of differentiation. (B) Western blots of whole cell lysate from DMSO or BDM treated C2C12
cells. Myogenin staining was used to measure myogenic differentiation progression and p27 staining was used to assess cell-cycle exit. 'Asterisk'
indicates -60kDa non-specific band detected by p27 antibody. (C) Four groups each depicting four representative examples of splicing transitions
distinguished based on myogenic differentiation dependence. BDM (dashed lines) or DMSO vehicle (solid lines) was added to media at Hour 0.
Group i exhibited a complete block of splicing transitions following addition of BDM. Group ii exhibited partial reversion of splicing transitions to
undifferentiated (-24h) state upon treatment with BDM. Group iii continued to undergo splicing transitions after BDM treatment, but at a reduced
level compared to DMSO. Group iv events were not affected by addition of BDM. Splicing events depicted (in the order: black, green, red, orange)
are as follows: Group i: Dtna_78,93; Atp2bl_87; Lrrfip2_93,102; Anxa7_66. Group ii: Dguok_100; 463241IB12R Rik_78; Mpp6_42; Azi2_47. Group
iii: Capzbl13; Art3_30; Akapl3_54; Binl_45. Group iv: R3hdm_42; 5830434P21Rik_82; 5230400G24Rik_60; Pkp4_129.
<75% of that seen in control) (Figure 3Ciii) and four
events showed comparable levels of regulation in both
BDM treated and control conditions (Figure 3Civ).
Similar results were obtained using C2C12 suspension
cultures which, similar to BDM treatment, uncouples
cell-cycle exit from differentiation (47) (data not shown).
We conclude that the majority of AS transitions
identified are dependent upon and integrated into the
myogenic differentiation program. Interestingly, this
analysis also identified splicing transitions that are
induced by cell-cycle withdrawal independent of the
myogenic program, suggesting separate networks of
regulated AS transitions controlled by distinct signaling
mechanisms during myogenic differentiation.
Cis-regulatory elements associated with myogenic
splicing transitions
To identify cis-acting regulatory elements associated with
the validated splicing transitions in our data set, we first
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examined the introns flanking all alternatively spliced
regions that undergo transitions of >10 percentage
points for enrichment of pentanucleotide motifs relative
to a first-order Markov background model (13). We
analyzed the first and last 250 nt of the upstream and
downstream introns relative to the regulated alternative
region. To avoid the inclusion of sequence motifs
associated with constitutive splicing, the first 9 and last
30 nt of the intron which contain the conserved 5' and 3'
splice sites, respectively were excluded from the analysis.
We identified several significantly enriched motifs
(P <0.05 after Bonferroni correction, italics indicates cor-
rected P < 0.0001 in Figure 4), including recognition se-
quences for FOX, CELF, PTB and hnRNP L splicing
factors of which CELF and hnRNP L sites were most
enriched (P < 1.13 x 10-" after Bonferroni correction)
(Figure 4 upper panel and Supplementary Table S3).
Additionally, several motifs not associated with known
RNA-binding proteins were identified.
A second analysis was performed to identify motifs
within the flanking introns of regulated alternative
regions that were conserved between mouse and seven
other mammalian species. This analysis identified several
of the same motifs including FOX, PTB and the
NA(A>C)TAAY (STAR) motif (Figure 4 lower panel
and Supplementary Table S4) previously found to be
associated with skeletal muscle specific AS in adult tissue
(23,42). FOX motifs within the first 250-nt downstream of
the alternative region were both significantly enriched
(P = 1.25 x 10~6) and conserved (P < 5.25 x 10-9). Based
on the significance values, frequency of binding sites, and
combined enrichment and conservation, we conclude that
FOX, CELF, PTB, STAR and hnRNP L splicing regula-
tors are particularly strong candidates for proteins that
regulate different or overlapping subsets of splicing tran-
sitions during myogenic differentiation.
A
ACACA (hnRNP L)
CACAC (hnRNP L)
CGCGC
ACACG
To identify enriched motifs that correlate with specific
temporal splicing patterns, we performed regression
analysis using the time course data regressed against
enriched motifs within different intronic regions.
Different enriched motifs were identified within specific
intronic regions that strongly correlated with temporal
splicing patterns (Figure 5 and Supplementary
Figure Sl). FOX motifs downstream from regulated alter-
native regions strongly correlated with continuous
increased inclusion of variably spliced regions during dif-
ferentiation, while upstream FOX motifs were correlated
with an early decrease. For PTB, motifs located upstream
of the variably spliced region correlated with continuous
inclusion and downstream motifs correlated with late ex-
clusion. Upstream hnRNP-L motifs correlated with an
early increase in variably spliced region inclusion, while
upstream STAR motifs correlated with an early decrease
in inclusion. Overall, these data suggest different position-
and time-dependent effects for several known splicing
regulators and identified novel motifs associated with
specific location and time-dependent effects.
Coordinated waves of splicing transitions occur
throughout myogenic differentiation
To determine whether splicing transitions show different
coordinated temporal patterns during myogenic differen-
tiation, we examined the inclusion levels of 117 validated
events at seven to nine time points from 24h before, until
120 h after addition of differentiation media
(Supplementary Table Sl). Clusters of splicing events
that share similar temporal patterns of regulation were
identified by subjecting the time course data set to
affinity propagation analysis, in which the behaviors of
splicing events are compared to identify distinct clusters
that share a common pattern of regulation with a set of
'exemplar' events (38). Four major clusters of >10 events
Enriched motifs
CTGTG (CELF/MBNL)
TTCCT (PTB)
TTTCT (PTB)
ACGTG
AGAAA
TGTGG
B Conserved motifs
TCTCT (PTB) TGCAT(FOX) CTAAT (STAR)
AATGT GCA TG (FOX) GCATG (FOX)
ACTAA (STAR) CATGC
GGAAT
GAATG
Figure 4. Motif enrichment and conservation in intronic regions flanking regulated variable regions. Pentameric motifs that are significantly enriched
(upper panel) within the flanking intronic sequences of exons exhibiting AS changes during C2C12 differentiation or conserved (lower panel) among
seven other mammalian species. Motifs were identified using a first-order Markov background model (corrected P < 0.05, motifs in italics indicate
corrected P < 0.0001). Intronic regions analyzed included the first and last 250 nt of the upstream and downstream introns, excluding the first 9 nt and
last 30nt of the introns. Motifs matching the recognition sequences of known splicing regulators are indicted. Only motifs with significance
P<0.05 (standard text) or P<0.0001 (italic text) are shown in the figure. For a complete list of all enriched and conserved motifs, see
Supplementary Tables S3 and S4, respectively.
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Figure 5. Regression analysis identified enriched motifs associated with temporal splicing transitions. Regression analysis was used to identify
correlations between enriched motifs and specific temporal patterns of splicing transitions. The enrichment of each motif within the various
intronic regions was regressed against the magnitude of each splicing transition (% of total change) at -24, 0, 12, 24, 48, 72 and 120h relative
to differentiation induction. Green denotes positive correlations (motif associated with increased inclusion of alternative region during differenti-
ation); red denotes inverse correlations (decreased inclusion of alternative region during differentiation). Early (before 24h), late (after 24h) and
continuous refers to period in the differentiation time course to which a given motif is most strongly correlated. For a full display of all regression
analysis heatmap data see Supplementary Figure Sl.
(comprising 102 out of the 111 with >10 point change
events that were analyzed by affinity propagation) were
defined based on the timing of maximal transition and
are named based on the exemplar event that best repre-
sents the behavior of the cluster (Figure 6). Among the
four major clusters, there were 82 events that showed
increasing alternative region inclusion and 20 events that
showed increased skipping (Figure 6A). The ALS2CR2e8
cluster (10 events) exhibits an extremely early increase in
alternative region inclusion between -24 and 12 h relative
to induction of differentiation, the DTNA cluster
(30 events) exhibits an early (12-24 h) increase in inclu-
sion, while the KIFIB cluster (42 events) underwent a
late increase in alternative region inclusion between
24 and 72h. The PHKAI cluster (20 events) exhibited
early/continuous increased skipping. For a full list of
events and their assigned cluster see Supplementary
Table S5. In addition, two minor clusters consisting of
<8 events each (9 total) are shown in Supplementary
Figure S2.
To identify cis-regulatory elements associated with
specific splicing clusters, the four largest clusters were
analyzed for motif enrichment and conservation
(Figure 6B and Supplementary Tables S6 and S7). This
analysis provides an independent assessment of motifs
associated with temporal patterns that can be compared
to the regression analysis presented in Figure 5. TIA and
hnRNP-L motifs were significantly enriched within the
upstream intronic regions of events in the KIFIB
cluster, while CELF, FOX and hnRNP-L motifs were sig-
nificantly enriched in the DTNA (early increase) cluster.
Interestingly, hnRNP-L motifs were identified in the late
as well as the early cluster suggesting the potential involve-
ment in different temporal events as components of
combinatorial regulation (see Discussion). Conservation
analysis of different clusters identified significantly
conserved FOX motifs within the proximal downstream
intronic regions of both the KIFiB (late increase) and
DTNA (early increase) clusters. These data, in addition
to the regression analysis described earlier, strongly
suggest a role for FOX, CELF and hnRNP L proteins
in the regulation of AS transitions during myogenic dif-
ferentiation that is specific with regard to binding site
location and timing of activity.
Several splicing factors undergo different temporal
transitions during myogenic differentiation
We performed western blot analysis on nuclear and cyto-
plasmic fractions during a time course of C2Cl2 differen-
tiation to assess the steady-state nuclear abundance of
splicing regulators during muscle differentiation
(Figure 7). Of particular interest were those regulators
for which binding sites were enriched near the variably
spliced region. The protein expression levels of CELF,
FOX, hnRNP L and MBNL family members were
examined during C2Cl2 differentiation. All western
blots shown in Figure 7 contain 30 pg of nuclear and cyto-
plasmic extracts prepared from the same differentiation
time course. Except CUGBP1 which shows small
differences, the results are representative of what was
observed in at least two independent cultures (data not
shown). TATA-Binding Protein (TBP) and GAPDH
were used to determine the purity of nuclear and cytoplas-
mic fractions, respectively. Myogenin was used as an early
marker of differentiation. It is difficult to find proteins
that show constant steady-state levels during C2CI2 dif-
ferentiation, therefore, Ponceau S red staining was used to
confirm even loading.
152
Global regulation of alternative splicing during myogenic differentiation
ALS2CR2e8 (10 events)
3
0
-2 1ca
-C -2<0
o -3
-24 01224 72 120
DTNA (30 events)
3
E -
0
~0
~ 1
c -2
0-3
-24 01224 72 120
Hrs relative to diff
PHKA1 (20 events)
3
2
0
-1
-2
-3
-24 01224 72 120
KIF B (42 events)
-2 L V
-3
-24 01224 72 120
Hrs relative to diff
Exemplar profile
Maximum % change across time points (dynamic Range)
0 20 40 60 80 100
B
Enrichment
CACAC (hnRNP L)
ACACA (hnRNP L)
IiTTT- (TIA)
CGCGC
ACACG
GGGAA
KIFB Cluster
ACACA (hnRNP L) GCATG (FOX)
GTGTG (CELF) GTGTG (CELF)
TGTGT (CELF) TGTGT (CELF)
GGTTT
Conservation
TTAAG
CTTAA
TTGGC CATGT
GCATG (FOX)
TGCAT (FOX)
AATCA
TGCA T (O)
ACTAA (TR
ATGTA
TCTAA
DTNA Cluster
ALS2CR2e8 Cluster
PHKA1 Cluster
KIF1B Cluster
DTNA Cluster
Figure 6. Clusters of splicing transitions with similar temporal patterns exhibit enrichment of specific motifs. Splicing transitions that share similar
temporal patterns were grouped together in clusters using affinity propagation analysis. Each cluster contains a single 'exemplar' event (red), which
typifies the temporal behavior of that cluster. The remaining events in each cluster are plotted in various shades of gray, where darker gray represents
a larger maximum difference in inclusion level across all time points. (A) Four major clusters (n > 10) representing 102 out of Ill events analyzed by
affinity propagation analysis. A total of six clusters were identified in all; the two remaining contain <8 events and are shown in Supplementary
Figure S2. (B) Motif enrichment and conservation analysis identical to that described in Figure 4A was performed on the four clusters shown in
Figure 5A. Significantly enriched (corrected P <0.05, italics indicate corrected P < 0.0001) motifs are shown. Motifs matching the recognition
sequences of known splicing regulators are indicted. For a list of all cluster-specific enriched motifs, see Supplementary Table S5. For a full list of all
cluster specific enrichment and conservation date see Supplementary Tables S6 and S7, respectively.
We found that several splicing regulators undergo
dramatic changes in nuclear steady-state levels that correl-
ate with different temporal clusters of splicing transitions.
Factors showing early transitions (within the first 24h)
include all three MBNL family members and hnRNP C.
MBNL1 shows a particularly dramatic increase of a
doublet at -42 kDa between 0 and 24 h as well as a
weaker -32kDa band that decreases during differenti-
ation. Both MBNL2 and MBNL3 undergo changes in
nuclear abundance as well as nuclear and cytoplasmic dis-
tribution early in differentiation, with nuclear protein first
detectable at 12h. Five proteins (hnRNP L, CUGBP1,
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Figure 7. Western blot analysis shows dynamic regulation of candidate splicing factors during C2C12 differentiation. Steady-state nuclear and
cytoplasmic protein levels of MBNL, CELF, FOX, PTB, hnRNP C and hnRNP L splicing regulators during C2C12 differentiation. TBP and
GAPDH serve as nuclear and cytoplasmic markers, respectively. Ponceau S staining serves as a loading control.
CUGBP2, FOXI and PTB) showed modulation of
nuclear abundance >24 h following induction of differen-
tiation. Nuclear levels of CUGBP1 and CUGBP2 pro-
teins shown a respective slight decrease and increase
during C2C12 differentiation. FOXl levels increased
modestly, while FOX2 protein levels remained constant
throughout differentiation and PTB decreases during
differentiation.
Overall, changes in nuclear levels of some proteins
correlated well with the preceding analyses associating
known binding motifs with specific temporal patterns.
Motifs associated with hnRNP L and PTB correlated pre-
dominantly with late changes, which is consistent with the
late changes in protein expression. It is important to note
that regulated splicing is likely to involve combinatorial
control such that expression levels of individual proteins
might be involved in but not solely determinative of
splicing patterns (see Discussion). We conclude that
several of the splicing regulators identified through
enriched/conserved binding motifs and that undergo
changes in nuclear abundance are likely to play important
roles in regulating myogenic splicing transitions.
DISCUSSION
Although there is ample evidence for extensive regulation
of AS in metazoans, there are conflicting views as to the
extent of its biological significance (18-21). By amassing a
large validated data set of AS transitions that occur in
response to myogenic differentiation, we characterized
global splicing regulation directly and in a biologically
relevant context. We found nearly 100 splicing transitions
that were robustly regulated during differentiation, most
AS events detected in both mouse and quail myoblasts
underwent conserved transitions during differentiation,
were dependent on the myogenic program, and can be
grouped into four temporal patterns, demonstrating
coordinated regulation. In addition, AS transitions
initiate prior to the appearance of the earliest transcrip-
tional markers of differentiation, indicative of links to
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myogenic differentiation program within proliferating
myoblasts. These findings strongly support a biologically
significant role for AS as an integral component of
myogenic differentiation. This conclusion is further
supported by results from mRNA-Seq analysis
published while this manuscript was in revision,
demonstrating extensive splicing changes during C2C12
differentiation (48).
We found that more than half of the splicing transitions
detectable in the QM7 quail cell line were conserved with
mouse. This high level of conservation is particularly
striking given the 300 million years of evolution that sep-
arates mammals and birds and the fact that not only is AS
conserved, but also a regulated transition of splicing
patterns during a shared developmental process.
Genome-wide analysis using EST and full-length cDNA
databases have detected low levels of AS conservation
across species (21,49-51). However, here we find that a
high proportion of splicing transitions in myogenic differ-
entiation are conserved, consistent with previous results
(13). Previously, we identified a conserved network of
splicing transitions that occur during postnatal murine
heart development (13). It is interesting to note that 49
out of 78 (62.8%) of the splicing transitions that occur
during postnatal heart development are regulated during
C2Cl2 differentiation. Additionally, in both systems
splicing transitions occurred in tightly grouped temporal
waves, suggesting that the splicing regulatory programs in
myoblast differentiation and heart development at least
partially overlap. GO analysis of the regulated transcripts
in C2C12 showed a strong enrichment in molecular
function terms relating to muscle development and
function, even when compared against a muscle specific
background (Figure ID), consistent with other muscle
splicing data sets (23,42). Additionally, several of the
regulated AS transitions we observed during C2Cl2 dif-
ferentiation have already been experimentally shown to be
important for normal muscle function (52-56), further
supporting the view that AS regulation is affecting
processes that are biologically significant to muscle. A
substantial subset of alternative exons that have been pre-
viously shown to be enriched in human (42) and mouse
(23) muscle were found to undergo transitions in exon
inclusion during C2Cl2 differentiation. Specifically, of
the 56 muscle-enriched human exons described by
Das et al., 21 (37.5%) were orthologous to exons we
observed to undergo splicing transitions during C2C2
differentiation. Consistent with our results, this study
identified enrichment of Fox and CELF-binding sites
within 200-nt downstream of muscle enriched exons.
Sugnet et al. reported 28 exons enriched in adult mouse
skeletal muscle. Of these 28 exons, 12 (42.9%) were found
to undergo regulated splicing transitions during C2C2
differentiation. However, it should be noted that both of
these studies examined adult tissues, thus it is likely that
many of the events they identified were excluded from our
study because they do not undergo regulated changes in
the level of alternative exon inclusion during C2C2 dif-
ferentiation (despite being enriched in adult muscle). It is
also important to note that we did not attempt to exhaust-
ively identify all exons that undergo changes in inclusion
levels during C2C12 differentiation, but instead our goal
was to identify a large set of robust splicing transitions
which we could then use for computational and molecular
analysis, and it is likely that many splicing transitions that
occur during C2Cl2 differentiation were not detected in
our study.
To determine whether the splicing transitions are
specific to the myogenic differentiation pathway or are a
general response to cell-cycle withdrawal, we included
BDM in the differentiation medium which allows induc-
tion of cell-cycle arrest but prevents progression of the
differentiation program (46). The results indicated that
most of the splicing transitions tested are dependent on
induction of the myogenic program and cannot be induced
through serum deprivation, cellular confluence and/or
cell-cycle exit alone. Time course experiments showed
that >10 splicing transitions occur largely before the
addition of differentiation media (Hour 0), suggesting
that these events are regulated by signals associated with
increasing cell density or cell-cycle exit. It is particularly
interesting that for the majority of the early events tested,
the transition initiated in proliferative cells was reversed
when myogenic differentiation was blocked by using
BDM treatment (Figure 3Cii). These results indicate the
presence of a signaling mechanism that links early
differentiation-dependent splicing transitions with compo-
nents of the myogenic program that initiate as
proliferating myoblasts become confluent.
Two independent computational analyses to identify
motifs associated with specific temporal patterns showed
that specific sequence motifs are associated with distinct
temporal splicing transition patterns. Both analyses
identified hnRNP-L motifs (ACACA) within the
proximal upstream intronic region of alternative regions
as strongly associated with an early increase in alternative
region inclusion (Figures 5 and 6B). FOX-binding motifs
were also identified in both analyses as strongly associated
with increased inclusion when located within the proximal
downstream intronic region of alternative regions. Such
concordance of two independent computational analyses
is strongly supports a position-dependent role for these
two proteins in AS regulation.
Computational analysis demonstrated that motifs
associated with known regulators of AS, including the
FOX, CELF, PTB, MBNL and hnRNP-L families of
splicing regulators, are enriched within the intronic
regions surrounding the variably spliced regions that
undergo regulation during differentiation. Many of these
enriched binding motifs are also conserved with regard to
sequence and relative location among eight mammalian
species. Regression analysis predicted that FOX-binding
upstream from alternative regions promotes skipping, and
downstream promotes inclusion, which is in agreement
with experimental evidence from other groups (57-59).
While FOX-binding sites are highly enriched near
differentiation-induced splicing events, steady-state
nuclear FOX2 levels remain relatively constant, while
FOXl levels modestly increase very early in C2C12 differ-
entiation but remain constant thereafter (Figure 5A).
Regression analysis showed that FOX sites are most
enriched in early AS changes, suggesting that the early
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increase in FOX1 steady-state levels could account for
early AS transitions observed. However, the FOX2 tran-
script contains two exons which undergo regulated
splicing changes of >20 percentage points during C2Cl2
differentiation, which could alter its activity independent
of its steady-state levels, leading to another mechanism for
the regulation of FOX activity. This possibility is sup-
ported by reports that show AS in the FOXI and FOX2
transcripts result in alterations in splicing regulatory
activity (11,60).
MBNL family members show dynamic regulation in
steady-state nuclear protein levels early in myogenic dif-
ferentiation. Considering the large proportion of validated
splicing transitions that show dramatic changes within the
first 24 h of differentiation, these data indicate that MBNL
family members are likely contributors to developmentally
regulated myogenic AS. While MBNL-binding motifs
were detected in our computational analysis, the high
stringency of the analysis combined with the relatively
high variability of MBNL-binding motifs likely led to
their under-representation. Nevertheless, MBNL-binding
motifs were still found to be significantly enriched (cor-
rected P = 9.55 x 10-6) in the downstream distal intronic
regions of regulated alternative region. Furthermore, the
well characterized role that MBNL family members play
in the pathogenesis of myotonic dystrophy suggest they
are important for normal muscle development (29,61).
Overall, these data demonstrate that AS during
myogenic differentiation is highly conserved, extensively
regulated and suggests that splicing regulation is
influenced by multiple regulatory factors associated with
distinct temporal clusters of splicing transitions.
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Methods
Mapping of mRNA-Seq reads to genome and transcriptome
mRNA-Seq reads were mapped to the human genome (hgl 8)' and a collection of splice junctions
(see below), allowing up to two mismatches, using the ELAND (Efficient Alignment of
Nucleotide Databases) module within the Illumina Genome Analyzer Pipeline software.
Mapping statistics are shown in Fig. S la. Mean read density values for exons, introns, and
intergenic regions were computed in units of reads per kilobase of exon [intron/intergenic] model
per million mapped reads (RPKM)2 and are displayed in Fig. Slc. Reads were mapped to the
annotated transcribed strand of the genome, since the sequencing protocol used does not
distinguish strand. All sequence read data have been submitted to the Short Read Archive
section of the GEO database at NCBI under accession numbers GSE12946
and SRA002355.1.
Sequencing error rate estimation
The sequencing error rate of our mRNA-Seq dataset was estimated by assessing the frequency of
reads mapping to the genome with 0, 1, and 2 mismatches. These counts closely followed a
Poisson distribution with mean k = 0.4 errors per 32-bp read. Considering all 32 bp segments
from Ensembl annotated exons, -91 % occurred uniquely in the genome, and most differed at
multiple positions from the closest 32 bp sequence in the genome. Thus, a sequencing error rate
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with mean k = 0.4 / read, that produces mainly reads with 0 or 1 incorrect bases out of 32, is
expected to produce a majority of reads that can be mapped uniquely to the genome. The
mismatch frequency had a U-shaped distribution as a function read position (Fig. Sl b). The
increase in error rate toward the end of a read is an intrinsic property of the Solexa sequencing
technology used, while the lesser increase in mismatch frequency at the first few positions likely
results from biases related to the random hexamer priming, with the necessity of perfect base
pairing increasing toward the 3' end (corresponding to base 6) of the primer.
Estimation of rate of mis-mapping
The frequency of mis-mapping of reads to the genome and splice junction dataset (see below)
was estimated by using all uniquely mapped reads for the low-coverage UHR sample (5M
reads). We first corrected all mismatches to match reference sequence to generate 5M perfectly
mapping reads. Then we generated a set of mock reads, introducing errors at a frequency of 0.4
errors/read, that were then mapped to the genome and junctions using ELAND, also allowing for
two mismatches. The fraction of mock reads mapping to a unique genomic location or junction
was 98.7%. Of those uniquely mapping reads, 99.9% were correctly remapped to their location
of origin.
Generation of splice junction database
A comprehensive list of known exons was compiled from UCSC knowngenes, Refseq and
Ensembl transcripts, together with predicted exons from GENSCAN, and EXONIPHY4 . All
possible splice junctions between any two known or predicted exons located within Ensembl
gene boundaries or within the full intergenic region flanking those gene boundaries were
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considered. Each generated splice junction sequence was 56 bp in length, containing the last 28
bases of the upstream exon and the first 28 bp of the downstream exon, yielding 13.8 million
junctions in total. Use of 28 bp on each side effectively ensured that each junction-mapped read
must match a minimum of 4 bases on each side of the junction, a requirement we have found is
sufficient to ensure unique mapping in the vast majority of cases. This comprehensive database
of potential splice junctions, as well as the database of known splice junctions used in assessment
of tissue-specific AS will be posted at http://genes.mit.edu/burgelab/mRNA-Seq.
Estimation of transcript abundance and comparison to real time RT-PCR data
Reads in the low coverage UHR sample (derived from Stratagene Universal Human Reference
RNA) and the low coverage brain sample (derived from Ambion Human Brain Reference RNA)
were mapped to all Refseq exons and splice junctions to obtain read counts for each transcript.
Taqman data from the MAQC project were downloaded from NCBI Gene Expression Omnibus
(GEO), specifically for four replicates each of Stratagene UHR RNA (tables GSM129638,
GSM129639, GSM129640, GSM129641) and the Ambion brain RNA (GSM129643,
GSM129644, and GSM129645). The ACt values with respect to POLR2A (endogenous control
gene) were averaged across the four replicates, using only data points for which expression was
detectable (< 35 cycles). The difference in average ACt value between brain and UHR (AACt)
for each Refseq transcript was compared with the log of the ratio of read counts in brain over
UHR for each Refseq transcript interrogated by Taqman assay, where mRNA-Seq read counts
were normalized by read counts for POLR2A (Fig. Sl d). The slope of the best fit line determined
by linear regression (MATLAB). The Pearson correlation coefficient value is also reported.
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While read counts varied substantially between different positions in exons (e.g., Fig.
1 A), summing these counts across a gene provided highly quantitative estimates of gene
expression (Fig. Sld). Using typical values of-100 mappable positions per exon and -2500 per
gene, percent spliced in (I) values based on exonic read densities are expected to have a
sampling error ~N/25 = 5-fold higher than expression values based on read density across the
gene, but ~/100 = 10-fold lower than for expression estimates based on read density at
individual read positions. Comparison of Wvalues estimated from mRNA-Seq data in 293T cells
to exon inclusion levels measured by qRT-PCR yielded correlations in the range of between 0.8
and 0.9 with mRNA-Seq qvalues (X. Xiao, R. Nutiu, G. S. and C. B. B., unpublished data).
Estimation of extent of alternative splicing in human genes
We first identified all single-exon transcripts using Refseq annotations (n=1330, 5% of total
number of transcripts). Since we frequently observed single-exon transcripts to be mapping to
genes with other annotated multi-exon transcripts, we filtered for gene loci with exclusively
annotated single-exon transcripts to create our set of 'single-exon genes' and the remaining loci
were designated 'multi-exon genes'. For both single- and multi-exon genes we grouped the
overlapping transcripts for each gene locus to generate a set of non-redundant gene boundary
annotations by selecting the most upstream genomic start and downstream end coordinates for
each locus. This procedure generated a set of 1056 single-exon genes and 16,810 multi-exon
genes. For the 6% of single-exon genes (1056 out of 17,866) we saw no evidence for alternative
splicing. The remaining non-redundant set of multi-exon genes was sorted and binned based on
read coverage, i.e. the number of reads that mapped between the genomic start and end
coordinates. The fraction of alternatively spliced genes was determined for each bin, where a
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gene was defined to be alternatively spliced if there was evidence of a 5'SS spliced to multiple
3'SS or of a 3'SS spliced to multiple 5'SS. Both termini of ajunction were required to be located
within the annotated gene boundaries, and each splice junction was required to be supported by
at least two reads with different alignment positions within the splice junction. Junctions
involving annotated alternative first exons (which are typically generated by alternative
promoters) were not considered to represent alternative splicing in this analysis.
One limitation of the analysis is that the read coverage of some genes may be insufficient
to detect all mRNA isoforms. Therefore, to estimate the true extent of alternative splicing
(essentially, the extent of alternative splicing that would be observed given saturating coverage),
a sigmoid curve of the form F(x) = 1 + e_ (x a)*b was fitted to the fraction of alternatively spliced
genes (F(x)) in each bin as a function of read coverage (x), where a, the upper asymptote,
represents the true extent of alternative splicing (Fig. S2a). Estimates were robust to the bin size
used, as similar results were obtained when using a range of different bin sizes (Fig. S2b).
To assess whether the genes with highest read coverage (genes in the top bin) exhibited a
frequency of alternative splicing different than that for genes with lower coverage (genes in
lower bins), a sub-sampling approach was used (Fig S 1 a). In this approach, reads were sampled
from the topmost bin to simulate levels of read coverage in the other bins, and the fraction of
genes alternatively spliced was evaluated in each sub-sampled bin. This procedure was repeated
100 times to obtain stable means.
To assess the contribution of the cell lines to estimates of the frequency of alternative
splicing, the analysis described above was performed using 9 tissues (excluding the 6 cerebellar
cortex and 5 cell line samples), and compared to the analysis using random subsets of 9 samples
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from the set consisting of the union of the 9 tissues and 5 cell lines (Fig. S2c). Both analyses
yielded similar fractions of alternative splicing, indicating that the estimates of the fraction of
alternative splicing were robust to the choice of samples and that the cell lines did not appear to
contribute disproportionately to estimates of the total fraction of alternative splicing.
While we found that essentially 100% of multi-exon genes (94% of all genes) undergo
alternative splicing, no evidence of alternative splicing was detected in the set of single-exon
genes (the remaining 6% of genes) in our data using the above criteria, even though predicted
exon-exon junctions were searched against.
Estimation of alternative splicing frequency with a minimum minor isoform threshold
To investigate the relative expression of the two splice junctions used to infer the
alternative splicing event, we compared the splice junction read counts for each alternative 3' (or
5') splice site, designating the splice site with lower read count as 'minor'. The fraction of splice
junction reads that supported the minor splice site was then compared to a given threshold. For
example, if 12 splice junctions reads mapped to a splice junction joining a 5'SS to a 3'SS, and 4
splice junction reads mapped to a splice junction joining the same 5'SS to a different 3'SS, the
second 3'SS would be considered minor, with a "minor isoform frequency" of 4 / (12+4)= 25%.
The fractions of genes with detected alternative splicing passing different minimum minor
isoform frequency thresholds are shown in Fig 1 c. The lowest minor isoform frequency that can
be detected depends on the read coverage (i.e. expression level) of the gene. The statistical power
available to detect minor isoforms with different frequencies as a function of the read coverage
(RPKM) was estimated by simulation (Fig. S3), where power was defined as the percentage of
time that the minor isoform can be detected, given predefined minor isoform frequency and read
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coverage values. For example, these results indicate that sequencing of 15M mappable reads
yields for the 1000 genes with highest expression level (RPKM > 100), power of 99%, 44% and
4% to detect both junctions (with 2 or more reads each) at minor isoform frequencies of 20%,
5% and 1%, respectively.
Estimation of false positive rate in discovery of high confidence novel exons
To estimate the fraction of novel exons which are potential false positives, we generated a set of
"modified" splice junctions, where 5 nucleotides were removed from the upstream exon
(positions -10 to -6 relative to the junction) and 5 nucleotides were removed from the
downstream exon (positions +6 to +10 relative to the junction). All reads from adipose and brain
samples were mapped using ELAND to the genome and to either (i) the set of authentic splice
junctions, or (ii) the set of "modified" splice junctions. Using authentic junctions, 1.4M adipose
reads were mapped, and 600K brain reads were mapped; using "modified" junctions, 771
adipose reads were mapped, and 370 brain reads were mapped, yielding an overall FDR of
0.056%. When counting the number ofjunctions with two or more reads mapping to distinct
positions, using authentic junctions yielded 38,265 adipose junctions and 54,602 brain junctions,
while using "modified" junctions yielded 33 adipose reads and 11 brain junctions (for an
estimated FDR < 0.047%). When counting the number of exons with both upstream and
downstream junctions supported by two or more reads mapping to different positions, the
authentic junctions yielded 46,581 exons (including 158 novel junctions) in adipose and brain
combined, and "modified" junctions yielded 0 exons (FDR<0.002%).
Since it is possible that a number of misannotated or (incorrectly) predicted junctions in
combination with real junctions may result in false discovery of novel exons, we considered
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addition of the "false" junctions identified for the "modified junctions" to the large set of real
junctions in adipose and brain. Twenty-one additional exons were identified, out of which 2
were supported by GENSCAN and/or EXONIPHY predictions alone. Therefore, we infer a
FDR for detection of novel exons of ~2/158, or ~1.3%.
Identification of tissue-regulated alternative transcript events
Eight different types of alternative mRNA processing events were analyzed: skipped exons (SE),
retained introns (RI), alternative 3' splice sites (A3SS), alternative 5' splice sites (A5SS),
mutually exclusive exons (MXE), alternative last exons (ALE), alternative first exons (AFE),
and tandem 3' UTR events. The set of events evaluated for tissue-regulation was derived from a
combination of EST evidence, UCSC known gene annotations, and a database of cleavage and
polyadenylation sites constructed based on EST alignments in a manner similar to that used in
PolyA_DB5 . For each event, mRNA-Seq reads were categorized as "common", "inclusion", or
"exclusion" reads, as illustrated in Fig. 2. To assess possible tissue-specific expression for each
event, a Fisher's exact test was performed to evaluate the significance of the 2x2 table in which
reads were divided by: 1) tissue of origin (e.g., brain versus all others); and 2) read type (i.e.
inclusion versus exclusion). Tissue-specific expression was assessed by comparing read data in
each tissue sample to that in the other 14. The tissues/cell lines used in this analysis were
adipose, brain, breast, cerebellum (Cerebellum #4), colon, heart, liver, lymph node, skeletal
muscle, testes, BT474, HME, MB435, MCF7, and T47D. For this analysis, inclusion ratio was
defined as the ratio of the number of inclusion reads to the sum of inclusion plus exclusion plus
"common" reads, i.e. those in regions (generally in adjacent exons) corresponding to gray reads
in Fig. 2, to increase power to detect tissue regulation. Those events which were significant at a
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P-value cutoff corresponding to a false discovery rate cutoff of 5% (in the Benjamini-Hochberg
sense), and which exhibited an inclusion ratio difference of at least 0.10 between at least one pair
of tissues were considered tissue-regulated. For this analysis, a minimum of 20 inclusion,
exclusion and common reads (in total) were required in each tissue for determination of an
inclusion ratio. The latter criterion was imposed based on the observation that SE events with
inclusion ratio difference at least 0.10 exhibited significantly increased sequence conservation in
the vicinity of the regulated exon relative to control events whose inclusion ratios differed less.
No such difference was observed at lower difference threshold (Fig. S4, see below), suggesting
that an inclusion ratio difference of 0.10 may represent a minimum difference that is commonly
associated with additional conserved biological function. While technical variation in sample
preparation and sequencing may yield false positives, analysis of technical replicates of mouse
liver and muscle sequence data2 suggested a false positive rate of <2% in determination of
differentially regulated alternative mRNA processing events.
Determination of minimum functional inclusion ratio difference
Phylogenetic conservation was examined for exons with different degrees of evidence for tissue-
specific regulation. Defining AIRmax as the maximum difference in inclusion ratio between any
pair of tissues (same set of tissues used in analysis shown in Fig. 2), phastCons scores were
obtained for regions containing and flanking each skipped exon (the same regions used in motif
analysis), using the UCSC 17-way alignments of 17 vertebrate genomes. Subsequently, all
skipped exons were grouped into n bins based on AIRmax values divided evenly from 0 to 1. The
CDF of phastCons scores for all skipped exons in each switch score bin was computed, and
compared to the CDFs of phastCons scores in every other bin, using a two-tailed Kolmogorov-
168
Appendix E. Supplementary Information for Alt. Isoform Regulation in Tissues
Smirnov test. In order of ascending switch score, the first bin to contain significantly greater
conservation than in the previous bin was used to define the AIRma, cutoff; that is, events
designated as significantly tissue-regulated were required to pass not only the FDR <5% criterion
imposed on the Fisher's exact test P-value, but also to exhibit a AIRm. value greater than or
equal to the cutoff value of 0.1. For all events types, AIRm. values were computed using the
same read count values used in the Fisher's exact test for tissue regulation. A summary of the
method and results are shown in Fig. S4.
Assessment of power to detect tissue regulation
The ability to detect tissue-regulation of an alternative mRNA processing event depends
fundamentally on read coverage, which is related to both the expression level of the transcript
isoforms and the size of the variably included regions. The statistical power to detect a given
degree of tissue-specific difference in inclusion level was assessed as a function of increasing
transcript expression level by simulation for each of the 8 alternative processing events analyzed
(Fig. S5). For each event, we first determined the median length of the regions used to determine
tissue regulation (i.e. core region of A3SS and A5SS, core region of tandem 3' UTR, skipped
exon and associated flanking exons, etc.). We used these values to specify the probability that a
read for a given gene containing an alternative event would map to one of these regions. Then,
given an underlying difference in inclusion ratio between two different tissues (we used 0.6 in
tissue I versus 0.4 in tissue 2, based on typical inclusion ratio values observed across events),
reads were randomly sampled at a level of read coverage corresponding to transcripts containing
the event of interest. For each level of read coverage, we determined the fraction of events
detected as tissue-regulated (at P<0.001), over many random sampling trials, which we define as
169
Appendix E. Supplementary Information for Alt. Isoform Regulation in Tissues
the statistical power. In our simulation, the ability to detect tissue regulation in one sample
relative to 13 other samples was considered, i.e. we used reads in 1 tissue as compared to the
sum of reads in 13 other tissues, each with expression levels matching the first. For reference, the
cumulative frequency of the number of reads per gene is shown for two representative tissues,
skeletal muscle and liver, in Fig. S5b. From this plot, one can infer that essentially 100% of
tandem 3' UTR events, -95% of ALE events, -45% of RI events, and so on can be detected for
genes with coverage above the median, i.e. genes with > 100 reads per gene.
Estimation of true fraction of tissue-regulated alternative mRNA processing events
In a manner similar to the procedure used to estimate the extent of AS in human genes, events
for each of the 8 alternative mRNA processing events were binned by read coverage (Fig. S6a).
Here, instead of sorting by the number of reads which map to each gene, we sorted by the
maximum number of reads available to detect tissue regulation across all tissues, i.e. the
maximum power to detect tissue regulation. We found that this value is correlated with the
power available to detect tissue bias, but possesses the additional advantage of being able to
distinguish events with saturating power values, i.e. when power is close to 1.0. To estimate the
true extent of tissue-regulated alternative splicing (essentially, the extent of tissue-regulated
alternative splicing that would be observed given saturating coverage), a sigmoid curve of the
a
form F(x) = 1 + e<x- a)b was fitted to the fraction of tissue-biased events (F(x)) in each bin as a
function of maximum read coverage per event across tissues (x), where a, the upper asymptote,
represents the true extent of tissue-biased events (Fig. S6b). To obtain estimates robust to the
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size of each bin, a values were obtained for sigmoid curves fitted using different sized bins, from
10 to 50 total bins (Fig. S6a, bar plot).
Assessment of tissue-specific versus individual-specific differences in alternative isoform
regulation
To assess the degree of similarity between different tissue/cell line samples, we performed
pairwise comparisons between every sample pair, correlating the inclusion ratios of skipped
exons for which sufficient read coverage (>=20 reads) was present in both samples, restricting
analysis to the set of skipped exons determined to be tissue-regulated as shown in Fig. 2.
Spearman correlation coefficients were computed for each pairwise comparison, and the
resulting correlation matrix was clustered using average linkage hierarchical clustering to
generate a dendrogram (MATLAB) as shown in Fig. 3.
To quantify the extent to which tissue regulation and inter-individual variation each
contribute to differences in alternative isoform expression, analyses analogous to that performed
for Fig. 2 were performed using only the 6 cerebellum samples, and 100 random subsets of 6
tissues (from adipose, brain, breast, colon, heart, liver, lymph node, skeletal muscle, and testes).
Sigmoid fitting to estimate the true fraction of alternative isoform regulation was performed for
the cerebellum samples and the 100 random subsets of tissues (Fig. S7).
Estimation of switch score for skipped exons, MXEs, and tandem 3' UTRs
The switch score was defined as the maximal difference in "Percent Spliced In" (PSI or i) of an
alternative region across all pairwise comparisons of tissues and cell lines. For skipped exons, Vf
was defined as (inclusion density / inclusion density + exclusion density), where inclusion
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density was computed as the density of reads mapping to the alternative exon and to both
inclusion junctions (density = no. reads spanning inclusion junctions and alternative exon / total
number of genomically unique positions in the region), and exclusion density was computed as
the read density of the exclusion junction. For MXEs, inclusion density was defined as the read
density of the first MXE and its supporting junctions; exclusion density was defined by the read
density of the second MXE and its supporting junctions. For tandem 3' UTRs, the estimated
inclusion level was computed using a Bayesian approach, which computes the expected density
of the extension region, given a uniform prior on the relative fraction of transcripts terminating at
each of the two alternative polyA sites, the observed read counts, and the number of uniquely
mappable positions in the core and extension regions. Specifically, we computed the posterior
probability of the k[ as p ( (p IN,, d )= p(NIP d,)*p , where Ne numberJ p(N,|p,d)-p(q'rx)-ax
extension reads, de = density of core region, and the prior p(V9 is uniform on [0,1]. The number
of extension reads was modeled as Poisson-distributed, where
p (Ne I, d )= e je;IpIJd) , in which Le length of the extension region.
Ne !
Conservation analysis of switch events
PhastCons scores were downloaded from the UCSC Genome Browser for regions in and around
all skipped exons and tandem 3' UTRs. In Figs. 4d and 5a, the per-position average phastCons
score was plotted for skipped exons or tandem 3' UTRs grouped by switch score, showing means
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at all base pair positions and standard errors every 2 bp for skipped exons and every 5 bp for
tandem 3' UTRs.
Identification of UGCAUG occurrences enriched near skipped exons
The total number of UGCAUG occurrences was counted in five different regions in and around
SEs. These regions included the intronic region from +10 to +150 relative to the upstream 5'
splice site, the intronic region from -150 to -30 relative to the upstream 3'SS, the skipped exon
itself, the intronic region +10 to +150 downstream of the downstream 5'SS, and the intronic
region -150 to -30 relative to the downstream 3'SS. A binomial test was performed to determine
whether increased occurrences of the hexamer was associated with increased inclusion or
exclusion of significantly tissue-regulated skipped exons in each tissue, where the number of
UGCAUG occurrences was compared to the occurrence frequency of control 6-mers derived by
permuting the bases of the UGCAUG 6-mer, requiring also that the number of CpG
dinucleotides - 0 in this case - be preserved in the controls. This analysis was also performed to
identify all non-CpG-containing 6-mers enriched in regions upstream and downstream of
skipped exons exhibiting increased inclusion or exclusion in different tissues (Table S8).
Signal to Background (S:B) motif analysis
MAF alignment files for tandem 3' UTR extension regions and skipped exon regions were
downloaded from the UCSC Genome Browser. The number of conserved (across the human,
mouse, rat, and dog genomes) and total occurrences of each k-mer were counted. The number of
conserved occurrences in each region was tested for significance using a binomial test, where
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controls were chosen by matching GC content and total number of occurrences (~40-80 control
motifs per tested k-mer).
Singular value decomposition (SVD) analysis
RNA processing events for which there was sufficient read coverage in every sample (>10 reads/
event) were chosen for SVD analysis. A matrix of inclusion ratios was computed for each event
type (tissues x events) and column means were subtracted. The first and second principal
components were computed from the mean-centered matrices, as described6 and the data were
projected onto these axes for visualization (Fig. S8). For each event type, the pairwise Euclidean
distances between tissues (as projected onto 2-dimensional principal component space) were
computed between every pair of samples. This vector of pairwise distances was correlated with
analogous vectors derived from the other event types to yield Spearman correlation coefficients.
For analysis of gene expression, the procedure was identical, except that the analysis was
restricted to the set of genes possessing non-zero read density in all tissues, and the log of the
estimated expression was used as input, instead of the inclusion ratio value.
The consistent separation of cell lines from tissues on the basis of alternative splicing and
gene expression seen in Fig. S8 might be attributable to the effects of cell culture conditions per
se or to the effects of selection for high in vitro proliferation rate. Whatever its source, the
existence of this difference strongly suggests that studies seeking to profile cancer-specific
transcriptomes that make use of cell lines will need to contend with and control for a very strong
cell line expression signature affecting both transcription and RNA processing in order to
identify authentic cancer-specific differences.
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Genomic Reads
Samples
Adipose
Brain
Breast
Colon
Heart
Liver
Lymph node
Skeletal muscle
Testes
BT474
HME
MB435
MCF7
T47D
Cerebellum 1
Cerebellum 2
Cerebellum 3
Cerebellum 4
Cerebellum 5
Cerebellum 6
Brain (low cov.)
UHR (low cov.)
Total
Fractions (%)
Junction Reads
No. Reads unique non-unique unique
27,752,231
17,246,957
16,120,746
28,435,996
20,169,301
18,517,121
27,492,254
22,640,454
27,303,938
18,424,533
19,657,452
18,610,758
16,059,515
16,719,597
12,890,252
12,180,619
25,402,905
24,486,091
24,347,196
24,016,465
8,762,894
7,970,336
435M
100%
17.6 M
11.0 M
10.6 M
17.7 M
11.3 M
11.5 M
15.8 M
14.4 M
18.6 M
11.5 M
12.4 M
12.5 M
10.2 M
9.9 M
6.6 M
5.8 M
16.4 M
15.9 M
17.5 M
17.4 M
4.8 M
3.2 M
2.9 M
5.5 M
5.1 M
3.6 M
6.6 M
4.0 M
4.1 M
3.2 M
3.7 M
3.2 M
3.2 M
2.8 M
1.6 M
1.5 M
3.7 M
3.6 M
3.5 M
3.9 M
5.7 M 1.6 M
4.9 M 1.7 M
275 M 77 M
60% 17%
X = 0.4 errors/read
10- 10- 10- 10 100 101 102 103 104
Relative expression (Taqman)
Figure SI. Mapping of Illumina reads to transcriptomes.
a, Summary of mRNA-SEQ read counts and mapping statistics. b, Mismatch frequency at each
read position using all uniquely mapped reads from all tissues. The barplot displays the mean
and standard deviation (across all tissues and cell lines) of the fraction of reads mismatched at
each read position. c, RPKM of exons, introns, and intergenic regions. d, Scatter plot shows
relative expression of 787 Refseq transcripts between brain and UHR samples as measured by
Taqman Gene Expression Assays and by mRNA-SEQ read counts. Expression in the two
samples was normalized to that of POLR2A, the control used in the Taqman assays. The
Pearson correlation coefficient and slope of the best fit linear regression line are shown.
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Figure S2. Assessment of frequency of alternative splicing in human genes.
a, Fraction of alternatively spliced genes binned by read coverage using a bin size
of 250 genes per bin. The upper asymptote of the sigmoid curve which best fits the
observed data was used to infer the true fraction of alternative spliced genes (1.0
using bin size of 250). To assess whether high coverage genes exhibit a different
fraction of alternative splicing, a subsampling approach was implemented (blue
x's). b, Results from curve fitting using different sized bins. The fraction of
alternatively spliced genes was estimated using bin sizes ranging from 50 to 500.
The mean and standard deviation of results from each bin size are displayed. c,
The fraction of alternatively spliced genes using only 9 tissue samples (black) or
random subsets of 9 out of all 14 samples (blue). Mean and standard deviations
after 100 randomizations are shown.
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Figure S3. Power to detect minor isoforms.
a, Estimated statistical power to detect minor isoforms as a function of expression level
(RPKM). A simulation was implemented to estimate the read coverage required to
detect minor isoforms at various minor isoform frequencies. At least two reads mapping
to at least two junction alignment positions were required for detection of both major and
minor isoform junctions. The simulation was performed using minor isoform frequencies
of 1%, 5%, 10%, and 20%, a sequence depth of 15M uniquely mapping reads, and an
average number of 20 unique positions within splicing junctions. b, Estimated power to
detect minor isoform of genes at varying expression levels and varying minor isoform
frequencies. c, Number of genes expressed above different RPKM thresholds for lymph
node, adipose, testes, and breast samples.
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1) Skipped exons were divided into 40 AIR. bins.
2) phastCons scores were obtained for regions surrounding skipped exons
3) For each region, pairwise comparisons were performed between the
skipped exons in each AIR. bin, measuring the difference in overall
phastCons score by using a Kolmogorov-Smimov test. P values for each
KS test were recorded.
4) For each region, the pairwise comparisons between each AIR, bin are
illustrated as heatmaps, in which color represents an increase in conserva-
tion with higher AIR, (red) or a decrease in conservation with higher
AIR. (blue), and intensity of color represents -log,,(p value).
AIR Bin
0.0
0.0 ~~pKS 4 e3
0.0 0.2 0.4 0.6 0.8 1.0
phastCons score
Illustrated above is an example comparison between skipped exons found in the
0.025-0.05 AIR bin and skipped exons found in the 0.125-0.15 AIR bin. The
cumulative distribution function of phastCons scores in the skipped axon region is
plotted for each group of skipped exons. There is increased conservation in the
skipped exons with higher AIR values, as indicated by the shift of the CDF to the
right and the significant p value
0 -og(p) 5
AIR. t, phastcons T
AIR. T, phastcons 1EA
Figure S4. Determination of a threshold for change in inclusion ratio indicative of tissue-biased function.
a, Outlined is the procedure by which we determined the threshold for the change in inclusion ratio as indicative of function. Essentially, skipped exons
were grouped by their maximum dynamic range in inclusion ratio (AiR), and queried for conservation in regions within and surrounding the skipped exons.
b, A Kolmogorov Smimov test was used to evaluate whether conservation of skipped exons in one AIR. bin was significantly greater or less than conserva-
tion of skipped exons in another AIR- bin. c, Results of the KS tests are displayed in the form of heat maps, where color denotes direction of the change
(increased conservation = red, decreased = blue), and intensity of color denotes significance. Clearly visible is the increased conservation in events having
AIR > 0.10 vs. events having AIR.- < 0.10, particularly in the intronic region directly upstream of the skipped exon, the intronic region directly downstream
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Figure S5. The power available to detect alternative mRNA processing.
a, Estimated statistical power to identify tissue-biased alternative events as a
function of increased read coverage. b, Cumulative frequency of read coverage per
gene locus in skeletal muscle and liver samples.
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1) Events were binned by coverage, ie the maximum number of reads mapping
to the event across tissues.
2) A sigmoid curve was fitted to the fraction of tissue-biased events in each bin
using the function:
a
1 + e-(x-*)" b
where F is the fraction of tissue-biased events, and a is the estimat
fraction of events which are tissue-biased.
3) The procedure was repeated such that a curve is fit for every bin
10, 11, 12 ... 50 total bins.
21 bins
a=.71810 bins I b i 2 nsa =.717 a=.717 a=.717
- Increasing # of bins (decreasing bin size)
4) The a values derived from all curve fittings across all bin sizes w
averaged.
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Figure S6. Estimation of the extent of tissue-bias in alternative transcript events.
a, The procedure for obtaining a robust estimate of the "true" fraction of tissue-biased events is outlined. The a values, or upper asymptotes of the sigmoid
curves, are displayed in a boxplot, along with means and standard deviations across 41 independent bin sizes. b, Examples of the analysis described in (A).
The fraction of events which are tissue-biased are plotted (black dots), along with their best fit sigmoid curves (red lines). Events are grouped by read coverage
into approximately 20 bins for all event types, except for RIs and MXEs, in which events are grouped into 10 bins.
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Figure S7. The extent of individual-specific differences in alternative isoform
expression.
Differential expression of alternative transcript events among anatomically distinct
tissues relative to cerebellar cortex samples from different individuals. The
fractions of differentially regulated skipped exon, MXE, ALE, and Tandem 3' UTR
events were estimated among 6 cerebellum samples (white bars), and compared
to the fractions estimated using 6 randomly selected tissues (out of 10). The mean
and standard deviation over 100 random trials are shown (black bars). The ratio
of tissue-specific vs. individual-specific regulation was observed to be lower for
event types not shown.
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Figure S8. SVD Analysis.
SVD analysis of vectors of inclusion ratios for five different mRNA
processing events and vector of expression levels for gene expression
across nine human tissues and five cell lines. Only events exhibiting
sufficient read coverage across all tissues and cell lines were used in the
analysis. Projections are shown in the dimensions corresponding to the two
leading eigenvalues. Cell lines are displayed as black circles and tissue
samples are gray.
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Tandem 3' UTRs biased in brain
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Figure S9. Enrichment of CTAAC motifs in 3' UTRs differentially processed in brain.
a, Shown is the enrichment of CTAAC occurrences (observed/expected) relative to motif
controls in the core and extension regions of tandem 3' UTRs that are tissue-biased in brain.
Double green arrows and a single green arrow denote the more commonly and less
commonly used cleavage and polyadenylation site used in the set of UTRs analyzed,
respectively. CTAAC is significantly enriched in the extension region of tandem 3' UTRs
biased towards distal pA site usage in brain, and in the core region of tandem 3' UTRs biased
towards proximal pA site usage in brain. b, CTAAC is significantly enriched in the upstream
intron and UTR region of alternative last exons biased towards distal pA usage in brain.
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Table S1. Origin of tissue samples.
Tissue
Adipose
Brain
Breast
Colon
Heart
Liver
Lymph node
Skeletal muscle
Testes
Cerebellum 1
Cerebellum 2
Cerebellum 3
Cerebellum 4
Cerebellum 5
Cerebellum 6
Sex
Female
Male
Female
Female
Male
Male
Female
Male
Male
Male
Male
Male
Male
Male
Male
Age (y)
73
23
29
68
77
37
86
77
19
48
50
33
43
47
27
Race
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
African American
Caucasian
Caucasian
African
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Table S2. Estimation of read mis-mapping frequency.'
General summary
No. simulated reads generated
No. of uniquely mapping simulated reads
No. of non-uniquely mapping simulated reads
No. unmapped reads allowing for 2 mismatches
No. reads
5057532
4992854
27694
36984
% reads
100.00%
98.72%
0.55%
0.73%
Statistics for unique mapping of simulated reads to genome or splice No. of mismatches (simulated vs. reference)
junctions allowing for 0, 1 or 2 mismatches 0 1 2 Total
Correct 3380064 1347875 260541 4988480
Incorrect 2788 1299 287 4374
% Correct 99.92% 99.90% 99.89% 99.91%
% Incorrect 0.08% 0.10% 0.11% 0.09%
Statistics for unique mapping of simulated reads to genome allowing No. of mismatches (simulated vs. reference)
for 0, 1 or 2 mismatches 0 1 2 Total
Correct 3145118 1255080 242746 4642944
Incorrect 2483 1151 259 3893
% Correct 99.92% 99.91% 99.89% 99.92%
% Incorrect 0.08% 0.09% 0.11% 0.08%
Statistics for unique mapping of simulated reads to splice junctions No. of mismatches (simulated vs. reference)
allowing for 0, 1 or 2 mismatches 0 1 2 Total
Correct
Incorrect
% Correct
% Incorrect
234946
305
99.87%
0.13%
92795
148
99.84%
0.16%
17795
28
99.84%
0.16%
345536
481
99.86%
0.14%
'Protocol described in Supplementary Information.
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Read coverage at the MBNL1 exon 3 locus by RNA-seq.
Read coverage across the MBNL1 exon 3 locus is illustrated for all 5 wild type
and MBNL1AE3AE3 mice in brain, heart, and muscle. The Xbal and BamHI sites
used for cloning of homologous arms are illustrated. Read coverage between
these regions is absent in MBNL1AE/AE3mie
Figure F-i: Read coverage at the MBNL1 exon 3 locus by RNA-seq.
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Cassette exon 'P In tissues and myoblasts depleted of MBNLs.
T values for cassette exons are illustrated, where x-axis values are derived from wild
type or control myoblasts, and y-axis values are derived from tissues or myoblasts
depleted of MBNLs, and size of points reflect Bayes Factor magnitude. The total
number of exons considered is shown above each scatter plot, and the number of
signficantly up- or down-regulated exons (Bayes Factor > 5, AT > 0.05) is shown in
the upper left and lower right comers, respectively.
Figure F-2: Cassette exon T in tissues and myoblasts depleted of MBNLs.
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A RNA-seq vs. MBNL1 knockout (Du et. al., 2010)
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Correlation in A' as estimated by RNA-seq and splicing microarray.
Cassette exon AY values derived from this study were compared to splicing change
"Separation Scores" derived from all 55 significantly regulated cassette exons
described in Du et. al., 2010. Comparisons were made between changes observed
following MBNL depletion in each sample and A) MBNL1 knockout relative to wild type
and B) HSALR relative to wild type experiments. Correlation R values are shown, along
with the numbers of cassette exons considered in each comparison.
Figure F-3: Correlation in AT as estimated by RNA-seq and splicing microarray.
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shRNA: C
a-UPF1
a-MBNL1
shRNA:
a-UPF1
a-MBNL2
MBNL protein levels in myoblasts depleted of MBNLs.
Western blots show levels of A) MBNL1 and B) MBNL2 relative to UPF1(loading control) in C2C12 mouse myoblasts depleted of MBNLs by lentivi-
ral shRNA.
Figure F-4: MBNL protein levels in myoblasts depleted of MBNLs.
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Correlation between extent of MBNL depletion and splicing changes or gene expres-
sion changes.
The correlation in extent of MBNL1, MBNL2, or MBNL1 + MBNL2 depletion was correlated
to changes in cassette exon T, gene expression changes, alternative 3' splice site usage,
and alternative 5' splice site usage following MBNL depletion. For the splicing analysis,
events expressed in all samples and significantly regulated (BF > 5, AT > 0.05) in at least
one sample were analyzed. For the gene expression analysis, genes exhibiting a 2-fold or
greater change were defined as "regulated".
Figure F-5: Correlation between extent of MBNL depletion and splicing changes or
gene expression changes.
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CO
H4
Tubulin
KDEL
Anillin
Patched
Western blot analysis of marker proteins in fly S2 cells.
Western blots were performed using lysates from each cellular
compartment. RNA was isolated from the cytosolic, mem-
brane, and insoluble compartments and prepared for RNA-
seq.
Figure F-6: Western blot analysis of marker proteins in fly S2 cells.
193
Appendix F. Supplementary Information for Transcriptome Regulation by MBNLs
CuP-seq, brain"9svJ
intron CDS
4.3e+05 2.le+05
(35.1%) (16.9%)
5' UTR
1,9e+04
(1L6%)
3' UTR
5.7e+05
(46.5%)
CLIP-seq, brainc57BL/6
intron
3.9e+04 CDs
(30.8%) 1.0e+04(8.0%)
5' UTR
1.2e+03
(1.0%)
3' UTR
7.6e+04
(60.3%)
CLIP-seq, heartc5tBL/6
Intron CDs
5' UTR
1.0e+03
(1.9%)
3'UTR
3.8e+04
(70.7%)
CLIP-seq, musclecr5BL/6
intron CDs
13e+04 5.9e+03
(30.6%) (14.0%)
5' UTR
1.0e+03(2.5%)
3' UTR
2.2e+04
(52.9%)
CLIP-seq, myoblasts
CDs
2.4e+ 05
intron (14.4%)
1.le+06 5' UTR
(65.5%) 2.7e+04(1.6%)
3'% UTR
3.le+05
(18.5%)
RNA-seq, brainB"l/'
CDS
8.6e+06 5' UTR(49.2%) 6.5e+05
(3.8%)
2intro "t2.5e+06 3'UTR
(14.3%) 5.7e+06
(32.7%)
RNA-seq, heartas5BL/6
Coo
1.2e+07 5' UTR
(65.6%) 6.4e+05(3.5%)
3' UTR
4.2e+06
Intran (22.9%)
1.5e+06(8.0%)
RNA-seq, muscec57BL/6
CDs
7.5e+06 5' UTR
(68.5%) 2.9e+05(2.7%)
ntron (24.8%)
4 .3e+05
(4.0%)
RNA-seq, myoblasts
CDs
7.6e+06 5' U'R
(59.3%) 4.6e+05(3.6%)
SUTR
Intron 3.le+06
1.6e+06 (24.5%)
(12.5%)
:r brain 129SVJ
3.0 - -
2.25
1.5 _
:r
0.757
0 8.0
-brain c57BL/6
4u .01I-
2.25
1.5
Ln0 .75
] 0.0
er hea rtl29SV
4 .0z 3  -
2.0
0 .0
z 4.5 -
4-0 -
z 1.5 -
cx 2
- (.0
Proportion of CLIP-seq reads mapping to regions of the transcriptome.
A) The number and percentage of reads mapping to 5' UTRs, CDS, introns, and 3' UTRs
is displayed for each CLIP-seq library in pie charts. B) Identical statistics for RNA-seq
libraries generated from similar tissues and myoblasts are also displayed in pie charts for
reference. C) The ratio of CLIP-seq vs. RNA-seq percent coverage in each region is
displayed in bars.
Figure F-7: Proportion of CLIP-seq reads mapping to regions of the transcriptome.
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